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Abstract 
The development of an expeditious and room-temperature conversion of aliphatic 
aldehydes to chiral terminal epoxides is described.  α-Chloroaldehydes were prepared via 
asymmetric enamine catalysis with an imidazolidinone catalyst followed by in situ 
reduction and cyclization to generate the terminal epoxide.  Epoxides with a variety of 
aliphatic groups and functionalities were produced in 75 minutes with good yields and 
excellent selectivities.  
The catalytic enantioselective direct α-fluorination of aldehydes and ketones is also 
reported.  α-Fluoroaldehydes were conveniently prepared via enamine catalysis with an 
imidazolidinone catalyst and N-fluorobenzenesulfonimide (NFSI) as an electrophilic 
fluorine source.  The method tolerated a wide variety of aldehyde substrates and functional 
groups.  Catalyst loadings as low as 1 mol% generated the fluorinated products in good 
yield and excellent enantioselectivity.  Additionally, various catalyst architectures were 
studied to apply the α-fluorination reaction to ketone substrates.  Cinchona alkaloid-
derived catalysts were found to successfully facilitate the α-fluorination of ketones in high 
yields and excellent enantioselectivities.   
 
Also presented is the advent of SOMO catalysis, a new mode of organocatalytic 
activation based on the catalytic generation of radical cations.  A secondary amine catalyst 
reacts with an aldehyde to transiently generate an enamine that, in turn, undergoes a single-
electron oxidation to yield a stabilized radical cation that is subject to enantiofacial 
discrimination.  While the parent enamine reacts only with electrophiles, the radical cation 
combines with SOMO nucleophiles at the same reacting center, thereby enabling a diverse 
range of previously unknown asymmetric transformations.  As a first example and proof of 
principle, the development of the direct and enantioselective α-allylation of aldehydes 
using SOMO catalysis is described. 
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Chapter 1  
Asymmetric Organocatalysis: New Modes of Chemical Activation 
 
Introduction 
 The chemical substances that make up living organisms are predominantly chiral 
and often exist as single enantiomers in the body.  For example, mammalian proteins are 
composed exclusively of L-amino acids and carbohydrates of D-sugars.  Mammals are 
unable to metabolize the L-enantiomer of sugars except via intestinal bacteria, which has 
made the sugars prospects for reduced-calorie substitutes.1 Intestinal bacteria are 
incapable of L-glucose metabolism, which results in the sugar’s powerful laxative 
qualities.2  Enzymes and receptors that control biological pathways are highly substrate 
specific and often will not recognize stereoisomers of their targets.  During the early 
years of pharmaceutical development, the importance of this biological phenomenon was 
not appreciated and due to the lack of methods for generating pure stereocenters, 
pharmaceuticals were produced and tested only in racemic forms.  However, racemic 
drug formulations contain a 50-50 mixture of two similar, yet distinct compounds that 
often act very differently within the body, the tragic consequences of thalidomide being 
the most infamous example.   Thalidomide was prescribed to pregnant mothers as an anti-
emetic for morning sickness between 1957 and 1961 and caused well over 10,000 cases 
                                                
1 Livesey, G.; Brown, J. C. J. Nutr. 1995, 125, 3020. 
2 Raymer, G. S.; Hartman, D. E.; Rowe, W. A.; Werkman, R. F.; Koch, K. L. Gastrointest. Endosc. 2003, 58, 30. 
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Figure 1.  Pharmaceuticals marketed as racemic mixtures.  Many were later marketed in the 
enantiopure form when generics of the racemic drug became available. 
 
of birth defects.3  It was later discovered that only the (S)-enantiomer of the drug is 
teratogenic.  Since that time, numerous racemic drug formulations have been marketed 
worldwide.  Due to required rigorous safety testing, drugs with toxic enantiomers like 
thalidomide no longer reach the consumer.  However, many racemic formulations have 
been marketed in which one enantiomer is inactive, in essence doubling the minimum 
effective dose.  History has shown that all pharmaceuticals have some degree of 
undesirable side effects, a risk that could be significantly reduced by removal of the 
unwanted enantiomer to provide a generally safer drug.  For this reason, the development 
of new methods for inducing asymmetric transformations has been a focal point of 
extensive research in the chemical field over the last several decades. 
 
                                                
3 Bren, L. Frances Oldham Kelsey: FDA Medical Reviewer Leaves Her Mark on History.  FDA Consumer–U.S. 
Food and Drug Admin. 2001, 35, No. 2. 
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Asymmetric Catalysis 
 Of the known methods for generating enantiomerically pure stereocenters from 
achiral starting materials, asymmetric catalysis is the most desirable for both cost and 
environmental reasons as a single chiral catalyst that is used in very small quantities can 
induce the production of large quantities of enantio-enriched material.  Additionally, 
catalysts are often reusable, resulting in a significant reduction in the amount of waste 
produced during the process compared to a stoichiometric reaction.  In order for an 
asymmetric catalyst to successfully induce chirality in the final desired product, the 
reaction rate of the uncatalyzed process must be significantly slower than the catalyzed 
reaction.  To achieve this, a catalyst must sufficiently activate one or more of the 
chemical reagents, attaining essentially new reactivity. 
 Over the years, chemists have invented a plethora of asymmetric catalytic 
reactions, yet most have been generated using relatively few chemical activation modes, 
such as metal-insertion, atom transfer, and Lewis acid catalysis.4  The importance of the 
discovery of these early activation modes on the field of chemical synthesis was 
demonstrated by the 2001 Nobel Prize in Chemistry being awarded to William S. 
Knowles, Ryoji Noyori, and K. Barry Sharpless for their “work on chirally catalyzed 
hydrogenation reactions” and “chirally catalyzed oxidation reactions.”5    
 Until recently, the field of asymmetric catalysis was predominated by chiral 
transition metal catalysts.  These metallic catalysts induce chirality via their enantiopure 
                                                
4 (a) Comprehensive Asymmetric Catalysis I–III; Jacobsen, E. N., Pfaltz, A., Yamamoto, H., Eds.; Springer-Verlag: 
Heidelberg, 1999. (b) Asymmetric Catalysis in Organic Synthesis; Noyori, R., Ed.; Wiley: New York, 1994. (c) 
Catalytic Asymmetric Synthesis, 2nd ed.; Ojima, I., Ed.; Wiley-VCH: New York, 2000.  
5 (a) Knowles, W. S. Angew. Chem. Int. Ed. 2002, 41, 1998. (b) Noyori, R. Angew. Chem. Int. Ed. 2002, 41, 2008. (c) 
Sharpless, K. B. Angew. Chem. Int. Ed. 2002, 41, 2024. 
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ligands, which are often expensive and difficult to synthesize.  The metals themselves are 
typically expensive and unstable to air and water in the atmosphere, which requires 
special handling and storage capabilities.  In addition, these catalysts are often difficult to 
isolate for reuse and their toxicity makes them especially undesirable in pharmaceutical 
manufacturing processes.  Luckily, these catalysts are typically highly efficient, such that 
only extremely small quantities are required for the synthesis of large amounts of desired 
material.   
 An alternative to metal catalysis that went almost completely unexplored until ten 
years ago is the field of organocatalysis, where the catalyst is itself an organic molecule.  
Organic molecules have the advantage of being insensitive to air and moisture, which 
makes handling them easier and the reactions performed with them more reproducible.  
The first organocatalyzed reaction was reported in 1912 by Bredig and Fiske, who found 
that cinchona alkaloids significantly accelerated the addition of HCN to benzaldehyde.6  
Since then, isolated examples of organocatalyzed reactions have been reported, but their 
general applicability to a wide range of organic transformations has only recently been 
realized.  For example, in 1971 Eder, Sauer and Wiechert discovered that the amino acid 
L-proline is capable of catalyzing asymmetric intramolecular aldol reactions.7  The 
reaction was not explored further for nearly thirty years, until Barbas et al. reported the 
proline-catalyzed intermolecular aldol condensation between ketones and aldehydes.8  
This sparked research efforts towards utilizing the enamine intermediate as an enolate 
                                                
6 Bredig, G.; Fiske, W. S. Biochem Z. 1912, 7. 
7 (a) Eder, U.; Sauer, G.; Wiechert, R. Angew. Chem. 1971, 83, 492; Angew. Chem. Int. Ed. 1971, 10, 496. (b) Hajos, 
Z. G.; Parrish, D. R. J. Org. Chem. 1974, 39, 1615. 
8 List, B.; Lerner, R. A.; Barbas, C. F. J. Am. Chem. Soc. 2000, 122, 2395. 
 
 
5 
surrogate, leading to many new asymmetric transformations, and the process became 
known as “enamine catalysis.” 
Organocatalytic Modes of Activation 
 In the last ten years, the field of organocatalysis has exploded from a few isolated 
reactions in the literature to a thriving new field of chemical research encompassing a 
broad range of useful reactions and unprecedented reactivities.9  In many respects, 
organic catalysts have been able to accomplish many of the same reactions and emulate 
many of the modes of reagent activation as metal catalysts.  More importantly, organic 
catalysts have also enabled new chemical reactivities that were historically unattainable 
with metal catalysts.  For example, emulating the atom transfer capabilities of transition 
metal catalysts (Figure 2), the ketone-catalyzed epoxidation and aziridination reactions 
developed by Shi (equation 1),10 Denmark,11 and Yang12 were among the first 
organocatalytic reactions to be widely used in organic synthesis community. 
O
OO
O
N
O
O
Boc
O
N
O
t-Bu
t-Bu
N
t-BuO
t-Bu
Mn
O
HH
dioxirane reactive species Metal-oxo reactive species
 
Figure 2.  Reactive species of the atom transfer reactions catalyzed by Shi’s 
chiral fructose-derived ketone catalyst and Jacobsen’s manganese salen catalyst. 
                                                
9 Asymmetric Organocatalysis, Berkessel, A., Gröger, H., Eds.; Wiley-VCH: Weinheim, 2005. 
10 (a) Tu, Y.; Wang, Z. X.; Shi, Y. J. Am. Chem. Soc. 1996, 118, 9806.  (b) Tian, H. Q.; She, X. G.; Shu, L.-H.; Yu, 
H. W.; Shi, Y. J. Am. Chem. Soc. 2000, 122, 11551.  (c) Hickey, M.; Goeddel, D.; Crane, Z.; Shi, Y. Proc. Natl. 
Acad. Sci. U.S.A. 2004, 101, 5794. 
11 Denmark, S. E.; Wu, Z. C. Synlett 1999, 847. 
12 Yang, D.; Wong, M. K.; Wang, X. C.; Tang, Y. C. J. Am. Chem. Soc. 1998, 120, 6611. 
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O
O
O
O
N
O
O
Boc
Me
Me
O
H
H
(1)
oxone
pH 10.5
20 mol% 1
100% conv.
91% ee
 
 Likewise, the traditional Lewis acid-catalyzed highest occupied molecular orbital 
(HOMO)-raising activation of carbonyls to form nucleophilic metal enolates is 
successfully mimicked by the reversible condensation of a secondary amine with a ketone 
or aldehyde, which tautomerizes to form a nucleophilic enamine (equations 2 and 3).  In 
addition to aldol reactions, this strategy has been successfully employed for many 
enantioselective transformations including Mannich-type reactions and α-heteroatom 
functionalization of ketones and aldehydes.13   
(2)Me
O
Me
O
LALewis acid (LA)
Me
O
R
N
H
R
+
+
Me
N
R
R
•HCl
substrate catalyst HOMO–activation
(3)
 
 Similar activation is achieved by ammonium enolates,14 which can be formed via 
nucleophilic addition of a tertiary amine to ketenes, α,β-unsaturated carbonyls, and α-
halogenated carbonyls (Figure 3a-c), or via deprotonation with an ammonium base as in 
phase-transfer catalyzed reactions (Figure 3d).15  Addition of N-heterocyclic carbenes to 
aldehydes generates a nucleophile of umpolung reactivity, enabling nucleophilic 
additions to the carbonyl carbon and enabling reactions such as the catalytic asymmetric 
                                                
13 Mukerjee, S.; Yang, J. W.; Hoffmann, S.; List, B. Chem. Rev. 2007, 107, 5471. 
14 Gaunt, M. J.; Johansson, C. C. C. Chem. Rev. 2007, 107, 5596. 
15 Maruoka, K.; Ooi, T. Angew. Chem. Int. Ed. 2007, 46, 4222. 
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benzoin condensation and Stetter reaction (Figure 3e).16  All of these HOMO-raising 
activation modes have now been applied to many different asymmetric transformations 
with great success. 
R
O
N
Me
O
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O NR3
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•
O
MeMe
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Me
Me
Me
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Br
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O
Ph
Ph
NR3 NR3 NR3
R
O
N
Ph
Ph
NR4OH
(a) (b) (c)
(d)
tertiary amine catalysis phase transfer catalysis
H R
O
R
OH
N
S
Me
Me
Me
(e)
N S
Me Me
Me
N-heterocyclic carbene catalysis
 
Figure 3.  Organocatalytic modes of HOMO-raising activation. 
 
 In contrast to the HOMO-raising modes of activation that generate activated 
nucleophiles, our lab simultaneously envisioned emulating the Lewis acid activation of 
electrophiles via the reversible condensation of a secondary amine catalyst with α,β-
unsaturated aldehydes and ketones to form activated iminium species (equations 4 and 5).  
This lowest unoccupied molecular orbital (LUMO)-lowering activation mode, termed 
“iminium catalysis,” proved broadly useful for the invention of many new 
organocatalytic reactions such as cycloadditions, Friedel Crafts alkylations, and  
(4)
O O
LALewis acid (LA)
O
R
N
H
R
+
+ N
R
R
•HCl
substrate catalyst LUMO–activation
(5)
 
                                                
16 (a) Marion, N.; Díez-González, S.; Nolan, S. P. Angew. Chem. Int. Ed. 2007, 46, 2988. (b) Enders, D.; Niemeier, 
O.; Henseler, A. Chem. Rev. 2007, 107, 5606. 
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heteroatom conjugate additions.17  Various other forms of LUMO-lowering activation of 
electrophiles have now come to fruition, such as H-Bonding and Brønsted acid catalysis18 
in which coordination of a hydrogen atom enhances a reagent’s electrophilicity, and 
Lewis base catalysis,19 in which the catalyst binds to a silicon atom, causing it to become 
a strong Lewis acid (Figure 4). 
N
N
H
N
H
St-Bu
HO
t-Bu OMe
O
N
Me
Me
thiourea Schiff base
N
NN
H
Ph Ph
bicyclic guanidine
O
O OH
OH
Ph Ph
Ph Ph
TADDOL
O
O
P
O
OH
Ar
Ar
BINOL phosphoric acids
HN
NH
O
O
Ph
N
HN
cyclic dipeptide
TfHN
Ph Ph
NHTf
bis-triflylamide
H-Bonding Catalysts
Brønsted Acid Catalysts
N
N
H
Me
Me
Me O
Ph
O
O
P
O
N
Ar
Ar
Lewis Base Catalyst
Me
(CH2)5
2Imidizolidinone
Iminium Catalyst
 
Figure 4.  Organocatalysts used in LUMO-lowering activation of electrophiles. 
 
Summary of Thesis Research 
 The following chapters describe applications of the HOMO-raising activation of 
enamine catalysis and the subsequent development of a new mode of organocatalytic 
activation, SOMO-catalysis.  Chapter 2 discusses the development of a rapid and 
enantioselective one-pot conversion of aliphatic aldehydes to terminal epoxides using the 
                                                
17 Lelais, G.; MacMillan, D. W. C. Aldrichimica Acta 2006, 39, 79. 
18 Doyle, A. G.; Jacobsen, E. N. Chem. Rev. 2007, 107, 5713. 
19 Denmark, S. E.; Beutner, G. L. Angew. Chem. Int. Ed. 2008, 47, 1560. 
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organocatalyzed α-chlorination of aldehydes as a chiral synthon intermediate.  Chapter 3 
details the development of the enantioselective α-fluorination of aldehydes using chiral 
imidizolidinone catalysts and electrophilic fluorinating agents.  Chapter 4 reports 
advancements towards the asymmetric α-fluorination of ketones by the identification of a 
suitable catalyst class.  Chapter 5 chronicles the invention of SOMO-catalysis, from 
concept to implementation, as a new mode of organocatalytic activation that enables an 
entirely new variety of catalytic asymmetric transformations and details the development 
of the enantioselective SOMO-catalyzed α-allylation of aldehydes as a proof of principle. 
  10 
Chapter 2  
Direct and Enantioselective Conversion of Aliphatic Aldehydes to 
Terminal Epoxides 
 
Introduction 
Epoxides constitute one of the most powerful synthons in synthetic organic 
chemistry.  Their ability to react with a wide range of nucleophiles stereospecifically to 
generate alcohol stereocenters has made epoxides a common intermediate in both organic 
synthesis1 and nature.2  Over the past few decades, a host of catalytic methodologies have 
been developed towards the asymmetric construction of epoxides3 and excellent 
selectivities have been achieved for a broad range of substrates including allylic 
alcohols,4 α,β-unsaturated carbonyls,5 and styrene derivatives.6  However, at the time of 
this work, there were surprisingly few methods for the catalytic enantioselective 
construction of terminal aliphatic epoxides.  For the past ten years, the state of the art for 
                                                
1 (a) Nicolaou, K. C.; Sorensen, E. J. Classics in Total Synthesis; VCH: Weinheim, 1996; pp 293–315.  (b) Nicolaou, 
K. C.; Snyder, S. A. Classics in Total Synthesis II; Wiley-VCH; Weinheim, 2003; pp 137–159. 
2 Stryer, L. Biochemistry; W. H. Freeman and Company; New York, 1995; pp 695. 
3 Jacobsen, E. N.; Pfaltz, A.; Yamamoto, H. Comprehensive Asymmetric Catalysis; Springer; Berlin, 1999; Vol. 2. 
4 (a) Katsuki, T.; Sharpless, K. B. J. Am. Chem. Soc. 1980, 102, 5974.  (b) Gao, Y.; Hanson, R. M.; Klunder, J. M.; 
Ko, S. Y.; Masamune, H.; Sharpless, K. B. J. Am. Chem. Soc. 1987, 109, 5765. 
5 Berkessel, A. in Asymmetric Synthesis: the Essentials; Christmann, M.; Braese, S., Eds.; Wiley-VCH; Weinheim, 
2007; pp 176–180. 
6 See reference 3 and (a) Rose, E.; Ren Q.-Z.; Andrioletti, B. Chem. Eur. J. 2004, 10, 224.  (b) Hickey, M.; 
Goeddel, D.; Crane, Z.; Shi, Y. Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 5794. (c) Bulman Page, P. C.; Buckley, B. 
R.; Blacker, A. J. Org. Lett. 2004, 6, 1543. 
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directly obtaining terminal epoxides in an enantioenriched form has been the cobalt(III)-
salen catalyzed kinetic resolution developed by Jacobsen (equation 1).7  With catalyst 
loadings as low as 0.2 mol%, epoxides can be obtained in exceedingly high 
enantioselectivities (98-99% ee) and isolated yields up to 46%.   
0.2 mol% 1
0.4 mol% AcOH
H2O, 12 h
Me
O
44% yield
98% ee
(1)Me
O
Me
OH
OH
50% yield
98% ee
N
O
t-Bu
t-Bu
N
t-BuO
t-Bu
Co
HH
1
 
Alternatively, Shi and coworkers have developed a two-step process for 
generating terminal epoxides via the ketone-catalyzed asymmetric epoxidation of 
vinylsilanes, which may be secondarily treated with tetrabutylammonium fluoride 
(TBAF) to reveal the terminal epoxide (equation 2).8  Excellent selectivities (up to 92% 
ee) in good-to-moderate yields were obtained but required catalyst loadings of 65 mol%.  
Subsequent to this work, Shi reported a single example of a direct enantioselective 
epoxidation of a terminal aliphatic olefin, vinylcyclohexanone, which was converted to 
the terminal epoxide in 93% yield and 71% ee (equation 3).9  However, this was the only 
aliphatic terminal epoxide the authors reported.10   
                                                
7 (a) Tokunaga, M.; Larrow, J. F.; Kakiuchi, F.; Jacobsen, E. N. Science 1997, 277, 936.  (b) Larrow, J. F.; Schaus, S. 
E.; Jacobsen, E. N. J. Am. Chem. Soc. 1996, 118, 7420.  (c) Robinson, D. E. J. E.; Bull, S. D. Tetrahedron Asymmetry 
2003, 14, 1407. 
8 Warren, J. D.; Shi, Y. J. Org. Chem. 1999, 64, 7675. 
9 (a) Tian, H.; She, X.; Yu, H.; Shu, L.; Shi, Y. J. Org. Chem. 2002, 67, 2435.  (b) Tian, H.; She, X.; Xu, J.; Shi, Y. 
Org. Lett. 2001, 3, 1929. 
10 Asymmetric epoxidation of terminal aliphatic olefins catalyzed by transition metals has recently been 
accomplished: (a) Calladon, M.; Scarso, A.; Sgarbossa, P.; Michelin, R. A.; Strukul, G. J. Am. Chem. Soc. 2006, 
128, 14006.  (b) Sawada, Y.; Matsumoto, K.; Katsuki, T. Angew. Chem. Int. Ed. 2007, 46, 4559.   
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65 mol% 2,
Oxone, K2CO3,
2
O
O
O
O
O
O
51-80% yield
84-92% ee
(2)
Et
R R
TMS
O
Et
pH 10, 0 ºC, 3 h
1)
2) TBAF
 
15 mol% 3,
Oxone, K2CO3
3
O
O
O
NBoc
O
O
93% yield
71% ee
(3)
O
pH 10, –10 ºC, 3.5 h
 
An alternative strategy for preparing unfunctionalized terminal epoxides is the 
base-induced cyclization of chiral halohydrins.  Corey and Helal developed a two-step 
process for the asymmetric synthesis of chiral halohydrins with subsequent cyclization to 
the oxirane under basic conditions (equation 4).11  The authors employed a catalytic 
oxazaborilidine reduction of trichloromethyl ketones to generate chiral trichlorohydrins 
that were subsequently dechlorinated under tin-mediated conditions to the chlorohydrin.  
After base-induced cyclization, three aliphatic terminal epoxides were prepared using this 
three-step, two-pot process in good-to-moderate yield (59–75% yield) and excellent 
stereoselectivity (90–96% ee). 
Bu3SnCl, NaCNBH3
CCl3R
(4)
R
O
AIBN, EtOH, reflux;
NaOH, EtOH
O 2)
N
B
O
n-Bu
Ph
PhH
4
10 mol% 4, catecholborane1)
75% yield
90% ee
O
59% yield
96% ee
O
67% yield
96% ee
O
 
                                                
11 Corey, E. J.; Helal, C. J. Tetrahedron Lett. 1993, 34, 5227. 
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5 mol%, acetone
–30 ºC, 6 h
O
H
O
H
n-Hex
O
Cl
Cl
Cl
Cl
Cl
Cl
n-Hex
Cl
1 equiv. 1.2 equiv. 71% yield, 92% ee
(5)
N
N
H
MeO
Ph
Me
Me
·TFA
6
5
 
Recently, our lab developed a direct organocatalytic α-chlorination of aldehydes 
using 5 mol% of imidazolidinone catalyst 6 and hexachlorocyclohexadieneone 5 as the 
chlorine source (equation 5).12  Like Corey’s trichloromethyl carbinols, we also saw our 
chiral chloroaldehydes as potential intermediates for the synthesis of important chiral 
synthons.  While most asymmetric processes are capable of synthesizing a single 
structure class, we envisioned the α-chloroaldehyde to be a modular platform from which 
a variety of asymmetric motifs could be constructed in situ (Figure 1).  We felt that the 
catalytic production of α-chloroaldehydes as intermediates during the synthesis of chiral 
motifs would be a viable alternative to the development of separate methodologies for 
each structure class.  In this manner, a variety of important chiral synthons could be 
produced from simple achiral aldehydes in a single transformation simply by changing 
the reaction conditions of the second step. 
H
Cl
O
ON
R
Cl
HO HO
NH2
O
terminal epoxidesterminal aziridines
chloro alcohols !-amino acids
enantiopure
!-chloroaldehyde  
Figure 1.  The α-chloroaldehyde as a platform for chiral structural diversity. 
                                                
12 (a) Brochu, M. P.; Brown, S. P.; MacMillan, D. W. C. J. Am. Chem. Soc. 2004, 126, 4108.  (b) Simultaneously 
developed by: Halland, N.; Braunton, A.; Bachmann, S.; Marigo, M.; Jørgensen, K. A. J. Am. Chem. Soc. 2004, 
126, 4790. 
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Initial Strategy   
Initially, our efforts towards the asymmetric conversion of simple achiral 
aldehydes into valuable chiral structural classes began with the synthesis of terminal 
aliphatic epoxides.  We envisioned that terminal epoxides might be accessed by a rapid 
three-step single transformation comprising a simple aldehyde reduction followed by 
base-induced cyclization, and that these chemical steps could be performed in situ 
without epimerization of the α-chloroaldehyde intermediate (equation 6) or the need for 
laborious chemical isolations and purifications. 
R
O
O
H
R
Cl
reduction;
(6)
versatile chiral
electrophile
O
H
R
simple
aldehydes
terminal
epoxides
cyclization;
 
Initially, we pursued a procedure using our published reaction conditions for the α-
chlorination using catalyst 6 at sub-ambient temperatures.  However, the optimal reaction 
medium for the α-chlorination is acetone, which itself can react with sodium borohydride 
(NaBH4) and other reducing agents used to convert the α-chloroaldehyde to the 
corresponding chlorohydrin.  As shown in Table 1,13 acetone and chloroform (CHCl3) are 
both optimal solvents for the α-chlorination reaction (entries 5–6) but both are unsuitable 
solvents for subsequent hydride reduction and basic conditions required for oxirane 
formation.  Dichloromethane (CH2Cl2) provides slightly lower conversion and 
enantioselectivity than acetone and CHCl3 (entry 4); however, its compatibility with the 
conditions for subsequent epoxide formation led us to select it as the reaction medium. 
                                                
13 Reproduced from: Iminium and Enamine Activation: Methods for Enantioselective Organocatalysis. Brown, S. P., Ph.D. 
Thesis: California Institute of Technology, Pasadena, CA, 2005. 
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Table 1.  Survey of Solvents with Catalyst 613 
EtOAc
THF
toluene
CH2Cl2
CHCl3
acetone
entry
1
2
3
4
5
6
87
89
89
90
92
92
% eeb
93
56
83
86
91
93
% conversionasolvent
5 mol% 6
0.5M solvent
–30 ºC
O
H
O
H
n-Hex
O
Cl
Cl
Cl
Cl
Cl
Cl
12
18 
18
8
8
7
time (h)
n-Hex
Cl
1 equiv. 1.2 equiv. 5
 
(a) Conversion determined by GLC analysis relative to an internal 
standard (benzyl methyl ether).  (b) Enantiomeric excess determined 
by GLC analysis (Bodman G-TA). 
Next, a sampling of bases for affecting the epoxidation from the halohydrin was 
studied to determine conditions that could be successfully applied in situ after a NaBH4 
reduction (Table 2).  A 50% solution of potassium hydroxide (KOH) was found to give the 
highest levels of conversion (entry 1) and a time study of the reduction and cyclization 
steps found that they were each completed in 30 min at ambient temperature.  Longer 
cyclization reaction times resulted in reduced conversions due to unwanted epoxide 
opening and diol formation.  While adequate levels of conversion to the desired terminal  
Table 2.  Comparison of Bases for Oxirane Formation 
50% aq. KOH
50% aq. NaOH
25% NaOMe in MeOH
21% NaOEt in EtOH
entry
1
2
3
4
89
81
59
71
% conversionabase
NaBH4, CH2Cl2, EtOH;
O
H
n-Hexn-Hex
O
Cl
Base
 
(a) Conversion determined by GLC analysis with tridecane as an 
internal standard. 
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epoxide from the chloroaldehyde intermediate could now be achieved, the α-chlorinations 
were necessarily conducted at or below –30 ºC to obtain adequate levels of 
enantioselectivity; at warmer temperatures catalyst 6 readily epimerizes the α-chloro 
stereocenter, and complete racemization occurs in only a few hours.13  However, the 
necessary warming of the reactions during the reduction of the chloroaldehyde to the 
chlorohydrin resulted in a decrease in enantioselectivity.  To maintain high levels of 
selectivity during the reduction step, it was necessary to use pre-cooled ethanol (EtOH) and 
the reactions were slowly warmed to 0 ºC over a period of an hour to maintain the desired 
enantiopurities of the final epoxides.  After base-induced oxirane formation, aqueous 
workup and purification, terminal epoxides were isolated in good yields and high 
selectivities.  While enantioselectivities for the octanal-derived oxirane were consistently 
high at 90% ee, expansion of the substrate scope to include a variety of functionalized 
oxiranes led to difficulties with reproducibility and often inconsistent results (equations 7 
and 8). 
10 mol% 6,
CH2Cl2, –30 ºC;
O
Cl
Cl
Cl
Cl
Cl
Cl
Ph
1 equiv. 1.2 equiv. 5 64-98% ee
(7)O
NaBH4, EtOH;
50% KOH
H
O
 
10 mol% 6,
CH2Cl2, –30 ºC;
O
H
O
Cl
Cl
Cl
Cl
Cl
Cl
ADM
1 equiv. 1.2 equiv. 5 82-88% ee
(8)
NaBH4, EtOH;
50% KOH
O
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Improved Strategy 
During the course of this work, graduate student Sean Brown began work on 
developing a new imidazolidinone catalyst that would be capable of maintaining high 
levels of enantioselectivity while being less apt to epimerize products after their formation.  
It was proposed that increasing the steric bulk of the catalyst would decrease the 
nucleophilicity of the amine, thereby reducing the propensity to reform enamine with the 
α-chloroaldehyde product.  Catalyst 7 was developed as a pseudo C2-symmetric catalyst in 
which the nitrogen lone pair is less accessible due to the bulky tert-butyl group (Figure 2). 
N
N
H
Me O
Me
Me
Me
N
N
H
MeO
Ph
Me
Me
catalyst 6 catalyst 7
·TFA
·TFA
Me
Increased steric bulk
Less nucleophilic amine
 
Computational model of catalyst 6 Computational model of catalyst 7
Increased
steric bulk
decreased 
nucleophilicity
 
Figure 2. 3D models showing increased coverage of the nitrogen 
lone pair in catalyst 7 compared to catalyst 6. 
Notably, catalyst 7 was found to successfully affect the α-chlorination of aldehydes 
with excellent enantioselectivities, at ambient temperature.13  In addition, the α-chloro 
stereocenter was stable for at least 2 hours at room temperature in the presence of catalyst 
7, as opposed to the rapid epimerization observed with catalyst 6.  Additionally, optimal 
solvents for the α-chlorination reaction with catalyst 6 were acetone and CHCl3; however, 
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neither solvent is compatible with the single transformation procedure for terminal 
epoxides and a less optimal solvent providing lower enantioselectivities was chosen for the 
three-step process.  In contrast, reactions using catalyst 7 were found to work exceedingly 
well in tetrahydrofuran (THF), diethyl ether (Et2O), and ethyl acetate (EtOAc).13 
In order to reduce the overall time needed for the three-step construction of terminal 
epoxides, the effect of concentration on the α-chlorination was evaluated and showed that 
complete conversion to the α-chloroaldehyde was obtained in 15 minutes using only 2.5 
mol% of catalyst 7 without affecting the enantioselectivity of the reaction (Table 3). 
Notably, the use of catalyst 7 in THF achieved 96% ee for octanal, as opposed to 89% ee 
with catalyst 6 in THF and 90% ee in CH2Cl2.  Also, since the reaction was now performed 
at ambient temperature, the reduction step could now be conducted in only 30 minutes as 
the slow warming process was no longer necessary to prevent epimerization.  Using these 
new conditions, reaction times were reduced to a 15 minute α-chlorination, 30 minute 
NaBH4, reduction and 30 minute cyclization for a total overall reaction time of 75 minutes.   
Table 3. Effect of Concentration using Catalyst 7 
0.5 M
0.75 M
1 M
1.5 M
2 M
2.5 M
entry
1
2
3
4
5
6
96
96
96
96
96
96
% eeb
82
89
93
96
97
97
% conversionaconcentration
2.5 mol% 7
THF, 23 ºC
15 min
O
H
O
H
n-Hex
Cl
Cl
Cl
Cl
Cl
Cl
n-Hex
Cl
1 equiv. 1.2 equiv. 5
O
 
(a) Conversion determined by GLC analysis relative to an internal 
standard (benzyl methyl ether).  (b) Enantiomeric excess 
determined by GLC analysis (Bodman Γ-TA). 
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Table 4.  Enantioenriched Terminal Epoxides: Substrate Scope 
entry % yield % ee
1
2
3
4
5
6
83
82
78
76
77
96a
94
92
94
95
93
94
product
7 75 93OMOM
NHBoc
6
6
Me
O
O
O
O
O
O
8 83 95
9 81 >99b
O
10 86a 96
3
O
Me
O
Et
O
O
OMe
OMe
11 50c 89
NBoc
O
4
6
7
3
reactant
OMOM
NHBoc
6
6
Me
3
Me
Et
OMe
OMe
NBoc
4
6
7
3
O
O
O
O
O
O
O
O
O
O
O
O
NaBH4, 0 ºC, 30 min;
O
H
R
R
O
KOH, 25 ºC, 30 min
1.2 eq. 5, 25 ºC, 15 min;
2.5 mol% 7
N
N
H
OMe
Met-Bu
 
(a) Total reaction time of 90 min.  (b) 10:1 dr.  (c) α-Chlorination 
using 20 mol% catalyst 6, –40 ºC for 12 hr. 
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Finally, reactions were performed using a variety of structurally diverse aldehydes 
to determine the generality of this new protocol.  As shown in Table 4, the reaction was 
found to be general for a broad range of functionalities including protected amines (entries 
8 and 10), labile ethers (entry 7), and alkynes (entry 4).  Sterically hindered substrates were 
also provided in excellent selectivities (entries 10 and 11), although the adamantyl substrate 
was a poor substrate for catalyst 7 and the initial protocol using catalyst 6 was used to 
provide the desired adamantyl epoxide.  A bis-terminal epoxide was successfully 
synthesized using this new method in high yield and excellent selectivity (entry 9) and 
aromatic substrates were also obtained, with no evidence of electrophilic aromatic 
substitution on even highly electron-rich benzene rings (entries 5–6).  Notably, while the 
generation of olefinic epoxides using typical olefin epoxidation methods is difficult to 
achieve due to regioselectivity requirements, such substrates are easily prepared using this 
new technology, which showed no evidence of olefin isomerization under the reaction 
conditions (entries 2 and 3). 
 
Conclusion 
In summary, the rapid enantioselective synthesis of chiral terminal epoxides from 
simple achiral aldehydes in a single transformation has been accomplished, providing the 
first example of the α-chloroaldehyde intermediate as a valuable chiral synthon.  The use of 
a trans-imidazolidinone catalyst enabled the asymmetric chlorination of aldehydes at 
ambient temperatures in only fifteen minutes without product epimerization and allowed 
the development of a rapid, 75-minute one-pot protocol for constructing terminal aliphatic 
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epoxides. Using this new protocol, terminal epoxides containing a wide variety of 
functionalities including olefins, alkynes, and aromatic rings were easily prepared in good 
yields and excellent enantioselectivities.14 
 
                                                
14 Recently and subsequent to the completion of this work, a three-step synthesis of trans-epoxides was reported 
employing chlorohydrins as intermediates: Kang, B.; Britton, R. Org. Lett. 2007, 9, 5083. 
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S u p p o r t i n g  I n f o r m a t i o n  
General Information.  Commercial reagents were distilled prior to use following the 
guidelines of Perrin and Armarego.15  Organic solutions were concentrated under reduced 
pressure on a Büchi rotary evaporator. Chromatographic purification of products was 
accomplished using forced-flow chromatography on EMD Silica Gel 60 230-400 mesh or 
Iatrobeads 6RS–8060 according to the method of Still.16 Thin-layer chromatography 
(TLC) was performed on EM Reagents 0.25 mm silica gel 60-F plates.  Visualization of 
the developed chromatogram was performed by fluorescence quenching, ceric 
ammonium molybdate, or anisaldehyde stain.  High performance liquid chromatography 
(HPLC) and gas liquid chromatography (GLC) assays to determine enantiometric excess 
were developed using racemic samples. 
1H and 13C NMR spectra were recorded on Varian Mercury 300 (300 MHz and 75 
MHz respectively) as noted, and are internally referenced to residual protio solvent 
signals.  Data for 1H are reported as follows: chemical shift (δ ppm), multiplicity (s = 
singlet, d = doublet, t = triplet, q = quartet, m = multiplet), integration, coupling constant 
(Hz), and assignment.  Data for 13C NMR are reported in terms of chemical shift.  IR 
spectra were recorded on a Perkin Elmer Spectrum BX FT-IR spectrometer and are 
reported in terms of frequency of absorption (cm-1).  Mass spectra were obtained from the 
California Institute of Technology Mass Spectral Facility.  Gas liquid chromatography 
(GLC) was performed on a Hewlett-Packard 6850 Series gas chromatograph equipped 
                                                
15 Perrin, D. D.; Armarego, W. L. F.  Purification of Laboratory Chemicals, 3rd edition; Pergamon Press; Oxford, 1988. 
16 Still, W. C.; Kahn, M.; Mitra, A. J. J. Org. Chem. 1978, 43, 2923. 
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with a split-mode capillary injection system and flame ionization detectors using a 
Bodman Chiraldex Γ-TA (30 m 0.25 mm) column.  High performance liquid 
chromatography (HPLC) was performed on a Hewlett Packard 1100 Series 
chromatograph using a Chiralcel®OD-H, Chiralcel®OJ or Chiralpak®AD column (25 cm, 
5 cm guard), as noted. 
 
Starting Materials 
 10-(Methoxymethoxy)decanol:  To a flask containing 1,10-decanediol (5.00 g, 
28.7 mmol) and diisopropylethylamine (6.00 mL, 17.2 mmol) in CH2Cl2 (30 mL) was 
slowly added chloromethyl methyl ether (1.09 ml, 14.3 mmol) at 0 °C.  The solution was  
warmed to room temperature and stirred for 12 h.  The reaction was then treated with 
saturated aqueous NH4Cl, extracted with CH2Cl2 (3 × 100 mL), dried over Na2SO4, and 
concentrated in vacuo. The resulting residue was purified by silica gel chromatography 
(20–40% EtOAc/hexanes) to provide 10-(methoxymethoxy)decan-1-ol.  IR (film) 3435, 
2929, 2855, 2360, 1466, 1385, 1214, 1148, 1112, 1045, 920.5, 722.1 cm-1; 1H NMR (300 
MHz, CDCl3) δ 4.61 (s, 2H, CH2OMe), 3.62 (t, 2H, J = 6.7 Hz, CH2OH), 3.50 (t, 2H, J = 
6.7 Hz, CH2CH2O), 3.35 (s, 3H, CH3), 1.65–1.21 (m, 16H, (CH2)8CH2OH); 13C NMR (75 
MHz, CDCl3) δ 96.35, 67.85, 55.05, 32.76, 29.70, 29.49, 29.47, 29.37, 26.16, 25.69; 
HRMS (FAB+) exact mass calculated for (C12H25O3) [(M+H)-H2]+  requires m/z 
217.1804, found m/z 217.1796.   
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10-(Methoxymethoxy)decanal:  To a flask containing 10-
(methoxymethoxy)decan-1-ol (1.46 g, 6.70 mmol) in CH2Cl2 (7.0 mL) was added 
TEMPO (105 mg, 0.670 mmol) followed by iodobenzene diacetate (2.36 g, 7.30 mmol).  
The reaction was stirred for 1 h and then diluted with CH2Cl2 (50 mL). Saturated aqueous 
solution of Na2S2O3 (50 mL) was added and extracted with CH2Cl2 (3 × 25 mL).  The 
combined organics were washed with saturated aqueous NaHCO3 (75 mL) and brine (75 
mL), dried over Na2SO4, and concentrated in vacuo.  The resulting residue was purified 
by silica gel chromatography (15% EtOAc/hexanes) to provide the title compound.  IR 
(film) 2929, 2856, 2718, 2360, 1726, 1466, 1389, 1214, 1147, 1111, 1044, 919.3, 723.1, 
668.1 cm-1; 1H NMR (300 MHz, CDCl3) δ 9.76 (t, 1H, J = 1.9 Hz, CHO), 4.62 (s, 2H, 
CH2OMe), 3.51 (t, 2H, J = 6.6 Hz, CH2CH2O), 3.36 (s, 3H, CH3), 2.42 (dt, 2H, J = 1.9, 
7.2 Hz CH2CHO), 1.68–1.54 (m, 4H, CH2CH2CHO, CH2CH2O), 1.40–1.24 (m, 10H, 
(CH2)5CH2CH2O); 13C NMR (75 MHz, CDCl3) δ 202.8, 96.34, 67.79, 55.02, 43.84, 
29.67, 29.29, 29.23, 29.08, 26.13, 22.01; HRMS (EI+) exact mass calculated for [M+•]+ 
(C12H24O3) requires m/z 216.1726, found m/z 216.1716. 
 
Dodec-9-ynal:  To a flask containing dodec-9-yn-1-ol (4.56 g, 25.0 mmol) in 
CH2Cl2 (25 mL) was added TEMPO (390 mg, 2.50 mmol) followed by iodobenzene 
diacetate (8.86 g, 27.5 mmol).  The reaction was stirred 1 h and then diluted with CH2Cl2 
(100 mL). Saturated aqueous solution of Na2S2O3 (100 mL) was added and extracted with 
CH2Cl2 (3 × 50 mL).  The combined organics were washed with saturated aqueous 
NaHCO3 (150 mL) and brine (150 mL), dried over Na2SO4, and concentrated in vacuo.  
The resulting residue was purified by silica gel chromatography (5% Et2O/pentanes) to 
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provide the title compound.  IR (CH2Cl2) 3052, 2978, 2937, 2859, 1710, 1435, 1266, 
896.4, 747.2, 735.7, 705.3 cm-1; 1H NMR (300 MHz, CDCl3) δ 9.76 (t, 1H, J = 1.9 Hz, 
CHO), 2.42 (dt, 2H, J = 1.9, 7.2 Hz, CH2CHO), 2.20–2.09 (m, 4H, CH2CH2CC, 
CH2CH3), 1.68–1.26 (m, 10H, (CH2)5CH2CHO), 1.11 (t, 3H, J = 7.1 Hz, CH3); 13C NMR 
(75 MHz, CDCl3) δ 202.8, 81.64, 79.33, 43.82, 28.99, 28.96, 28.81, 28.53, 21.97, 18.63, 
14.32, 12.35; HRMS (EI+) exact mass calculated for [M+•]+ (C12H20O) requires m/z 
180.1514, found m/z 180.1507. 
 
tert-Butyl 10-Formyldecylcarbamate:  To a flask containing 11-tert-
butoxycarbonylamino-undecanoic acid (3.60 g, 12.0 mmol) in CH2Cl2 (120 mL) was 
added N,O-dimethylhydroxylamine hydrochloride (1.30 g, 13.2 mmol) followed by 1-[3-
(dimethylamino)propyl]-3-ethylcarbodiimide hydrochloride (2.30 g, 12.0 mmol), 4-
dimethylaminopyridine (59.0 mg, 0.480 mmol), and diisopropylethylamine (2.30 mL, 
13.2 mmol).  The reaction was stirred 12 h and then diluted with CH2Cl2 (300 mL). The 
reaction was washed with water (2 × 100 mL), saturated aqueous citric acid solution (100 
mL) and brine (100 mL), dried over Na2SO4, and concentrated in vacuo to obtain an oily 
residue.  THF (60 mL) was added and the solution cooled to 0 °C.  LiAlH4 (1.03 g, 27.1 
mmol) was added in portions and stirred 2 h.  20% aqueous citric acid solution was added 
slowly (300 mL) and stirred vigorously for 30 min.  The reaction was diluted with 20% 
aqueous citric acid solution (200 mL) and extracted with Et2O (3 × 150 mL).  The 
combined organics were washed with saturated NaHCO3 solution (150 mL), brine (150 
mL), dried over Na2SO4, and concentrated in vacuo to obtain the title compound.  IR 
(film) 3374, 2978, 2918, 2850, 2361, 1720, 1681, 1517, 1463, 1390, 1366, 1250, 1172, 
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1042, 864.5, 783.1, 725.0, 666.4 cm-1; 1H NMR (300 MHz, CDCl3) δ 9.78 (t, 1H, J = 1.9 
Hz, CHO), 4.54 (s, 1H, NH), 3.13 (q, 2H, J = 6.7 Hz, CH2NH), 2.45 (dt, 2H, J = 1.9, 7.4 
Hz, CH2CHO), 1.76–1.22 (m, 25H, (CH2)8CH2CHO, C(CH3)3); 13C NMR (75 MHz, 
CDCl3) δ 202.8, 155.9, 78.91, 43.83, 40.56, 30.01, 29.38, 29.24, 29.18, 29.07, 28.37, 
26.71, 22.00; HRMS (CI+) exact mass calculated for [M+•]+ (C16H31NO3) requires m/z 
285.2304, found m/z 285.2312. 
 
Nonanedial:  To a flask containing nonane-1,9-diol (2.40 g, 15.0 mmol) in 
CH2Cl2 (30 mL) was added TEMPO (351 mg, 2.25 mmol) followed by iodobenzene 
diacetate (10.15 g, 31.5 mmol).  The reaction was stirred for 2 h and then diluted with 
CH2Cl2 (100 mL). Saturated aqueous solution of Na2S2O3 (100 mL) was added and 
extracted with CH2Cl2 (3 × 50 mL).  The combined organics were washed with saturated 
aqueous NaHCO3 (150 mL) and brine (150 mL), dried over Na2SO4, and concentrated in 
vacuo.  The resulting residue was purified by silica gel chromatography (20–40% 
Et2O/pentanes) to provide the title compound, which was identical to the known literature 
compound.17 
 
tert-Butyl 4-(formylmethyl)piperidine-1-carboxylate:  To a flask containing 
tert-butyl 4-(2-hydroxyethyl)piperidine-1-carboxylate (4.40 g, 19.2 mmol) in CH2Cl2 (20 
mL) was added TEMPO (300 mg, 1.92 mmol) followed by iodobenzene diacetate (6.80 
g, 21.1 mmol).  The reaction was stirred 3 h and then diluted with CH2Cl2 (100 mL). 
Saturated aqueous solution of Na2S2O3 (100 mL) was added and extracted with CH2Cl2 (3 
                                                
17 Roels, J.; Metz, P. Syn. Lett. 2001, 6, 789. 
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× 50 mL).  The combined organics were washed with saturated aqueous NaHCO3 (150 
mL) and brine (150 mL), dried over Na2SO4, and concentrated in vacuo.  The resulting 
residue was purified by silica gel chromatography (40–70% Et2O/pentanes) to provide the 
title compound, which was identical to the reported literature compound.18  13C NMR (75 
MHz, CDCl3) δ 201.5, 154.7, 79.37, 50.31, 43.68, 31.86, 30.63, 28.39. 
 
Terminal Epoxides 
General Procedure for Epoxide Formation: To a 10 mL round-bottom flask 
equipped with a magnetic stir bar and charged with (2R,5S)-2-tert-butyl-5-methyl-3-
methylimidazolidin-4-one 7 (8.6 mg, 0.05 mmol) and THF (0.8 mL) was added TFA (5.8 
mg, 0.05 mmol) followed by 2,3,4,5,6,6-hexachloro-2,4-cyclohexadien-1-one 5 (722 mg, 
2.4 mmol).  The aldehyde substrate (2.0 mmol) was added and the reaction mixture 
stirred 15 min.  The reaction was cooled to 0 °C and diluted with 0.4 mL THF and 
0.8 mL EtOH.  NaBH4 (189 mg, 5.0 mmol) was added and after 5 min the resulting 
suspension warmed to 25 °C and stirred an additional 25 min.  50% aqueous KOH 
solution (5 mL) was added and stirred vigorously for 30 min, drawing the organic phase 
completely into the aqueous phase.  The cloudy suspension was allowed to separate and 
10 mL of H2O was added.  The solution was extracted 3 times with Et2O (10 mL) and the 
combined organics dried over Na2SO4.  Filtration was followed by concentration in vacuo 
to afford a yellow oil that was then purified by forced flow chromatography to afford the 
                                                
18 Sato, T.; Okamoto, K.; Nakano, Y.; Uenishi, J.; Ikeda, M. Heterocycles 2001, 54, 747. 
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title compounds.  The enantioselectivity was determined either by chiral GLC analysis, or 
chiral HPLC analysis after epoxide opening with naphthalene-2-thiol. 
 
Me
6
O  
(R)-2-Nonyloxirane (Table 4, entry 1):  Prepared according to the general 
procedure from undecanal (206 µL, 1.0 mmol) to afford a yellow oil.  Purification on 
silica gel (5% Et2O/pentanes) afforded (R)-2-nonyloxirane as a colorless liquid (142 mg, 
83% yield, 94% ee).  IR (film) 3043, 2956, 2926, 2855, 1466, 1410, 1378, 1259, 1129, 
916.4, 836.9, 722.0 cm-1; 1H NMR (300 MHz, CDCl3) δ 2.93–2.87 (m, 1H, OCHCH2), δ 
2.74 (dd, 1H, J = 4.1, 5.1 Hz, OCHCH2), δ 2.46 (dd, 1H, J = 2.8, 5.0 Hz, OCHCH2), δ 
1.57–1.20 (m, 16H, (CH2)8CH3), δ 0.88 (t, J = 7.2 Hz, 3H, CH3); 13C NMR (75 MHz, 
CDCl3) δ 52.40, 47.12, 32.49, 31.87, 29.55, 29.50, 29.44, 29.29, 25.96, 22.66, 14.09; 
HRMS (CI+) exact mass calculated for [M+H]+ (C11H23O) requires m/z 171.1749, found 
m/z 171.1746.  [α]D = +5.88 (c = 1.0, CHCl3).  Enantiopurity was determined by chiral 
HPLC analysis of the 1-naphthyl-2-hydroxyundecane derivative (Chiralcel®OD-H 
Isocratic 5% IPA/hexanes).  tR(minor) = 11.9 min.  tR(major) = 14.2 min. 
 
6
O  
(R)-2-(Non-8-enyl)oxirane (Table 4, entry 2):  Prepared according to the general 
procedure from undec-10-enal (416 µL, 2.00 mmol) to afford a yellow oil.  Purification 
on silica gel (5% Et2O/pentanes) afforded (R)-2-(non-8-enyl)oxirane as a colorless liquid 
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(277 mg, 82% yield, 92% ee).  IR (film) 3584, 3077, 3044, 2977, 2928, 2856, 1641, 
1465, 1411, 1259, 994.3, 909.8, 836.4, 665.8 cm-1; 1H NMR (300 MHz, CDCl3) δ 5.81 
(ddt, 1H, J = 6.7, 10.1, 17.3 Hz, CH2CH=CH2), δ 5.03–4.96 (m, 1H, CH=CH2), δ 4.96–
4.91 (m, 1H, CH=CH2), δ 2.93–2.87 (m, 1H, OCHCH2), δ 2.74 (dd, 1H, J = 2.9, 5.1 Hz, 
OCHCH2), δ 2.46 (dd, 1H, J = 2.9, 5.1 Hz, OCHCH2), δ 2.07–2.00 (m, 2H, 
CH2CH=CH2), δ 1.56–1.31 (m, 12H, OCH(CH2)6); 13C NMR (75 MHz, CDCl3) δ 139.1, 
114.1, 52.33, 47.06, 33.74, 32.45, 29.35, 28.97, 28.84, 25.92; HRMS (CI+) exact mass 
calculated for [M+H]+ (C11H21O) requires m/z 169.1592, found m/z 169.1596.  [α]D = 
+7.12 (c = 1.0, CHCl3).  Enantiopurity was determined by chiral HPLC analysis of the 1-
naphthyl-2-hydroxyundec-10-ene derivative (Chiralcel®OD-H Isocratic 5% 
IPA/hexanes).  tR(minor) = 14.1 min.  tR(major) = 17.5 min. 
 
3
O
Me  
(R)-2-((Z)-Oct-5-enyl)oxirane (Table 4, entry 3): Prepared according to the 
general procedure from (Z)-dec-7-enal (366 µL, 2.00 mmol) to afford a yellow oil.  
Purification on silica gel (5% Et2O/pentanes) afforded (R)-2-((Z)-oct-5-enyl)oxirane as a 
colorless liquid (240 mg, 78% yield, 94% ee).  IR (film) 3369, 2932, 2861, 2360, 1461, 
1413, 1373, 1260, 1137, 1066, 968.3, 915.0, 833.4, 668.0 cm-1; 1H NMR (300 MHz, 
CDCl3) δ 5.42–5.27 (m, 2H, CH=CHEt), δ 2.93–2.87 (m, 1H, OCHCH2), δ 2.75 (dd, 1H, 
J = 4.0, 5.1 Hz, OCHCH2), δ 2.46 (dd, 1H, J = 2.9, 5.1 Hz, OCHCH2), δ 2.08–1.99 (m, 
4H, CH2CH=CHCH2), δ 1.58–1.35 (m, 6H, OCH(CH2)3), δ 0.95 (t, J = 7.4 Hz, 3H, CH3); 
13C NMR (75 MHz, CDCl3) δ 131.9, 128.8, 52.31, 47.11, 32.38, 29.51, 26.94, 25.56, 
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20.50, 14.35; HRMS (CI+) exact mass calculated for [M+H]+ (C10H19O) requires m/z 
155.1436, found m/z 155.1430.  [α]D = +7.95 (c = 1.0, CHCl3).  Enantiopurity was 
determined by chiral HPLC analysis of the 1-naphthyl-2-hydroxyoct-5-ene derivative 
(Chiralcel®OD-H Isocratic 2% IPA/hexanes).  tR(minor) = 30.2 min.  tR(major) = 43.7 
min. 
 
O
Et
4
 
(R)-2-(Dec-7-ynyl)oxirane (Table 4, entry 4): Prepared according to the general 
procedure from dodec-9-ynal (405 µL, 2.00 mmol) to afford a yellow oil.  Purification on 
silica gel (5-10% Et2O/pentanes) afforded (R)-2-(dec-7-ynyl)oxirane as a colorless liquid 
(275 mg, 76% yield, 95% ee).  IR (film) 3044, 2975, 2934, 2858, 1462, 1410, 1320, 
1260, 1131, 1063, 916.6, 834.6 cm-1; 1H NMR (300 MHz, CDCl3) δ 2.93–2.87 (m, 1H, 
OCHCH2), δ 2.74 (dd, 1H, J = 4.0, 5.1 Hz, OCHCH2), δ 2.46 (dd, 1H, J = 2.7, 5.1 Hz, 
OCHCH2), δ 2.20–2.11 (m, 4H, CH2CCCH2), δ 1.59–1.30 (m, 10H, OCH(CH2)5), δ 1.11 
(t, J = 7.2 Hz, 3H, CH3); 13C NMR (75 MHz, CDCl3) δ 81.68, 79.38, 52.35, 47.13, 32.41, 
28.96, 28.93, 28.69, 25.84, 18.65, 14.36, 12.39; HRMS (CI+) exact mass calculated for 
[M+H]+ (C12H21O) requires m/z 181.1592, found m/z 181.1589.  [α]D = +6.97 (c = 1.0, 
CHCl3).  Enantiopurity was determined by chiral HPLC analysis of the 1-naphthyl-2-
hydroxydodec-9-yne derivative (Chiralcel®OD-H Isocratic 5% IPA/hexanes).  tR(minor) 
= 31.9 min.  tR(major) = 47.0 min.  
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O
 
(R)-2-Benzyloxirane (Table 4, entry 5): Prepared according to the general 
procedure from hydrocinnamaldehyde (263 µL, 2.00 mmol) to afford a yellow oil.  
Purification on silica gel (5–8% Et2O/pentanes) afforded (R)-2-benzyloxirane as a 
colorless liquid (207 mg, 77% yield, 93% ee) that matched literature data.19  1H NMR 
(300 MHz, CDCl3) δ 7.35–7.22 (m, 5H, Ph), δ 3.19–3.14 (m, 1H, OCHCH2), δ 2.94 (dd, 
1H, J = 5.6, 14.7 Hz, CH2Ph), δ 2.86–2.79 (m, 2H, OCH2CHCH2Ph), δ 2.56 (dd, 1H, J = 
2.7, 4.8 Hz, OCHCH2); 13C NMR (75 MHz, CDCl3) δ 137.2, 129.0, 128.5, 126.6, 52.42, 
46.86, 38.75; HRMS (EI+) exact mass calculated for [M+•]+ (C9H10O) requires m/z 
134.0732, found m/z 134.0734.  [α]D = +16.7 (c = 1.0, EtOH).  Reported rotation for (S)-
benzyl oxirane [α]D = -17.3 (c = 1.94, EtOH).  Enantiopurity was determined by GLC 
using a Bodman Chiraldex Γ-TA (30 m x 0.25 mm) column (70 °C isotherm);  (R) isomer 
tr = 52.4 min and (S) isomer tr = 57.4 min. 
 
O
OMe
OMe  
(R)-2-(3,4-Dimethoxybenzyl)oxirane (Table 4, entry 6):  The catalyst 7 (17.0 
mg, 0.100 mmol) and 2,3,4,5,6,6-hexachloro-2,4-cyclohexadien-1-one 5 (361 mg, 1.20 
mmol) in THF (2.0 mL) and TFA (11.4 mg, 0.100 mmol) was treated with 3-(3,4-
dimethoxyphenyl)propanal (194 mg, 1.00 mmol) and stirred at rt for 30 min.  The 
                                                
19 Klunder, J. M.; Onami, T.; Sharpless, K. B. J. Org. Chem. 1989, 54, 1295. 
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reaction was cooled to 0 °C and diluted with EtOH (1.3 mL).  NaBH4 (95.0 mg, 2.50 
mmol) was added and after 5 min the reaction was warmed to rt and stirred an additional 
25 min.  50% aqueous KOH solution (6.0 mL) was added and the stirred vigorously for 
30 min.  12 mL of H2O was added and the solution extracted with Et2O (3 × 12 mL).  The 
combined organics were dried over Na2SO4, filtered, and concentrated in vacuo to afford 
a yellow oil.  Purification on Iatrobeads (20–60% Et2O/Pentanes) afforded (R)-2-(3,4-
dimethoxybenzyl)oxirane as a colorless oil (186 mg, 96% yield, 94% ee) which matched 
literature data.20  IR (film) 2996, 2936, 2836, 1608, 1590, 1517, 1464, 1420, 1335, 1262, 
1237, 1157, 1141, 1028, 969.9, 833.6, 765.4 cm-1; 1H NMR (300 MHz, CDCl3) δ 6.84–
6.77 (m, 3H, Ph), δ 3.88 (s, 3H, PhOCH3), δ 3.87 (s, 3H, PhOCH3), δ 3.17–3.11 (m, 1H, 
OCHCH2), δ 2.83–2.78 (m, 3H, CH2Ph, OCHCH2), δ 2.54 (dd, 1H, J = 2.7, 4.5 Hz, 
OCHCH2); 13C NMR (75 MHz, CDCl3) δ 148.90, 147.81, 129.73, 120.90, 112.25, 
111.25, 55.90, 55.84, 52.58, 46.77, 38.27; HRMS (EI+) exact mass calculated for [M+•]+ 
(C11H14O3) requires m/z 194.0943, found m/z 194.0946.  [α]D =  +9.2 (c = 1.0, CHCl3).  
Reported rotation [α]D =  +9.7 (c = 0.5, CHCl3).  Enantiopurity was determined by chiral 
HPLC analysis (Chiralcel®OD-H Isocratic 4% IPA/hexanes).  tR(major) = 27.1 min. 
tR(minor) = 32.1 min. 
 
 
 
                                                
20 Gooding, O. W.; Bansal, R. P. Synth. Commun. 1995, 25, 1155. 
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O
6  
(R)-2-(8-(Methoxymethoxy)octyl)oxirane (Table 4, entry 7): Prepared 
according to the general procedure from 10-(methoxymethoxy)decanal (433 mg, 2.00 
mmol) to afford a yellow oil.  Purification on Iatrobeads (5–30% Et2O/pentanes) afforded 
(R)-2-(8-(methoxymethoxy)octyl)oxirane as a colorless liquid (326 mg, 75% yield, 93% 
ee).  IR (film) 3044, 2930, 2857, 1467, 1410, 1386, 1260, 1214, 1149, 1111, 1046, 918.6, 
834.6, 723.9 cm-1; 1H NMR (300 MHz, CDCl3) δ 4.62 (d, 2H, J = 0.8 Hz, OCH2O), δ 
3.52 (t, 2H, J = 6.4 Hz, CH2CH2O), δ 3.36 (d, 3H, J = 0.8 Hz, OCH3), δ 2.93–2.87 (m, 
1H, OCHCH2), δ 2.74 (dd, 1H, J = 4.8, 4.5 Hz, OCHCH2), δ 2.46 (dd, 1H, J = 2.7, 5.1 
Hz, OCHCH2), δ 1.63–1.32 (m, 14H, OCH(CH2)7); 13C NMR (75 MHz, CDCl3) δ 96.39, 
67.84, 55.08, 52.36, 47.11, 32.47, 29.72, 29.47, 29.36, 29.31, 26.17, 25.94; HRMS (CI+) 
exact mass calculated for [M+H]+ (C12H25O3) requires m/z 217.1804, found m/z 217.1798.  
[α]D =  +5.97 (c = 1.0, CHCl3).  Enantiopurity was determined by chiral HPLC analysis 
of the 1-naphthyl-2-hydroxy-8-(methoxymethoxy)octane derivative (Chiralpak®AD 
Isocratic 2% IPA/hexanes).  tR(minor) = 71.4 min.  tR(major) = 75.7 min. 
 
NHBoc
O
7  
(R)-tert-Butyl 9-(oxiran-2-yl)nonylcarbamate (Table 4, entry 8):  The catalyst 
7 (4.30 mg, 25.0 µmol) and 2,3,4,5,6,6-hexachloro-2,4-cyclohexadien-1-one 5 (361 mg, 
1.20 mmol) in THF (1.0 mL) and TFA (2.90 mg, 25.0 µmol) was treated with tert-butyl 
10-formyldecylcarbamate (286 mg, 1.00 mmol) and stirred at rt for 15 min.  The reaction 
was cooled to 0 °C and diluted with THF (0.50 mL) and EtOH (1.0 mL).  NaBH4 (95.0 
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mg, 2.50 mmol) was added and after 5 min the reaction was warmed to rt and stirred an 
additional 25 min.  50% aqueous KOH solution (5.0 mL) was added and the stirred 
vigorously for 30 min.  10 mL of H2O was added and the solution extracted with Et2O (3 
× 10 mL).  The combined organics were dried over Na2SO4, filtered and concentrated in 
vacuo to afford a yellow oil.  Purification on Iatrobeads (20–50% Et2O/pentanes) 
afforded (R)-tert-butyl 9-(oxiran-2-yl)nonylcarbamate as a colorless oil (237 mg, 83% 
yield, 95% ee).  IR (film) 3358, 3045, 2977, 2929, 2856, 2361, 1715, 1523, 1456, 1391, 
1366, 1250, 1174, 1042, 996.4, 916.0, 835.6, 781.1, 722.9 cm-1; 1H NMR (300 MHz, 
CDCl3) δ 4.50 (s, 1H, NH), δ 3.09 (app. q, 2H, J = 6.7 Hz, CH2NH), δ 2.93–2.87 (m, 1H, 
OCHCH2), δ 2.74 (dd, 1H, J = 4.0, 5.1 Hz, OCHCH2), δ 2.46 (dd, 1H, J = 2.7, 5.1 Hz, 
OCHCH2), δ 1.57–1.34 (m, 16H, OCH(CH2)8), δ 1.28 (s, 9H, C(CH3)3); 13C NMR (75 
MHz, CDCl3) δ 155.6, 78.92, 52.33, 47.06, 40.57, 32.43, 30.01, 29.37, 29.34, 29.19, 
28.39, 26.72, 25.90; HRMS (CI+) exact mass calculated for [M+H]+ (C16H32NO3) 
requires m/z 286.2382, found m/z 286.2372.  [α]D =  +4.0 (c = 1.0, CHCl3). Enantiopurity 
was determined by chiral HPLC analysis of the 1-naphthyl-2-hydroxyundecane 
derivative (Chiralcel®OJ Isocratic 10% IPA/hexanes).  tR(major) = 36.6 min.  tR(minor) = 
41.4 min. 
 
O O
3  
(R)-2-(5-(Oxiran-2-yl)pentyl)oxirane (Table 4, entry 9):  The catalyst 7 (8.60 
mg, 50.0 µmol) and 2,3,4,5,6,6-hexachloro-2,4-cyclohexadien-1-one 5 (722 mg, 2.40 
mmol) in THF (0.80 mL) and TFA (5.8 mg, 50.0 µmol) was treated with nonanedial (174 
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µL, 1.00 mmol) and stirred at rt for 15 min.  The reaction was cooled to 0 °C and diluted 
with THF (0.40 mL) and EtOH (0.80 mL).  NaBH4 (132 mg, 3.50 mmol) was added and 
after 5 min the reaction was warmed to rt and stirred an additional 25 min.  50% aqueous 
KOH solution (5.0 mL) was added and the stirred vigorously for 30 min.  10 mL of H2O 
was added and the solution extracted with Et2O (3 × 10 mL).  The combined organics 
were dried over Na2SO4, filtered and concentrated in vacuo to afford a yellow oil.  
Purification on Iatrobeads (15–40% Et2O/pentanes) afforded (R)-2-(5-(oxiran-2-
yl)pentyl)oxirane as a colorless liquid (126 mg, 81% yield, >99% ee, 10:1 dr).  IR (film) 
3046, 2982, 2932, 2859, 1483, 1464, 1410, 1260, 1132, 915.8, 837.1 cm-1; 1H NMR (300 
MHz, CDCl3) δ 2.93–2.87 (m, 2H, OCHCH2), δ 2.74 (dd, 2H, J = 4.0, 4.8 Hz, OCHCH2), 
δ 2.46 (dd, 2H, J = 2.9, 5.1 Hz, OCHCH2), δ 1.58–1.34 (m, 10H, OCH(CH2)5); 13C NMR 
(75 MHz, CDCl3) δ 52.29, 47.08, 32.33, 29.19, 25.89; HRMS (CI+) exact mass 
calculated for (C9H17O2) [M+H]+ requires m/z 157.1229, found m/z 157.1227.  [α]D = 
+18.1 (c = 1.0, CHCl3).  Enantiopurity was determined by chiral HPLC analysis of the 
1,9-dinaphthyl-2,8-dihydroxynonane derivative (Chiralcel®OD-H Isocratic 10% 
EtOH/hexanes).  tR(minor) = 33.2 min. tR(diastereomer) = 39.4 min tR(major) = 44.9 min. 
 
NBoc
O  
(R)-tert-Butyl 4-(oxiran-2-yl)piperidine-1-carboxylate (Table 4, entry 10): The 
catalyst 7 (17.0 mg, 0.100 mmol) and 2,3,4,5,6,6-hexachloro-2,4-cyclohexadien-1-one 5  
(361 mg, 1.20 mmol) in THF (2.0 mL) and TFA (11.4 mg, 0.100 mmol) was treated with 
tert-butyl 4-(formylmethyl)piperidine-1-carboxylate (227 mg, 1.00 mmol) and stirred at 
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rt for 30 min.  The reaction was cooled to 0 °C and diluted with EtOH (1.3 mL).  NaBH4 
(95.0 mg, 2.50 mmol) was added and after 5 min the reaction was warmed to rt and 
stirred an additional 25 min.  50% aqueous KOH solution (6.0 mL) was added and the 
stirred vigorously for 30 min.  12 mL of H2O was added and the solution extracted with 
Et2O (3 × 12 mL).  The combined organics were dried over Na2SO4, filtered and 
concentrated in vacuo to afford a yellow oil.  Purification on Iatrobeads (20–50% 
Et2O/pentanes) afforded (R)-tert-butyl 4-(oxiran-2-yl)piperidine-1-carboxylate as a 
colorless oil (195 mg, 86% yield, 96% ee).  IR (film) 2975, 2930, 2954, 1693, 1480, 
1450, 1421, 1366, 1283, 1254, 1231, 1164, 1094, 1008, 976.7, 929.2, 872.4, 834.0, 809.9, 
769.5 cm-1; 1H NMR (300 MHz, CDCl3) δ 4.13 (d, 2H, J = 12.0 Hz, N(CH2)2), δ 2.78–
2.60 (m, 4H, N(CH2)2, OCHCH2), δ 2.55 (dd, 1H, J = 4.0, 3.3 Hz, OCHCH2), δ 1.85–
1.75 (m, 1H, CH(CH2)2), δ 1.63–1.57 (m, 2H, CH(CH2)2), δ 1.45 (s, 9H, C(CH3)3), δ 
1.42–1.22 (m, 2H, CH(CH2)2); 13C NMR (75 MHz, CDCl3) δ 154.76, 79.43, 77.20, 55.62, 
45.81, 38.75, 28.68, 28.43, 27.81; HRMS (EI+) exact mass calculated for [M+•]+ 
(C12H21NO3) requires m/z 227.1521, found m/z 157.1516.  [α]D = +1.23 (c = 1.0, EtOH).  
Enantiopurity was determined by chiral HPLC analysis of the 1-naphthyl-2-
hydroxypiperidine derivative (Chiralcel®OD-H Isocratic 5% IPA/hexanes).  tR(major) = 
34.6 min.  tR(minor) = 39.8 min. 
 
O  
(R)-Tricyclo[3.3.1.10,0]dec-1-yl-oxirane (Table 4, entry 11):  To a flask 
containing (5S)-5-benzyl-2,2,3-trimethylimidazolidin-4-one 6 (66 mg, 0.2 mmol) and 
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2,3,4,5,6,6-hexachloro-2,4-cyclohexadien-1-one 5 (361 mg, 1.2 mmol) in CH2Cl2 (2 mL) 
at –40 °C was added tricyclo[3.3.1.10,0]dec-1-yl-acetaldehyde (169 µL, 1.00 mmol) and 
stirred for 24 h.   The flask was cooled to –78 oC and diluted with cooled CH2Cl2 (4 mL) 
and EtOH (4 mL).  NaBH4 (95 mg, 2.5 mmol) was added and the reaction allowed to 
warm slowly to rt.  After stirring 25 min at rt, 50% KOH solution (20 mL) was added and 
then stirred vigorously 6 hr.  20 mL of H2O was added and the solution extracted with 
Et2O (3 × 20 mL).  The combined organics were dried over Na2SO4, filtered and 
concentrated in vacuo to afford a yellow oil.  Purification on silica gel (5% 
Et2O/Pentanes) afforded (R)-Tricyclo[3.3.1.10,0]dec-1-yl-oxirane as a colorless oil (90 
mg, 50%, 89% ee).  1H NMR (300 MHz, CDCl3) δ 2.67 (dd, 1H, J = 3.2, 4.5 Hz, 
OCHCH2), δ 2.60 (dd, 2H, J = 4.0, 5.0 Hz, OCHCH2), δ 2.02–1.95 (m, 3H), δ 1.77–1.51 
(m, 12H); 13C NMR (75 MHz, CDCl3) δ 60.48, 42.99, 38.40, 37.01, 32.20, 27.99; HRMS 
(EI) exact mass calculated for (C12H18O) requires m/z 178.1358, found m/z 178.1362.  
[α]D = -9.42 (c = 1.0, EtOH).  The enantiomeric ratio of the epoxide was determined by 
GLC using a Bodman Chiraldex Γ-TA (30 m x 0.25 mm) column (100 °C isotherm, 1 
mL/min); (S) isomer tr = 44.4 min and (R) isomer tr = 46.4 min. 
  38 
Chapter 3  
Enantioselective Organocatalytic Direct α-Fluorination of Aldehydes∗ 
 
Introduction 
In the previous chapter, the utility of an asymmetric α-chloroaldehyde as an 
intermediate in the formation of valuable chiral synthons was discussed.  Using the 
enamine catalysis platform, we felt that other halogen stereocenters such as bromine, 
iodine, and fluorine could be envisioned as well.  We were particularly interested in the 
possibility of forming fluorine stereocenters due to the lack of direct methods for creating 
them and their pharmaceutical importance.1  A key goal of drug design is to prevent rapid 
degradation and excretion due to unwanted metabolism.  While many metabolites are 
rendered inactive, some may have adverse biological activity making the parent drug 
unsuitable for human use.  Due to its high metabolic stability, the carbon-fluorine bond is 
widely used as a surrogate for carbon-hydrogen bonds as a method for circumventing 
unwanted metabolism.2  Additionally, fluorine atoms provide improved lipohilicity and 
                                                
∗ A patent and communication of this work has been published: (a) Beeson, T. D.; MacMillan, D. W. C. 
Enantioselective alpha-Fluorination of Aldehydes Using Chiral Organic Catalysts.  U.S. Patent 7,265,249, 
September 4, 2007.  (b) Beeson, T. D.; MacMillan, D. W. C. J. Am. Chem. Soc. 2005, 127, 8826. 
1 Böhm, H. J.; Banner, D.; Bendels, S.; Kansy, M.; Kuhn, B.; Müller, K.; Obst-Sander, U.; Stahl, M. ChemBioChem, 
2004, 5, 637. 
2 Müller, K.; Faeh, C.; Diederich, F. Science 2007, 317, 1881. 
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bioavailability of pharmaceuticals in the body due to their electron-withdrawing effect on 
nearby heteroatoms whose basicities hinder membrane permeability.3   
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Differding and Lang Takeuchi Shibata
27-63% yield
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48-79% yield
43-88% ee
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OAc
N
N
H
F
O O
 
Figure 1.  Examples of chiral stoichiometric fluorinating 
reagents reported in the literature. 
It was therefore surprising that at the time of this work, most enantioselective 
methods for creating asymmetric C-F bonds required the use of stoichiometric amounts 
of chiral fluorinating agents4 (Figure 1) and the few known catalytic methods had focused 
exclusively on highly enolizable substrates such as β-ketoesters and malonates.5  The first 
transition metal-catalyzed fluorinations reported by Togni and coworkers using titanium 
TADDOL complexes6 had been further developed by Sodeoka using palladium BINAP 
complexes7 (equation 1) and Cahard using copper oxazolines8 to achieve high levels of 
                                                
3 (a) Avdeef, A. Curr. Top. Med. Chem. 2001, 1, 277.  (b) Morgenthaler, M.; Schweizer, E.; Hoffmann-Röder, A.; 
Benini, F.; Martin, R. E.; Jaeschke, G.; Wagner, B.; Fischer, H.; Bendels, S.; Zimmerli, D.; Schneider, J.; 
Diederich, F.; Kansy, M.; Müller, K. ChemMedChem. 2007, 2, 1100. 
4 (a) Differding, E.; Lang, R. W. Tetrahedron Lett. 1988, 29, 6087.  (b) Takeuchi, Y.; Suzuki, T.; Satoh, A.; 
Shiragami, T.; Shibata, N. J. Org. Chem. 1999, 64, 5708.  (c) Cahard, D.; Audouard, C.; Plaquevent, J. C.; Roques, 
N.; Org. Lett. 2000, 2, 3699.  (d) Shibata, N.; Suzuki, E.; Takeuchi, Y. J. Am. Chem. Soc. 2000, 122, 10728.  (e) 
Shibata, N.; Suzuki, E.; Asahi, T.; Shiro, M. J. Am. Chem. Soc. 2001, 123, 7001. 
5 (a) Ma, J.-A.; Cahard, D. Chem. Rev. 2004, 104, 6119.  (b) Bobbio, C.; Gouverneur, V. Org. Biomol. Chem. 2006, 4, 
2065. 
6 (a) Hintermann, L.; Togni, A. Angew. Chem., Int. Ed. 2000, 39, 4359.  (b) Togni, A.; Mezzetti, A.; Barthazy, P.; 
Becker, C.; Devillers, I.; Frantz, R.; Hintermann, L.; Perseghini, M.; Sanna, M. Chimia 2001, 55, 801. 
7  (a) Hamashima, Y.; Yagi, K.; Takano, H.; Tamas, L.; Sodeoka, M. J. Am. Chem. Soc. 2002, 124, 14530.  
8 Ma, J. A.; Cahard, D. Tetrahedron: Asymmetry 2004, 15, 1007. 
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enantioselectivity for a variety of cyclic and acyclic β-ketoesters.  At the same time, Kim 
and Park demonstrated that phase-transfer catalysis using quaternized cinchona alkaloid 
derivatives could also effectively induce high levels of enantiocontrol for the fluorination 
of β-ketoesters (equation 2).9   
P
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O
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Ar
2 BF4
–
Ar = 3,5-dimethylphenyl  1
O
CO2t-Bu2.5 mol% 1, NFSI
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(1)
O
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(2)
2O
CO2Me
O
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The Enamine Approach to α -Fluorinations 
Since catalytic asymmetric fluorinations were limited to highly enolizable 
substrates that were structurally precluded from product epimerization, we felt that a 
direct catalytic asymmetric α-fluorination of aldehydes would be a valuable addition to 
the current methods for generating fluorine stereocenters.  Initial studies in our lab 
performed by postdoctoral fellow Young-Kwan Kim involved the use of 20 mol% of L-
proline (Figure 2) as a catalyst and N-fluorobenzenesulfonimide (NFSI) as the 
electrophilic fluorine source (equation 3).  Unfortunately, proline was ineffective as a 
catalyst for the fluorination reaction and very poor conversions were obtained.  
                                                
9  Kim, D. Y.; Park, E. J. Org. Lett. 2002, 4, 545. 
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Figure 2. Catalysts for the enantioselective α-fluorination of 
aldehydes 
Subsequently, graduate student Michael Brochu showed that our lab’s first-
generation imidazolidinone catalyst 3 (Figure 2) could achieve good levels of 
enantioselectivity (equation 4); however, attempts to isolate the α-fluoroaldehyde 
products from the residual NFSI were hindered by tedious separations and significant 
product decomposition.  To complicate matters further, attempts at in situ reduction of 
the sensitive α-fluoroaldehydes were unsuccessful unless all NFSI and its acidic 
byproduct, dibenzenesulfonimide (DBSI) were first removed, which was accomplished 
only with difficulty and not reproducibly.  For these reasons, it was first necessary to 
develop a method for the consumption of excess NFSI in the reaction and subsequent 
removal of the DBSI byproduct.   
CHCl3, +4 ºC, 48 h
O
H
O
H
PhPh
20% NMR yield
(3)
Me Me
F
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S
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O O O O
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Interestingly, a report by Umemoto and coworkers in 1986 showed that 
N-fluoropyridinium triflates are able to α-fluorinate sulfides at room temperature.10  
Based on this report, we speculated that if NFSI was capable of reacting with sulfides in 
the same manner, a volatile sulfide such as dimethylsulfide (DMS) could be used to 
transform any remaining fluorinating agent into the DBSI byproduct and the resultant 
fluorosulfide could simply be removed by evaporation.  Gratifyingly, when DMS was 
added to a suspension of NFSI at +4 ºC, an instantaneous exothermic reaction occurred 
and the NFSI was completely consumed (equation 5).  However, the addition of DMS to 
the α-fluorination reaction in the presence of imidazolidinone catalyst resulted in rapid 
epimerization of the fluorine stereocenter.  On the other hand, it was observed that 
addition of DMS after removal of the catalyst by filtration had no effect on the stability of 
the fluoro stereocenter and product enantioselectivities remained stable over 24 hours.   
 
CHCl3/IPA
Me
S
Me
10 equiv. 100% yield
(5)
1 equiv.
+4 ºC, 2 min
NFSI DBSI
 
This observed stereocenter stability led us to wonder whether washing the reactions 
with a mildly basic sodium bicarbonate solution could remove the acidic DBSI byproduct 
without epimerizing or decomposing the α-fluoroaldehyde products.  Subsequent 
experiments showed that the α-fluoro stereocenter was indeed stable to the mildly basic 
conditions, and DBSI could be almost quantitatively removed with two or more 
bicarbonate washes.  
With a successful method for removing excess reagents and reaction byproducts in 
hand, we began to optimize the reaction conditions by investigating the effect of solvents. 
                                                
10 Umemoto, T.; Tomizawa, G. Bull. Chem. Soc. Jpn. 1986, 59, 3625. 
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As shown in Table 1, solvents such as toluene, CH2Cl2, and CHCl3 provided moderate 
enantioselectivites (entries 1–4), while THF and acetone achieved the highest levels of 
selectivity (entries 8 and 10).  In all cases except isopropanol (IPA), rapid consumption of 
the α-fluoroaldehyde product to the α,α-difluoroaldehyde was observed, resulting in low 
conversions of the desired mono-fluorinated product.   
Table 1. Survey of Solvents for Aldehyde α-Fluorination  
NFSI H
F
O
H
O
+
20 mol% catalyst 3
solvent, 23 ºC
entry
1
2
3
4
5
6
7
8
9
10
11
12
% conv.a
46
56
42
58
70
68
59
78
85
56
75
60
% eeb
55
93
62
80
96
91
82
96
97
97
98
92
30
30
30
60
60
60
60
20
60
5
30
360
time (min)
Toluene
CH3CN
CH2Cl2
CHCl3
CHCl3/10% IPA
CHCl3/10% IPA
CHCl3/10% IPA
Acetone
Acetone/10% IPA
THF
THF/10% IPA
IPA
solvent
5
5
5
5
5
3
1.2
5
5
5
5
5
equiv. NFSI
 
(a) Conversion determined by GLC analysis of product relative to 
an internal standard (benzyl methyl ether).  (b) Enantiomeric 
excess determined by chiral GLC analysis (Bodman Γ-TA). 
Interestingly, when 10% of IPA was added, difluoroaldehyde production was 
significantly slowed and enantioselectivities were enhanced (entries 5, 9, 11), presumably 
due to facile addition of IPA to the highly electrophilic carbonyl of the fluoroaldehyde, 
forming a hemi-acetal that serves as a protecting group to prevent the product from re-
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reacting with the catalyst.11  The excess of NFSI was also lowered to suppress 
difluoroaldehyde formation; however, reduced overall conversions and significantly lower 
enantioselectivities were obtained (entries 5–7).  Notably, when the reaction temperature 
was lowered, significant increases in reaction efficiency were observed at +4 ºC (Table 2, 
entry 9) and at –10 ºC, complete inhibition of difluoroaldehyde formation was obtained 
(Table 2, entry 10).   
Table 2. Effect of Catalyst and Temperature on the α-Fluorination 
20 mol% catalyst
THF, IPA
NFSI
H
F
O
H
O
entry
1
2
3
3
4
5
6
7
8
9
10
26
20
63
94
87
41
97
90
98
98
98
% eeb
76
46
97
91
22
25
71
70
78
97
98
% conversiona
4 h
10 h
15 min
7 h
4 h
4 h
15 min
15 min
30 min
6 h
8 h
time
+23
+23
+23
+23
+23
+23
+23
+23
+23
+4
–10
Temp. (°C)
L-proline
L-prolineamide
5
4
3•TfOH
3•HCl
3•TFA
3•TCA
3
3
3
catalyst
1 equiv. 5 equiv.
 
(a) Conversion determined by GLC analysis of product relative to 
an internal standard (benzyl methyl ether).  (b) Enantiomeric 
excess determined by chiral GLC analysis (Bodman Γ-TA). 
Further, using the optimized solvent conditions we compared catalyst 3 with 
imidazolidinone catalysts 4 and 5, as well as L-proline and L-prolineamide (Table 2).  
While L-proline yielded reasonable levels of conversion under the new reaction conditions, 
the stereoselectivity remained low (entry 1).  Catalyst 5 reacted very rapidly to excellent 
                                                
11 Other additives such as ethanol, methanol, and water had the same effect but required much longer reaction 
times and resulted in slightly lower enantioselectivities. 
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levels of conversion but yielded only moderate selectivity at this temperature (entry 3).  
While good levels of conversion and selectivity were achieved with catalyst 4 (entry 4), 
prolonged reaction times were required. Although imidazolidinone catalysts 4 and 5 could 
both be applied in this fluorination protocol, we pursued further optimization with catalyst 
3 due to its low cost and ease of synthesis.   
Subsequently, various co-catalysts were also analyzed.  As shown in Table 2, 
dichloroacetic acid (DCA) and trifluoroacetic acid (TFA) salts of catalyst 3 were optimal 
for both reaction efficiency and enantioselectivity (entries 4–8).  Additionally, catalyst 
loadings were evaluated to determine if lesser amounts of catalyst would reduce the 
preponderance for difluorination and allow reactions to be performed at ambient 
temperature (Table 3).  Notably, catalyst loadings as low as 1 mol% achieved excellent 
levels of enantioselectivity and conversion.  However, even with only 1 mol% of catalyst, 
difluorination was never fully inhibited at room temperature and conversions slowly 
decreased with time.  
Table 3. Effect of Catalyst Loading on the α-Fluorination 
NFSI
H
F
O
H
O catalyst 3
THF, IPA
entry
1
2
3
4
5
6
7
8
% conv.a
74
98
77
97
79
95
77
83
% eeb
98
98
98
98
98
98
98
98
30 min
8 h
1 h
8 h
3 h
25 h
6 h
24 h
time
20
20
10
10
5
5
2.5
1
mol% catalyst
+23
–10
+23
+4
+23
+4
+23
+23
Temp °C
1 equiv. 5 equiv.
 
(a) Conversion determined by GLC analysis of product relative to 
an internal standard (benzyl methyl ether).  (b) Enantiomeric 
excess determined by chiral GLC analysis (Bodman Γ-TA). 
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Table 4. Enantioselective α-Fluorination: Substrate Scope 
entry % yield % eea
(1)  THF, IPA
H HO
R
HO
HO
HO
HO
1
2
5
9
8
70
79
96
82
78
94
94
99
98
96
product
HO4 77 91
OEt
O
R
F
F
F
F
F
F
6
6
Me HO3 81 94
F
3
Et
HO
6 85 98
NBOC
F
HO
7 55 99
F
HO
F
O
(2)  NaBH4, CH2Cl2
1 equiv. product
Ph
S
N
S
Ph
O O O O
F
–10 °C, 12 h
entry % yield % eeaproduct
entry % yield % eeaproduct entry % yield % eeaproduct
20 mol% 3
N
N
H
Me O
Ph
·DCA
Me
Me
5 equiv.
 
(a) Entries 1–4, 6 and 9 enantiomeric excess determined by chiral HPLC analysis of the 
2-naphthoyl derivative (Chiralcel® OJ).  Entries 5, 7 and 8 enantiomeric excess 
determined by chiral GLC analysis (Macherey-Nagel Hydrodex-B-TBDAc). 
Lastly, the generality of the reaction was studied and a variety of aldehyde 
substrates were chosen to determine the effect of sterics and functional group compatibility.  
As shown in Table 4, olefinic aldehydes were successfully α-fluorinated without 
isomerization of the double bond configuration (entries 2–3).  Although NFSI is susceptible 
to electrophilic aromatic substitution,12 aromatic substrates were also obtained in good 
yields with excellent enantioselectivities (entries 7–8).  The acid-labile tert-butoxycarbonyl 
                                                
12 Differding, E.; Ofner, H. Synlett 1991, 187. 
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(BOC) nitrogen protecting group was also unaffected by the acidic reaction conditions 
(entry 6).  Surprisingly, there was no difference in reaction times between substrates of 
differing steric demands (entries 5–9), with even the highly hindered adamantyl 
acetaldehyde reacting in 12 hours to give excellent results for the α-fluoroaldehyde product 
(entry 9). 
 
Conclusion 
In summary, development of the direct and enantioselective α-fluorination of 
aldehydes has been described using an inexpensive and easily prepared imidazolidinone 
catalyst and NFSI as the fluorinating source.13,14  The mild reaction conditions have 
allowed the α-fluorination of a wide variety of structures and functionalities, including 
those of high steric demand and catalyst loadings as low as 1 mol% were capable of 
inducing high yields and enantioselectivities.  It is our hope that this new methodology for 
creating fluorine stereocenters will open the door for practitioners of pharmaceutical 
synthesis to pursue structural diversifications that have until now been inaccessible.   
                                                
13 After submission of this work for publication, the following papers appeared in the literature also describing the 
enantioselective organocatalyzed α-fluorination of aldehydes:  (a) Enders, D.; Hüttl, M. R. M. Synlett 2005, 991.  
(b) Marigo, M.; Fielenbach, D. I.; Braunton, A.; Kjærsgaard, A.; Jørgensen, K. A. Angew. Chem., Int. Ed. 2005, 44, 
3703.  (c) Steiner, D. D.; Mase, N.; Barbas, C. F. Angew. Chem., Int. Ed. 2005, 44, 3706. 
14 For reviews on recent advances in the field of asymmetric fluorination see: (a) Brunet, V. A.; O’Hagan, D. 
Angew. Chem., Int. Ed. 2008, 47, 1179.  (b) Shibata, N.; Ishimaru, T.; Nakamura, S.; Toru, T. J. Fluorine Chem. 
2007, 128, 469.  (c) Pihko, P. M. Angew. Chem., Int. Ed. 2006, 45, 544. (d) Prakash, G. K. S.; Beier, P. Angew. 
Chem., Int. Ed. 2006, 45, 2172.  (e) Bobbio, C.; Gouberneur, V. Org. Biomol. Chem. 2006, 4, 2065. 
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S u p p o r t i n g  I n f o r m a t i o n  
General Information.  Commercial reagents were distilled prior to use following the 
guidelines of Perrin and Armarego.15  Organic solutions were concentrated under reduced 
pressure on a Büchi rotary evaporator. Chromatographic purification of products was 
accomplished using forced-flow chromatography on EMD Silica Gel 60 230-400 mesh or 
Davisil® Silica Gel 200-425 mesh according to the method of Still.16 Thin-layer 
chromatography (TLC) was performed on EM Reagents 0.25 mm silica gel 60-F plates.  
Visualization of the developed chromatogram was performed by fluorescence quenching 
using potassium permanganate stain.  High performance liquid chromatography (HPLC) 
and gas liquid chromatography (GLC) assays to determine enantiometric excess were 
developed using racemic samples. 
1H, 13C and 19F NMR spectra were recorded on Varian Mercury 300 (300 MHz, 75 
MHz and 282 MHz respectively) as noted, and are internally referenced to residual protio 
solvent signals.  Data for 1H are reported as follows: chemical shift (δ ppm), multiplicity 
(s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet), integration, coupling 
constant (Hz), and assignment.  Data for 13C and 19F NMR are reported as follows: 
chemical shift (δ ppm), multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, m = 
multiplet), and coupling constant (Hz).  IR spectra were recorded on a Perkin Elmer 
Spectrum BX FT-IR spectrometer and are reported in terms of frequency of absorption 
(cm-1).  Mass spectra were obtained from the California Institute of Technology Mass 
                                                
15 Perrin, D. D.; Armarego, W. L. F.  Purification of Laboratory Chemicals; 3rd edition; Pergamon Press; Oxford, 1988. 
16 Still, W. C.; Kahn, M.; Mitra, A. J. J. Org. Chem. 1978, 43, 2923. 
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Spectral Facility.  Gas liquid chromatography (GLC) was performed on a Hewlett-
Packard 6850 Series gas chromatograph equipped with a split-mode capillary injection 
system and flame ionization detectors using a Macherey-Nagel Hydrodex-B-TBDAc (50 
m x 0.25 mm) column.  High performance liquid chromatography (HPLC) was 
performed on a Hewlett Packard 1100 Series chromatograph using a Chiralcel® OJ 
column (25 cm, 5 cm guard) as noted. 
 
General Procedure for the α-Fluorination of Aldehydes: To a 25 mL round-
bottom flask equipped with a magnetic stir bar and charged with 1 (R)-5-benzyl-2,2,3,-
trimethylimidazolidin-4-one dichloroacetic acid salt (139 mg, 0.400 mmol) and N-
fluorobenzenesulfonimide (3.15 g, 10.0 mmol) was added THF (9.0 mL) and IPA (1.0 
mL).  The mixture was stirred at rt until homogeneous then cooled to –10 °C.  The 
aldehyde substrate (2.0 mmol) was added and the reaction mixture stirred 12 h.  The 
reaction was cooled to –78 ºC, diluted with 10 mL Et2O and filtered through a pad of 
Davisil® Silica Gel, eluting with Et2O.  Me2S (5.0 mL) was added forming a white 
precipitate.  The resulting mixture was washed with sat. NaHCO3 (3 × 150 mL) and brine 
(1 × 150 mL) and dried over MgSO4, filtered and concentrated in vacuo.  The resulting 
oil was dissolved in CH2Cl2 (12 mL) and EtOH (8 mL), and NaBH4 (189 mg, 5.0 mmol) 
was added.  After 30 min the reaction was cooled to 0 ºC and sat. NH4Cl (150 mL) was 
added.  The mixture was warmed to rt and stirred vigorously 1 h.  The cloudy suspension 
was allowed to separate and 75 mL of CH2Cl2 was added.  The solution was extracted 
with CH2Cl2 (3 × 100 mL) and the combined organics washed with sat. NaHCO3 (3 × 150 
mL) and brine (1 × 150 mL) and dried over Na2SO4, filtered and concentrated in vacuo.  
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Purification of the resulting oil by forced flow chromatography afforded the title 
compounds.  The enantioselectivity was determined either by chiral GLC analysis, or 
chiral HPLC analysis after acylation of the alcohol with 2-naphthoylchloride.   
 
Starting Materials 
  
Ethyl 5-formylpentanoate:  To a flask containing ethyl 6-hydroxyhexanoate 
(4.07 mL, 25.0 mmol) in CH2Cl2 (25 mL) was added TEMPO (391 mg, 2.50 mmol) 
followed by iodobenzene diacetate (8.86 g, 27.5 mmol).  The reaction was stirred 2 h and 
then diluted with CH2Cl2 (100 mL). Saturated aqueous solution of Na2S2O3 (100 mL) was 
added and extracted with CH2Cl2 (3 × 50 mL).  The combined organics were washed with 
saturated aqueous NaHCO3 (150 mL) and brine (150 mL), dried over Na2SO4, and 
concentrated in vacuo.  The resulting residue was purified by silica gel chromatography 
(20-40% Et2O/pentanes) to provide the title compound, which was identical to the 
reported literature compound.17 
 
tert-Butyl 4-(formylmethyl)piperidine-1-carboxylate:  To a flask containing 
tert-butyl 4-(2-hydroxyethyl)piperidine-1-carboxylate (4.4 g, 19.2 mmol) in CH2Cl2 (20 
mL) was added TEMPO (300 mg, 1.92 mmol) followed by iodobenzene diacetate (6.8 g, 
21.1 mmol).  The reaction was stirred 3 h and then diluted with CH2Cl2 (100 mL). 
Saturated aqueous solution of Na2S2O3 (100 mL) was added and extracted with CH2Cl2 (3 
× 50 mL).  The combined organics were washed with saturated aqueous NaHCO3 (150 
                                                
17 Taber, D. F.; Teng, D. J. Org. Chem. 2002, 67, 1607. 
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mL) and brine (150 mL), dried over Na2SO4, and concentrated in vacuo.  The resulting 
residue was purified by silica gel chromatography (40–70% Et2O/pentanes) to provide the 
title compound, which was identical to the reported literature compound.18  13C NMR (75 
MHz, CDCl3) δ 201.5, 154.7, 79.4, 50.3, 43.7, 31.9, 30.6, 28.4. 
 
Adamantylacetaldehyde:  To a flask containing 2-adamantyl-1-ethanol (5 g, 
27.7 mmol) in CH2Cl2 (28 mL) was added TEMPO (433 mg, 2.77 mmol) followed by 
iodobenzene diacetate (9.8 g, 30.5 mmol).  The reaction was stirred 1 h and then diluted 
with CH2Cl2 (100 mL). Saturated aqueous solution of Na2S2O3 (100 mL) was added and 
extracted with CH2Cl2 (3 × 50 mL).  The combined organics were washed with saturated 
aqueous NaHCO3 (150 mL) and brine (150 mL), dried over Na2SO4, and concentrated in 
vacuo.  The resulting residue was purified by silica gel chromatography (5% 
Et2O/pentanes) to provide the title compound, which was identical to the reported 
literature compound.19 
 
α-Fluoro Alcohols 
HO
F
Me
 
 (R)-2-Fluoro-1-undecanol (Table 4, entry 1): Prepared according to the general 
procedure from undecanal (411 µL, 2.00 mmol) to afford a colorless oil.  Purification on 
silica gel (10–50% Et2O/Pentanes) afforded (R)-2-fluoro-1-undecanol as a colorless solid 
                                                
18 Sato, T.; Okamoto, K.; Nakano, Y.; Uenishi, J.; Ikeda, M. Heterocycles 2001, 54, 747. 
19 Luly, J. R.; Dellaria, J. F.; Plattner, J. J.; Soderquist, J. L.; Yi, N. J. Org. Chem. 1987, 52, 1487. 
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(261 mg, 70% yield, 94% ee).  IR (film) 3271 3171, 2954, 2914, 2848, 1470, 1071, 842.7 
cm-1; 1H NMR (300 MHz, CDCl3). δ 4.56 (dm, J = 46.8 Hz, 1H, FCH), δ 3.59–3.77 (m, 
2H, OCH2), δ 1.89 (s, 1H, -OH), 1.20–1.78 (m, 16H, (CH2)8), δ 0.88 (t, J = 6.9 Hz, 3H, 
CH3); 13C NMR (75 MHz, CDCl3)  δ;  96.3 (d, J = 166.3 Hz), 65.1 (d, J = 21.3 Hz), 31.9, 
30.9 (d, J = 20.3 Hz), 29.5, 29.4 (d, J = 3 Hz), 29.3, 24.9, 24.9, 22.7, 14.1.  19F NMR (282 
MHz, CDCl3) δ: –189.6 (m).  HRMS (EI+) exact mass calculated for [M-H]+ (C11H22FO) 
requires m/z 189.1655, found m/z 189.1660.  [α]D = 7.6 (c = 1.0, CHCl3).20  Enantiopurity 
was determined by chiral HPLC analysis of the 2-naphthoyl derivative (Chiralcel®OJ 
Isocratic 3% IPA/Hexanes).  tR(major) = 11.4 min.  tR(minor) = 15.0 min. 
 
HO
F  
 (R)-2-Fluoroundec-10-en-1-ol (Table 4, entry 2):  Prepared according to the 
general procedure from undec-10-enal (416 µL, 2.00 mmol) to afford a colorless oil.  
Purification on Davisil® silica gel (10–20% EtOAc/Pentanes) afforded (R)-2-fluoroundec-
10-en-1-ol as a colorless solid (296 mg, 79% yield, 94% ee).  IR (film) 3214, 2918, 2848, 
1641, 1460, 1348, 1073, 990.7, 914.2, 837.8, 806.0, 757.8, 724.4, 668.1 cm-1; 1H NMR 
(300 MHz, CDCl3).  δ 5.74–5.87 (m, 1H, CH2CH=CH2), δ 4.90–5.03 (m, 2H, 
CH2CH=CH2), δ 4.57 (dm, 1H, J = 50.7 Hz, FCH); δ 3.60–3.80 (m, 2H, OCH2), δ 2.03 
(q, 2H, J = 14.1, and 7.5 Hz, CH2CH=CH2), δ 1.83 (t, 1H, J = 6.6 Hz, -OH), δ 1.26–1.76 
(m, 12H, FCH(CH2)6); 13C NMR (75 MHz, CDCl3) δ; 139.1, 114.2, 94.8 (d, J = 166.5 
Hz), 65.1 (d, J = 21.8 Hz), 31.7, 30.9 (d, J = 20.0 Hz), 29.3, 29.3, 29.0, 28.8, 24.9 (d, J = 
                                                
20 [α]D = -8.6 (c = 2.0, Et2O) for (S)-2-fluoro-1-decanol and [α]D = -7.2 (c = 2.0, Et2O) for (S)-2-fluoro-1-
dodecanol. Nohira, H.; Kamei, M.; Nakamura, S.; Yoshinaga, K.; Kai, M. JPN Patent 62093248, 1987. 
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3 Hz).  19F NMR (282 MHz, CDCl3)  δ: –189.6 (m).  HRMS (EI+) exact mass calculated 
for [M+•]+ (C11H21FO) requires m/z 188.1576, found m/z 188.1575.  [α]D = 8.1 (c = 1.0, 
CHCl3).  Enantiopurity was determined by chiral HPLC analysis of the 2-naphthoyl 
derivative (Chiralcel®OJ Isocratic 3% IPA/Hexanes).  tR(major) = 15.7 min.  tR(minor) = 
22.7 min. 
 
HO
F
Me  
(R)-(Z)-2-Fluorodec-7-en-1-ol (Table 4, entry 3): Prepared according to the 
general procedure from (Z)-dec-7-enal (366 µL, 2.00 mmol) to afford a yellow oil.  
Purification on silica gel (5–20% EtOAc/Pentanes) afforded (R)-(Z)-2-fluorodec-7-en-1-
ol as a pale yellow liquid (283 mg, 81% yield, 94% ee).  IR (film) 3369, 3006, 2935, 
2861, 1462, 1376, 1172, 1056, 843.1 cm-1; 1H NMR (300 MHz, CDCl3) δ 5.26–5.42 (m, 
2H, CH2CH=HCCH2), δ 4.56 (dm, 1H, J = 50.5 Hz, FCH), δ 3.62–3.76 (m, 2H, OCH2), 
δ 1.98–2.10 (m, 4H, CH2CH=HCCH2), δ 1.89 (t, 1H, J = 6.4 Hz, -OH), δ 1.32–1.74 (m, 
6H, CFH(CH2)3), δ  0.95 (t, 3H, J = 7.4 Hz, CH3); 13C NMR (75 MHz, CDCl3)  δ: 132.0, 
128.7, 94.7 (d, J = 166.5 Hz), 65.1 (d, J = 21.3 Hz), 30.9 (d, J = 20.0 Hz), 29.5, 26.8, 
24.5 (d, J = 5.0 Hz), 20.5, 14.3.  19F NMR (282 MHz, CDCl3) δ: –189.6 (m).  HRMS 
(EI+) exact mass calculated for [M+•]+ (C10H19FO) requires m/z 174.1420, found m/z 
174.1421.  [α]D = 5.6 (c = 1.0, CHCl3). Enantiopurity was determined by chiral HPLC 
analysis of the 2-naphthoyl derivative (Chiralcel®OJ Isocratic 0.5% IPA/Hexanes).  
tR(major) = 32.2 min.  tR(minor) = 51.9 min. 
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HO
F
O
O
Me
 
 (R)-Ethyl 5-fluoro-6-hydroxyhexanoate (Table 4, entry 4): Prepared according 
to the general procedure from ethyl 5-formylpentanoate (319 µL, 2.00 mmol) to afford a 
colorless oil.  Purification on silica gel (20–40% EtOAc/Pentanes) afforded (R)-ethyl 5-
fluoro-6-hydroxyhexanoate as a colorless liquid (274 mg, 77% yield, 91% ee).  IR (film) 
3436, 2942, 1733, 1453, 1376, 1165, 1096, 1065, 1035, 849.9, 772.2 cm-1; 1H NMR (300 
MHz, CDCl3) δ 4.57 (dm, 1H, J = 49.4, FCH), δ 4.12 (q, 2H, J = 7.2 Hz, CO2CH2), 
δ 3.60–3.78 (m, 2H, OCH2), δ 2.34 (t, 2H, J = 7.0 Hz, CH2CO2), δ 2.04 (s, 1H, -OH), δ 
1.50–1.88 (m, 4H, CFH(CH2)2), δ 1.24 (t, 3H, J = 7.2 Hz, CH3); 13C NMR (75 MHz, 
CDCl3)  δ: 173.3, 94.2 (d, J = 167.3 Hz), 64.8 (d, J = 21.7 Hz), 60.4, 33.8, 30.2 (d, J = 
20.6 Hz), 20.4 (d, J = 5.0 Hz), 14.2.  19F NMR (282 MHz, CDCl3)  δ: –190.3 (m).  HRMS 
(EI+) exact mass calculated for [M+H]+ (C8H16FO3) requires m/z 179.1084, found m/z 
179.1083.  [α]D = 5.1 (c = 1.0, CHCl3). Enantiopurity was determined by chiral HPLC 
analysis of the 2-naphthoyl derivative (Chiralcel®OJ Isocratic 10% EtOH/Hexanes).  
tR(major) = 47.7 min.  tR(minor) = 68.7 min. 
 
HO
F  
 (R)-2-Cyclohexyl-2-fluoro-1-ethanol (Table 4, entry 5): Prepared according to 
the general procedure from 2-cyclohexyl-1-ethanol (291 µL, 2.00 mmol) to afford a 
colorless oil.  Purification on silica gel (10–50% Et2O/Pentanes) afforded (R)-2-
cyclohexyl-2-fluoro-1-ethanol as a colorless liquid (282 mg, 96% yield, 99% ee).  IR 
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(film) 3369, 2928, 2854, 1450, 1091, 1074, 1058, 1024, 977.7, 891.8, 858.9, 837.7 cm-1; 
1H NMR (300 MHz, CDCl3) δ 4.28 (dm, 1H, J = 49.2 Hz, FCH), δ 3.68–3.81 (m, 2H, 
OCH2), δ 1.83−1.94 (m, 2H, CH2), δ 1.56−1.84 (m, 5H, (CH2)2 and OH), δ 0.99−1.34 (m, 
5H, (CH2)2 and CFHCH); 13C NMR (75 MHz, CDCl3) δ: 98.4 (d, J = 168.3 Hz), 63.2 (d, 
J = 26.2 Hz), 30.2 (d, J = 19.1 Hz), 28.1 (dd, J = 22.7, 6.0 Hz), 26.1, 25.7 (d, J = 12.6 
Hz).  19F NMR (282 MHz, CDCl3) δ: –194.7 (m).   HRMS (EI+) exact mass calculated 
for [M+•]+ (C8H15FO) requires m/z 146.1107, found m/z 146.1101.  [α]D = –0.26 (c = 1.0, 
EtOH).  Enantiopurity was determined by GLC using a Macherey-Nagel Hydrodex-B-
TBDAc (50 m x 0.25 mm) column (100 °C isotherm);  (R) isomer tr = 79.9 min and (S) 
isomer tr = 88.8 min. 
 
HO
F
NBOC
 
(R)-tert-Butyl 4-(1-fluoro-2-hydroxyethyl)piperidine-1-carboxylate (Table 4, 
entry 6): Prepared according to the general procedure from tert-butyl 4-
(formylmethyl)piperidine-1-carboxylate (455 mg, 2.00 mmol) to afford a colorless oil.  
Purification on silica gel (25–50% EtOAc/Pentanes) afforded (R)-tert-Butyl 4-(1-fluoro-
2-hydroxyethyl)piperidine-1-carboxylate as a colorless oil (422 mg, 85% yield, 98% ee).  
IR (film) 3430, 2930, 1692, 1671, 1427, 1365, 1283, 1241, 1170, 1084, 1040, 971.6, 
940.0, 857.2, 770.1 cm-1; 1H NMR (300 MHz, CDCl3) δ 4.06–4.40 (m, 3H, N(CHaCHb)2, 
and FCH), δ 3.69–3.83 (m, 2H, OCH2), δ 2.68 (br m, 2H, N(CHaCHb)2), δ 2.01 (t, 1H, J 
= 6.0 Hz, -OH), δ 1.80−1.87 (m, 2H, (CHaCHbCH2)2N), δ 1.51−1.67 (m, 1H, CHFCH), 
δ 1.44 (s, 9H, (CH3)3), δ 1.22–1.32 (m, 2H, (CHaCHbCH2)2N); 13C NMR (75 MHz, 
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CDCl3)  δ: 154.7, 97.3 (d, J = 170.0 Hz), 79.5, 62.8 (d, J = 22.0 Hz), 60.4, 37.1 (d, J = 
19.7 Hz), 28.4, 27.3, 27.3;  19F NMR (282 MHz, CDCl3) δ: –194.5 (bs).  HRMS (EI+) 
exact mass calculated for [M+•]+ (C12H22FNO3) requires m/z 247.1584, found m/z 
247.1587.  [α]D = 3.0 (c = 1.0, CHCl3).  Enantiopurity was determined by chiral HPLC 
analysis of the 2-naphthoyl derivative (Chiralcel®OJ Isocratic 10% EtOH/Hexanes).  
tR(major) = 28.3 min.  tR(minor) = 41.1 min. 
 
HO
F  
(R)-2-Fluoro-2-phenyl-1-ethanol (Table 4, entry 7): Prepared according to the 
general procedure from phenylacetaldehyde (234 µL, 2.00 mmol) to afford a colorless 
oil.  Purification on silica gel (10–50% Et2O/Pentanes) afforded (R)-2-fluoro-2-phenyl-1-
ethanol as a colorless liquid (152 mg, 54% yield, 99% ee), which matched literature 
data.21  IR (film) 3369, 1496, 1454, 1078, 1043, 877.9, 834.2, 757.3, 698.8 cm-1; 1H NMR 
(300 MHz, CDCl3) δ 7.32–7.41 (m, 5H, C6H5), δ 5.57 (ddd, 1H, J = 48.9, 7.7, and 5.2 Hz, 
FCH), δ 3.73–4.01 (m, 2H, OCH2), δ 2.18 (dd, 1H,  -OH);  13C NMR (75 MHz, CDCl3)  
δ: 136.3 (d, J = 19.6 Hz), 128.8 (d, J = 2.0 Hz), 128.6, 125.7 (d, J = 6.9 Hz), 94.8 (d, J = 
170.9 Hz), 66.6 (d, J = 24.5 Hz);  19F NMR (282 MHz, CDCl3)  δ: –187.0 (ddd, J = 12.8, 
7.6, 4.5 Hz).  HRMS (EI+) exact mass calculated for [M+•]+ (C8H9FO) requires m/z 
140.0637, found m/z 140.0636.  [α]D = 47.9 (c = 1.0, CHCl3). Reported rotation for the S-
                                                
21 Watanabe, S.; Fujita, T.; Usui, Y. J. Fluorine Chem. 1986, 31, 247. 
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enantiomer [α]D = –52.5 (c = 1.1, CHCl3).22  Enantiopurity was determined by GLC using 
a Macherey-Nagel Hydrodex-B-TBDAc (50 m x 0.25 mm) column (110 °C isotherm);  
(R) isomer tr = 57.1 min and (S) isomer tr = 59.4 min.  
 
HO
F  
(R)-2-Fluoro-3-phenyl-1-propanol (Table 4, entry 8): Prepared according to the 
general procedure from hydrocinnamaldehyde (263 µL, 2.00 mmol) to afford a colorless 
oil.  Purification on silica gel (10–40% Et2O/Pentanes) afforded (R)-2-fluoro-3-phenyl-1-
propanol as a colorless liquid (218 mg, 71% yield, 96% ee), which matched literature 
data.23  IR (film) 3369, 3029, 2932, 1497, 1455, 1052, 904.3, 835.6, 745.7, 700.0 cm-1; 1H 
NMR (300 MHz, CDCl3) δ 7.21–7.36 (m, 5H, C6H5), δ 4.78 (dm, 1H, J = 48.6 Hz, FCH), 
δ 3.60–3.85 (m, 2H, OCH2), δ 2.87–3.10 (m, 2H, PhCH2), δ 1.97 (t, 1H, J = 6.1 Hz, -
OH); 13C NMR (75 MHz, CDCl3) δ: 136.3 (d, J = 6.0 Hz), 129.3, 128.6, 126.8, 95.6 (d, J 
= 170.6 Hz), 64.1 (d, J = 21.3 Hz), 37.4 (d, J = 20.0 Hz); 19F NMR (282 MHz, CDCl3) 
δ: –187.6 (m).  HRMS (EI+) exact mass calculated for [M+•]+ (C9H11FO) requires m/z 
154.0794, found m/z 194.0797.  [α]D = 16.7 (c = 1.0, CHCl3).  Reported rotation for the 
S-enantiomer [α]D = –17.6 (c = 1.7, CHCl3).23  Enantiopurity was determined by GLC 
using a Macherey-Nagel Hydrodex-B-TBDAc (50 m x 0.25 mm) column (120 °C 
isotherm);  (R) isomer tr = 76.1 min and (S) isomer tr = 84.3 min. 
 
                                                
22 Davis, F. A.; Han, W. Tetrahedron Lett. 1992, 33, 1153. 
23 Takeuchi, Y.; Nagata, K.; Koizumi, T. J. Org. Chem. 1989, 54, 5453. 
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HO
F  
 (R)-2-Adamantyl-2-fluoro-1-ethanol (Table 4, entry 9): Prepared according to 
the general procedure from adamantylacetaldehyde (334 µL, 2.00 mmol) to afford a 
colorless oil.  Purification on silica gel (5–20% EtOAc/Pentanes) afforded (R)-2-
adamantyl-2-fluoro-1-ethanol as a colorless solid (326 mg, 82% yield, 98% ee).  IR 
(film) 3306, 2903, 2850, 1451, 1348, 1087, 1058, 1028, 989.3, 859.0 cm-1; 1H NMR (300 
MHz, CDCl3) δ 4.07 (ddd, 1H, J = 49.7, 7.8, and 5.1 Hz, FCH), δ 3.62–3.88 (m, 2H, 
OCH2), δ 1.99 (s, 3H, CH(CH2)3) δ 1.54–1.84 (m, 13H, -OH, (CH2)6);  13C NMR (75 
MHz, CDCl3) δ: 101.8 (d, J = 170.3 Hz), 61.3 (d, J = 22.3 Hz), 37.7 (d, J = 4.1 Hz), 36.9, 
35.4 (d, J = 19.6 Hz), 27.9 (J = 0.6 Hz);  19F NMR (282 MHz, CDCl3) δ: –203.1 (ddd, J = 
48.5, 34.2, 17.2 Hz).  HRMS (EI+) exact mass calculated for [M+•]+ (C12H19FO) requires 
m/z 198.1420, found m/z 198.1417.  [α]D = –9.5 (c = 1.0, CHCl3).  Enantiopurity was 
determined by chiral HPLC analysis of the 2-naphthoyl derivative (Chiralcel®OJ Isocratic 
3% IPA/Hexanes).  tR(major) = 20.8 min.  tR(minor) = 26.5 min. 
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Chapter 4  
Enantioselective Organocatalytic Direct α-Fluorination of Ketones 
 
Introduction 
In the previous chapter, the development of the enantioselective enamine-
catalyzed α-fluorination of aldehydes was discussed.  Due to the importance of fluorine 
stereocenters and the scarcity of direct methods for creating them, we subsequently 
sought to expand on this valuable methodology to include the α-fluorination of ketones.  
As mentioned in the previous chapter, the majority of direct asymmetric fluorination 
methods have focused (with the exception of the enamine-catalyzed aldehyde 
fluorination) on highly enolizable substrates such as β-ketoesters that are precluded from 
product epimerization.1  Asymmetric construction of epimerizable α-fluoroketone 
stereocenters has only been accomplished with low yields and selectivities, or by multi-
step syntheses.  For example, a two-step procedure for preparing chiral α-fluoroketones 
introduced by Haufe and coworkers explored the possibility of desymmetrizing meso 
epoxides by catalytic asymmetric ring opening using a fluoride source, subsequent 
                                                
1 (a) Hintermann, L.; Togni, A. Angew. Chem. Int. Ed. 2000, 112, 4530.  (b) Frantz, R.; Hintermann, L.; Perseghini, 
M.; Broggini, D.; Togni, A. Org. Lett. 2003, 5, 1709.  (c) Hamashima, Y.; Yagi, K.; Takano, H.; Tamás, L.; 
Sodeoka, M. J. Am. Chem. Soc. 2002, 124, 14530.  (d) Kim, D. Y.; Park, E. J. Org. Lett. 2002, 4, 545.  (e) 
Hamashima, Y.; Yagi, K.; Takao, H.; Hotta, D.; Sodeoka, M. Org. Lett. 2003, 5, 3225.  (f) Ma, J.-A.; Cahard, D. 
Tetrahedron: Asymmetry 2004, 15, 1007.  (g) Shibata, N.; Ishimaru, T.; Nagai, T.; Kohno, J.; Toru, T. Synlett. 2004, 
1703. 
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oxidation of which would yield the desired fluoroketones.2  Using catalytic quantities of 
Jacobsen’s chromium salen complex 1, the fluorohydrin was obtained in 42% yield and 
67% ee (equation 1).  Higher conversions could be obtained but required stoichiometric 
amounts of the chromium complex.  
OH
F
20 mol% 1
20 mol% AgF
Bu4N
+H2F3
–, Et2O
rt, 140 h
42% yield
67% ee
(1)
1 equiv.
O
N
O
t-Bu
t-Bu
N
t-BuO
t-Bu
Cr
HH
Jacobsen's Cr-Salen complex 1
Cl
 
 
2.5 mol% [Pd2(dba)3]
THF, rt
95% yield
97% ee
(2)
1 equiv.
MeO
O
O
O
F
MeO
O
F
PPh2
N
O
t-Bu
6 mol%
 
Additionally, Nakamura et al. showed that racemic α-fluoro-β-ketoesters could 
undergo enantioselective decarboxylative allylation to generate α-allyl-α-fluoroketones 
in high yield and enantiomeric excess (equation 2).3  However, as with most 
methodologies that produce α-fluoro stereocenters, this method also generates a product 
that is precluded from post-epimerization. 
Recently, Szori, Szöllosi, and Bartók reported an asymmetric hydrogenation of 
racemic 2-fluorocyclohexanone over a cinchona alkaloid-modified platinum-aluminum 
oxide catalyst.4  As the reaction progressed, a kinetic resolution was observed and one 
                                                
2 (a) Haufe, G.; Bruns, S. Adv. Synth. Catalysis 2002, 344, 165. (b) Haufe, G.; Bruns, S.; Runge, M. J. Fluorine Chem. 
2001, 112, 55. 
3 (a) Nakamura, M.; Hajra, A.; Endo, K.; Nakamura, E. Angew. Chem. Int. Ed. 2005, 44, 7248.  (b) Burger, E. C.; 
Barron, B. R.; Tunge, J. A. Synlett 2006, 2824. 
4 Szori, K.; Szöllosi, G.; Bartók, M. J. Catalysis 2006, 244, 255. 
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enantiomer of the racemic starting material was accumulated in the reaction.  Using 
methoxy-cinchonidine (CD-OMe), α-fluorocyclohexanone was observed at 61% ee when 
the reaction had reached 60% conversion (equation 3).  
OMe
N
N
H
O
O
FPt/Al2O3, H2
AcOH/THF
61% ee at 
59% conv. to alcohol
(3)
1 equiv.
CD-OMe
F
OH
F
 
In an attempt to perform a direct α-fluorination of ketones using enamine 
activation, which had been successful with aldehydes, Enders and Hüttl studied α-
fluorination of ketones using proline-based catalysts and F-TEDA as the fluorine source 
(equation 4).5  Unfortunately, the best result obtained was 56% conversion and 34% ee 
for α-fluorocyclohexanone using 4-hydroxyproline as the catalyst.  Enders has also 
demonstrated the asymmetric synthesis of fluoroketones using the SAMP/RAMP chiral 
auxiliaries to α-silate ketones enantioselectively, which can then be fluorinated 
diastereoselectively and desilated to generate the desired fluoroketones; however, this 
method requires a minimum of five synthetic steps.6 
N
H
CO2H
HO
O
N
N
F
Cl
O
F30 mol%
CH3CN, rt
56% conv.
34% ee
(4)
1.3 equiv. 1 equiv.
F-TEDA
2 BF4
-
  
                                                
5 Enders, D.; Hüttl, M. R. M. Synlett, 2005, 991. 
6 Enders, D.; Faure, S.; Potthoff, M.; Runsink, J. Synthesis 2001, 2307. 
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α -Fluorination using Imidazolidinone Catalysts 
 Like Enders, we also felt that the enamine activation mode could potentially 
provide direct access to fluorinated ketones, and in contrast to other established methods 
for creating stereogenic fluorine centers, enamine catalysis should enable the induction of 
epimerizable stereocenters.  Since our lab’s class of imidazolidinone catalysts had been 
shown to perform readily as enamine catalysts and had already achieved high levels of 
stereoselectivities for the α-chlorination and α-fluorination of aldehydes, we felt that this 
class of catalyst might be able to overcome the reactivity and selectivity issues that 
Enders had faced with proline-based catalysts.  Although the typical imidazolidinone 
catalysts that yield high reactivities with aldehydes had been shown to react very poorly 
with ketones, former graduate student Alan Northrup successfully developed a furanyl-
imidazolidinone 2 that facilitated the first enantioselective ketone Diels-Alder reaction 
with excellent yields and stereoselectivities (equation 5).7,8  
Et
O OMe
COEt
OMe
20 mol% 2,
20 mol% HClO4
EtOH, –30 ºC
(5)
2
88% yield
96% ee
>200:1 dr
N
N
H
Me
O
Me
Ph
O
 
Employing catalyst 2 with our previously determined aldehyde fluorination 
reaction conditions and two equivalents of N-fluorobenzenesulfonimide (NFSI) as the 
fluorine source, we were delighted to find that 2-fluorocyclohexanone could be obtained 
in 85% conversion and 34% enantiomeric excess (ee) (equation 6). While this result was 
                                                
7 Northrup, A. B.; MacMillan, D. W. C. J. Am. Chem. Soc. 2002, 124, 2458. 
8 Tuttle, J. B.; Ouellet, S. G.; MacMillan, D. W. C. J. Am. Chem. Soc. 2006, 128, 12662. 
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very promising, the stereoselectivity was far from optimal.  Interestingly, when F-TEDA 
was used as the fluorine source, high levels of conversion were also obtained but with no 
stereoselectivity (equation 7).  This result is possible evidence for the transition state 
proposed for the aldehyde fluorination with NFSI in which the sulfonimide of the 
fluorinating agent is hydrogen-bonded to the enamine through a proton.  
O
O
F 85% conv.
34% ee
(6)
1 equiv. 2 equiv.
20 mol% 2
20 mol% TFA
10% IPA/THF
–10 ºC, 15 h
NFSI
 
O
O
F
20 mol% 2
20 mol% TFA
CH3CN, –10 ºC
16 h
82% conv.
6% ee
(7)
1 equiv. 1.5 equiv.
F-TEDA
 
During the development of the aldehyde α-fluorination (chapter 3), it was noted 
that the reaction medium had a large impact on the outcome of the reaction.  We 
therefore investigated the ketone fluorination in a variety of solvents, both with and 
without the addition of 10% isopropanol (IPA).  However, the initial reaction conditions 
were determined to be optimal and we next focused our efforts on evaluating the effect of 
catalyst architecture.  With the goal of developing a more broadly useful catalyst for the 
enamine and iminium-catalyzed functionalization of ketones, graduate student Anthony 
Mastracchio had prepared a number of imidazolidinone catalysts with modified catalyst 2 
architectures.  As shown in Table 1, all catalysts achieved excellent reactivity; however, 
no significant improvement in enantioselectivity was obtained for any of the catalysts 
studied.  A variety of pyrrolidine-based catalyst architectures were also studied but poor 
conversions and very low selectivities were obtained.  Subsequently, we turned our 
attention to a class of mono-substituted imidazolidinone catalysts (Figure 1), which had 
been demonstrated to induce high levels of selectivity for the transfer hydrogenation of 
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Table 1.  Effect of Modifications to Catalyst 2 Architecture 
10% IPA/THF
–10 ºC
entry
1
3
2
7
3
4
5
6
7
8
R1 time (h) % ee
b
N
N
H
R1
O Me
20 mol%
•TFA
% conversiona
O
O
F
1 equiv. product
R2
2 equiv. NFSI
O
R2
Ph
Ph
p-NO2-Ph
p-NO2-Ph
p-Ot-Bu-Ph
2-naphthyl
1-naphthyl
Me
CF3
7
Me
CF3
CF3
CF3
CF3
CF3
10
4
11
7
10
10
3
10
10
20
80
34
97
7
90
89
87
91
86
62c
34
3
29
7
8
14
36
27
13
13
Ph
Ph
 
(a) Conversion determined by GLC analysis relative to an internal 
standard (methyl cyclohexanecarboxylate).  (b) Enantiomeric excess 
determined by GLC analysis (Macherey-Nagel Hydrodex-B-
TBDAc).  (c) Reaction performed at +4 ºC. 
aldehydes9 and shown promise as a catalyst for enamine-catalyzed reactions of ketones.10  
As shown in Table 2, reactions performed with catalyst 3 achieved very high levels of 
enantioselectivity; however, the bulky tert-butyl group severely hindered the reaction 
efficiency and a maximum of 23% conversion was obtained.  Notably, the cis-diphenyl-
diamino catalyst 6 developed by Jørgensen and successfully used for the α-chlorination 
                                                
9 Ouellet, S. G.; Tuttle, J. B.; MacMillan, D. W. C. J. Am. Chem. Soc. 2005, 127, 32. 
10 Kim, Y.-K.; MacMillan, D. W. C. unpublished results. 
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and α-bromination of ketones11 yielded both low conversion and selectivity in the 
fluorination reaction. 
N
N
H
MeO
N
N
H
Me
Me
O
Me
N
N
H
Me
Me
O
Me
Me
HN
N
H
Ph
Ph
3 4 5 6
 
Figure 1.  Structures of monosubstituted imidazolidinone catalysts and 
Jørgensen’s cis-diphenyl-diamino catalyst. 
Table 2.  Mono-Substituted Imidazolidinone Catalysts 
3
3
3
4
4
5
5
6
entry
1
2
3
4
5
6
7
8
73
87
87
58
64
37
45
25
% eeb
23c
19c,d
21c,d
53
35
79
45
41e
% conversionacatalyst
+23
+4
–10
+4
–10
–20
–40
+23
Temp (ºC)
15
27
120
24
24
16
16
18
time (h)
O O
F
1 equiv. 2 equiv.
20 mol% catalyst
20 mol% TFA
10% IPA/THF
NFSI
product
 
(a) Conversion determined by GLC analysis relative to an internal 
standard (methyl cyclohexanecarboxylate).  (b) Enantiomeric 
excess determined by GLC analysis (Macherey-Nagel Hydrodex-
B-TBDAc).  (c) Reactions using 20 mol% TCA instead of TFA. 
(d) Reactions performed without IPA.  (e) Reactions using 20 
mol% BzOH instead of TFA. 
In an attempt to optimize the reaction efficiency using catalyst 3, studies were 
conducted in which the solvent, alcohol additive, catalyst loading and concentration were 
varied.  While increasing the reaction concentration from 0.125M to 1.0M did achieve 
                                                
11 (a) Marigo, M.; Bachmann, S.; Halland, N.; Braunton, A.; Jørgensen, K. A. Angew. Chem. Int. Ed. 2004, 43, 5507.  
(b) Bertelsen, S.; Halland, N.; Bachmann, S.; Marigo, M.; Braunton, A.; Jørgensen, K. A. Chem. Commun. 2005, 
4821. 
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conversions as high as 38%, the enantioselectivity decreased with increasing 
concentration.  Using 10% IPA as an additive, product epimerization with time was quite 
noticeable and switching to ethanol or methanol significantly slowed the loss of 
stereoselectivity; unfortunately the maximum conversions achieved were identical to 
those using IPA.  Variations in solvent and catalyst loading were also found to have no 
beneficial effect. 
Cinchona Alkaloid Catalysts 
NH2
N
N
9-epi-CDA
7
9-epi-QA
8
9-epi-DHQA
9
9-epi-CA
10
H
NH2
N
N
H
NH2
N
N
H
OMe
H2N
N
N
H
OMe
H2N
N
N
H
H2N
N
N
H
OMe OMe
9-epi-QDA
11
9-epi-DHQDA
12
 
Figure 2.  Structures of cinchona alkaloid-derived catalysts; 
CD=cinchonidine, Q=quinine, C=cinchonine, QD=quinidine 
DH=dihydro, A=amine. 
 Recently, McCooey and Connon introduced cinchona alkaloid-derived primary 
amine catalysts for the enamine-catalyzed addition of ketones to nitroolefins.12  Since 
then a number of papers have been published demonstrating the broad usefulness of this 
                                                
12 McCooey, S. H.; Connon, S. J. Org. Lett. 2007, 9, 599. 
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class of catalysts for both enamine13 and iminium catalysis.14  We investigated this 
catalyst class in the α-fluorination of ketones and found that while the tris-HCl salt of 9-
epi-DHQDA 12 resulted in no reaction, 20 mol% of the free-based catalyst with 40 mol% 
of para-toluenesulfonic acid (pTSA) as cocatalyst at ambient temperature achieved 
remarkably high enantioselectivity, albeit in low conversion (equation 8).  Use of 
acetonitrile as solvent achieved much higher reaction efficiency; however, the 
stereoselectivity was very low (equation 9).   
O
O
F
32% conv.
63% ee
(8)
1 equiv. 2 equiv.
20 mol% 12
40 mol% pTSA
THF, rt, 24 h
NFSI
 
O
O
F
53% conv.
15% ee
(9)
1 equiv. 2 equiv.
20 mol% 12
40 mol% pTSA
CH3CN, rt, 24 h
NFSI
 
Interestingly, while reactions performed without cocatalyst yielded much lower 
conversions, the use of anywhere from 20 to 40 mol% of cocatalyst achieved identical 
results to those performed with 40 mol%.  However, reactions performed with 60 mol% 
of cocatalyst resulted in precipitation of the catalyst and no reaction was observed.  This 
led us to speculate that as the reaction progresses and an equivalent of acid is produced, 
the catalyst would eventually form a tris-salt and precipitate out of solution, leading to 
the reaction stalling at low conversion.  To circumvent this problem, base additives were 
                                                
13 Liu, T.-Y.; Cui, H.-L.; Zhang, Y.; Jiang, K.; Du, W.; He, Z.-Q.; Chen, Y.-C. Org. Lett. 2007, 9, 3671. 
14  (a) Xie, J.-W.; Chen, W.; Li, R.; Zeng, M.; Du, W.; Yue, L.; Chen, Y.-C.; Wu, Y.; Zhu, J.; Deng, J.-G. Angew. 
Chem. Int. Ed. 2007, 46, 389. (b) Bartoli, G.; Bosco, M.; Carlone, A.; Pesciaioli, F.; Sambri, L.; Melchiorre, P. Org. 
Lett. 2007, 9, 1403.  (c) Ricci, P.; Carlone, A.; Bartoli, G.; Bosco, M.; Sambri, L.; Melchiorre, P. Adv. Synth. Catal. 
2008, 350, 49.  (d) Li, X.; Cun, L.; Lian, C.; Zhong, L.; Chen, Y.; Liao, J.; Zhu, J.; Deng, J. Org. Biomol. Chem. 
2008, 6, 349. 
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O
O
F
52% conv.
88% ee
(10)
1 equiv. 2 equiv.
20 mol% 12
20 mol% pTSA
1.5 equiv. NaHCO3
THF, rt, 18 h
NFSI
 
investigated and to our delight, it was found that the addition of 1.5 equivalents of 
sodium bicarbonate (NaHCO3) to the reaction mixture resulted in a significant increase in 
both conversion and enantioselectivity (equation 10).  Other additives such as alcohols 
and molecular sieves, which had been used in literature procedures with cinchona-derived 
amine catalysts,15 were not beneficial for the α-fluorination reaction. 
Table 3.  Effect of Concentration and Base 
0.5
0.33
0.33
0.33
0.33
0.25
0.167
0.125
entry
1
2
3
4
5
6
7
8
86
88
89
89
90
91
92
94
% eeb
54
57
52
53
51
56
39
34
% conversionaconc. (M)
1.5
1
1.5
2
4
1.5
1.5
1.5
equiv. NaHCO3
1
4
2
2
2
2
2
2
time (h)
O O
F
1 equiv. 2 equiv.
20 mol% 12
20 mol% p-TSA
NaHCO3, THF, rt
NFSI
product
 
(a) Conversion determined by GLC analysis relative to an internal 
standard (methyl cyclohexanecarboxylate).  (b) Enantiomeric 
excess determined by GLC analysis (Macherey-Nagel Hydrodex-
B-TBDAc). 
 Subsequently, studies were performed to determine the effect of concentration 
and additional base additive (Table 3).  Although increasing the amount of base used in 
the reaction resulted in slight increases in enantioselectivity (entry 5), conversions 
                                                
15 See reference 13. 
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remained unchanged.  On the other hand, more dilute reaction conditions achieved 
significantly higher enantioselectivities (entry 8), but with lower reaction efficiency.   
In all cases studied, it appeared that the reactions were stalling at about 50–60% 
maximum conversion, possibly due to tris-salt formation that was not being free-based by 
the excess NaHCO3, or more likely, due to reaction of the catalyst with NFSI over time, 
generating either an unreactive or insoluble form of the catalyst.  Notably, transfer 
fluorination from NFSI to cinchona alkaloids has been demonstrated in the literature and 
used for preparing cinchona-derived fluorinating agents.16   
Table 4.  Effect of Temperature and Stoichiometry 
+23
+4
–10
–20
+4
–20
–20
+23
entry
1
2
3
4
5
6
7
8
85
95
94
96
96
97
97
94
% eeb
53
64
71
70
72
72
88
70
% conversionaTemp (ºC)
1
1
1
1
1.5
1.5
2
3
equiv. ketone
2
8
24
44
8
24
24
2
time (h)
O O
F
20 mol% 12
20 mol% p-TSA
NaHCO3, THF
NFSI
product
 
(a) Conversion determined by GLC analysis relative to an internal 
standard (methyl cyclohexanecarboxylate).  (b) Enantiomeric 
excess determined by GLC analysis (Macherey-Nagel Hydrodex-
B-TBDAc). 
In order to circumvent unwanted fluorination of the catalyst and since the highly 
concentrated reactions were found to be complete in only 1 hour (Table 3, entry 1), the 
reaction temperature was lowered and the stoichiometry of the reaction was altered so 
                                                
16 Baudequin, C.; Loubassou, J.-F.; Plaquevent, J.-C.; Cahard, D. J. Fluorine Chem. 2003, 122, 189. 
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that NFSI was used as the limiting reagent.  As shown in Table 4, reactions performed at 
–20 ºC with excess of ketone achieved excellent levels of conversion and 
enantioselectivity (entry 7; 88% conv., 97% ee).   Reactions using these conditions 
performed in DME, EtOAc, CH3CN, and DMF demonstrated that the choice of THF as 
the reaction medium was optimal.17 
With these optimized reaction conditions in hand, we next investigated the use of 
other cinchona alkaloid-derived catalysts to determine if equal levels of enantioselectivity 
and reactivity could be achieved for the opposite enantiomer of the product.  
Gratifyingly, reactions performed with catalysts 7 and 8 resulted in equally high 
enantioselectivities and good conversions to the desired (S)-2-fluorocyclohexanone 
(equations 11 and 12).  Catalyst 10 resulted in slightly lower selectivities than those 
obtained with catalyst 12, but maintained excellent reaction efficiency (equation 13). 
O
O
F
74% conv.
98% ee
(11)
2 equiv. 1 equiv.
20 mol% 7
20 mol% pTSA
2 equiv. NaHCO3
THF, –20 ºC, 24 h
NFSI
 
O
O
F
84% conv.
97% ee
(12)
2 equiv. 1 equiv.
20 mol% 8
20 mol% pTSA
2 equiv. NaHCO3
THF, –20 ºC, 24 h
NFSI
 
O
O
F
84% conv.
95% ee
(13)
2 equiv. 1 equiv.
20 mol% 10
20 mol% pTSA
2 equiv. NaHCO3
THF, –20 ºC, 24 h
NFSI
 
 Lastly, these reaction conditions have now been applied to a variety of cyclic 
ketone substrates.  Postdoctoral fellow Dr. Piotr Kwiatkowski has successfully 
                                                
17 Reactions performed using 1.5 equiv. ketone, 2 equiv. NaHCO3 at –20 ºC for 24 h in DME: 68% conv., 96% 
ee; EtOAc: 63% conv., 90% ee; CH3CN: 53% conv. 79% ee; DMF: 13% conv., 92% ee. 
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synthesized chiral 2-fluorocyclohexyl ketones in good yields and excellent 
enantioselectivities (Table 5).  Further studies are being conducted by Dr. Kwiatkowski 
towards the fluorination of acyclic rings and heterocyclic ketones such as N-BOC-
piperidone and 4-tetrahydropyranone, which react under the optimized reaction 
conditions with excellent enantioselectivities, but are currently difficult to isolate as they 
readily form hydrates and epimerize under standard chromatographic methods.  Full 
details of the scope of this reaction will soon be reported. 
Table 5.  α-Fluorination of Ketone Substrates 
entry
1
3
2
7
3
product % yielda
O
O
O
O
Me Me
Ph Ph
O O
F
F
F
F
O
F
entry
4
3
5
product
O O
F
2 equiv. 1 equiv.
20 mol% 12
20 mol% p-TSA
NaHCO3, THF, –20 ºC
product
S
N
S
PhPh
O O O O
F
% ee % yield % ee
50b (88)
3
65b (95)
7
88
97
3
96
7
94
73 (79)
3
85 (90)
98
3
94
 
(a) Isolated yields after silica gel chromatography.  Yields in parentheses 
obtained by GLC analysis relative to an internal standard (methyl 
cyclohexanecarboxylate).  (b) Volatile products. 
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Conclusion 
In summary, the development of the first highly enantioselective direct α-
fluorination of ketones has been accomplished using cinchona alkaloid-derived catalysts.  
While traditional catalysts for the amine-catalyzed functionalization of ketones failed to 
provide desired levels of conversion and stereoselectivity, high yields with excellent 
enantioselectivities were obtained using 20 mol% of 9-Epi-DHQDA catalyst and NFSI as 
the fluorine source.  This method provides epimerizable fluorine stereocenters using an 
organocatalyst that is easily prepared and using reaction conditions that are insensitive to 
both air and moisture, making it a valuable tool for practitioners of pharmaceutical and 
synthetic chemistry.  
 
                                                   73 
S u p p o r t i n g  I n f o r m a t i o n  
General Information.  Commercial reagents were distilled prior to use following the 
guidelines of Perrin and Armarego.18  Organic solutions were concentrated under reduced 
pressure on a Büchi rotary evaporator. Chromatographic purification of products was 
accomplished using forced-flow chromatography on EMD Silica Gel 60 230-400 mesh or 
Davisil® Silica Gel 200-425 mesh according to the method of Still.19 Thin-layer 
chromatography (TLC) was performed on EM Reagents 0.25 mm silica gel 60-F plates.  
Visualization of the developed chromatogram was performed by fluorescence quenching 
using potassium permanganate stain.  High performance liquid chromatography (HPLC) 
and gas liquid chromatography (GLC) assays to determine enantiomeric excess were 
developed using racemic samples. 
1H, 13C and 19F NMR spectra were recorded on Bruker UltrashieldTM Plus 500 
(500 MHz, 125 MHz) and 19F NMR spectra were recorded on Varian Mercury 300 (282 
MHz) as noted, and are internally referenced to residual protio solvent signals.  Data for 
1H are reported as follows: chemical shift (δ ppm), multiplicity (s = singlet, d = doublet, t 
= triplet, q = quartet, m = multiplet), integration, coupling constant (Hz), and assignment.  
Data for 13C and 19F NMR are reported as follows: chemical shift (δ ppm), multiplicity (s 
= singlet, d = doublet, t = triplet, q = quartet, m = multiplet), and coupling constant (Hz).  
IR spectra were recorded on a Perkin Elmer Spectrum BX FT-IR spectrometer and are 
reported in terms of frequency of absorption (cm-1).  Mass spectra were obtained from the 
                                                
18 Perrin, D. D.; Armarego, W. L. F.  Purification of Laboratory Chemicals; 3rd edition; Pergamon Press; Oxford, 1988. 
19 Still, W. C.; Kahn, M.; Mitra, A. J. J. Org. Chem. 1978, 43, 2923. 
                                                   74 
Princeton University Mass Spectral Facility.  Gas liquid chromatography (GLC) was 
performed on a Hewlett-Packard 6850 Series gas chromatograph equipped with a split-
mode capillary injection system and flame ionization detectors using a Macherey-Nagel 
Hydrodex-B-TBDAc (50 m x 0.25 mm) column.  High performance liquid 
chromatography (HPLC) was performed on a Hewlett Packard 1100 Series 
chromatograph using a Chiralcel® OJ column (25 cm, 5 cm guard) as noted. 
 
Starting Materials 
H2N
N
N
H
OMe
9-epi-DHQDA
12  
9-Epi-DHQDA:  The triple HCl salt was prepared from hydroquinidine according to the 
procedure of McCooey and Connon.20  Isolation of the pure salt was accomplished by 
dissolving the residue (15 mmol scale reaction) in approx. 250 mL of MeOH while 
heating to 55 ºC.  EtOAc was dripped into the hot solution until the first signs of a fine 
powder begin to form.  The solution was cooled to rt, then placed in a –20 ºC freezer 
overnight.  Care must be taken not to crash out the powder by adding additional EtOAc, 
which results in impure catalyst.  The triple salt was free-based by partitioning between 
1N NaOH and DCM, extracting 3 x with DCM, and drying over Na2SO4.  1.9g obtained, 
29% yield. 
                                                
20 McCooey, S. H.; Connon, S. J. Org. Lett. 2007, 9, 599. 
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General Procedure for the α-Fluorination of Ketones:  To a 10 mL round-bottom 
flask equipped with a magnetic stir bar and charged with 9-Epi-DHQDA (16 mg, 0.05 
mmol), p-toluenesulfonic acid (9.5 mg, 0.05 mmol), N-fluorobenzenesulfonimide (79 mg, 
0.25 mmol), and NaHCO3 (42mg, 0.50 mmol) was added THF (1.0 mL) and the mixture 
was cooled to –20 °C.  The mixture was stirred for 15 min to allow time for the catalyst 
to dissolve.  Ketone (0.50 mmol) was added and the reaction mixture stirred at –20 ºC for 
24 h.  The reaction was filtered through a pad of silica gel, eluting with Et2O and purified 
by silica gel chromatography.  Purification of the resulting oil by forced flow 
chromatography afforded the title compounds.  The enantioselectivity was determined 
either by chiral GLC analysis, chiral HPLC or SFC analysis.  The GC yield was 
determined using methyl cyclohexane-carboxylate as an internal standard and calculated 
with a GC response factor. 
 
α-Fluoro Ketones 
O
F
 
(R)-2-Fluorocyclohexanone (Table 5, entry 1): Prepared according to the 
general procedure from cyclohexanone (259 µL, 2.50 mmol) to afford a colorless oil.  
Purification on silica gel (20–40% Et2O/Pentanes) afforded (S)-2-fluorocyclohexanone as 
a colorless liquid (73 mg, 50% yield, 88% GC yield, 97% ee).  IR (film) 2947, 2870, 
1729, 1452, 1431, 1316, 1086, 1067, 951.5, 912.7, 879.7, 836.9, 743.2, 665.5 cm-1; 1H 
NMR (Varian 400 MHz, CDCl3). δ 4.86 (dm, J = 49.0 Hz, 1H, FCH), δ 2.34–2.59 (m, 
1H, O=CCH2), δ 2.28–2.46 (m, 2H, O=CCH2, FCHCH2), δ 1.92–2.06 (m, 2H, 
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FCHCH2CH2), δ 1.78–1.92 (m, 1H, FCHCH2), δ 1.60–1.78 (m, 2H, O=CCH2CH2); 13C 
NMR (125 MHz, CDCl3)  δ;  205.9 (d, J = 14.8 Hz), 92.9 (d, J = 190.3 Hz), 40.4, 34.4 (d, 
J = 18.6 Hz), 27.1 (d, J = 1.0 Hz), 22.9 (d, J = 10.0 Hz).  19F NMR (282 MHz, CDCl3) 
δ: –188.7 (dm, J = 48.4 Hz).  HRMS (ES) exact mass calculated for [M+H]+ (C6H9FO) 
requires m/z 116.0637, found m/z 116.0637.  [α]D = +44.0 (c = 0.68, C6H6).21  
Enantiopurity was determined by GLC using a Macherey-Nagel Hydrodex-B-TBDAc (50 
m x 0.25 mm) column (120 °C, 15 min; 140 ºC, 30 min);  (S) isomer tr = 39.6 min and (R) 
isomer tr = 41.2 min. 
O
F
Me Me  
 (R)-2-Fluoro-4,4-dimethylcyclohexanone (Table 5, entry 2): Prepared 
according to the general procedure from 4,4-dimethylcyclohexanone (66 mg, 0.50 mmol) 
to afford a colorless oil.  Purification on silica gel (5–20% Et2O/Pentanes) afforded (S)-2-
Fluoro-4,4-dimethylcyclohexanone as colorless volatile crystals (24 mg, 65% yield, 95% 
GC yield, 96% ee).  IR (film) 2595, 2933, 2866, 1727, 1474, 1424, 1366, 1316, 1179, 
1129, 1115, 1083, 1048, 1016, 998, 911, 855, 732.1, 703.5 cm-1; 1H NMR (500 MHz, 
CDCl3). δ 5.03 (dddd, J = 48.4, 12.5, 6.6, 0.8 Hz, 1H, FCH), δ 2.34–2.59 (m, 2H, 
O=CCH2), δ 2.18 (dddd, J = 12.5, 6.8, 5.6, 3.2, 1H, FCHCH2), δ 1.61–1.88 (m, 3H, 
FCHCH2, O=CCH2CH2), 1.24 (s, 3H, CH3), δ 1.10 (s, 3H, CH3); 13C NMR (125 MHz, 
CDCl3)  δ;  206.3 (d, J = 13.4 Hz), 90.6 (d, J = 189.4 Hz), 46.3 (d, J = 15.7 Hz), 39.5 (d, 
                                                
21 (R)-2-Fluorocyclohexanone [α]D = +54.8 (c = 0.68, C6H6):  Enders, D.; Faure, S.; Potthoff, M.; Runsink, J. 
Synthesis 2001, 2307. 
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J = 1.0 Hz), 36.8, 32.5 (d, J = 10.0 Hz), 31.4, 25.0.  19F NMR (282 MHz, CDCl3) δ: –
193.9 (dm, J = 48.4 Hz).  HRMS (ES) exact mass calculated for [M+H]+ (C8H14FO) 
requires m/z 144.0950, found m/z 144.0950.  [α]D = +46.4 (c = 1.0, CHCl3).  
Enantiopurity was determined by GLC using a Macherey-Nagel Hydrodex-B-TBDAc (50 
m x 0.25 mm) column (120 °C, 15 min; 150 ºC, 30 min);  (S) isomer tr = 26.4 min and (R) 
isomer tr = 28.3 min. 
O
F
Ph Ph  
 (R)-2-Fluoro-4,4-diphenylcyclohexanone (Table 5, entry 3): Prepared 
according to the general procedure from 4,4-diphenylcyclohexanone (252 mg, 1.04 
mmol) to afford a colorless oil.  Purification on silica gel (5–20% EtOAc/Petroleum 
ether) afforded (S)-2-Fluoro-4,4-diphenylcyclohexanone as a colorless solid (119 mg, 
88% yield, 94% ee).  IR (film) 3.59, 2960, 1738, 1599, 1496, 1447, 1072, 1033, 886.4, 
841.1, 751.4, 700.5 cm-1; 1H NMR (500 MHz, CDCl3). δ 7.56 (dd, J = 8.4, 1.2 Hz, 1H, 
Ph), δ 7.43–7.51 (m, 1H, Ph), δ 7.32–7.38 (m, 1H, Ph), δ 7.24–7.32 (m, 2H, Ph), δ 7.13–
7.23 (m, 2H, Ph), δ 5.01 (ddd, J = 48.2, 12.8, 6.2 Hz, 1H, FCH), δ 3.28–3.54 (m, 1H, 
FCHCH2), δ 2.91–3.09 (m, 1H, FCHCH2), δ 2.51–2.66 (m, 2H, O=CCH2CH2), δ 2.29–
2.44 (m, 1H, O=CCH2); 13C NMR (125 MHz, CDCl3)  δ 205.0 (d, J = 13.5 Hz), 147.3, 
142.2, 129.6, 128.8, 127.3, 127.0, 126.8, 126.0, 90.5 (d, J = 190.3 Hz), 47.4 (d, J = 10.4 
Hz), 43.5 (d, J = 18.2 Hz), 37.5, 37.1.  19F NMR (282 MHz, CDCl3) δ: –192.5 (d, J = 49.0 
Hz).  HRMS (ES) exact mass calculated for [M+H]+ (C18H18FO) requires m/z 268.1263, 
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found m/z 268.1262.  [α]D = +2.6 (c = 1.1, CHCl3).  Enantiopurity was determined by 
SFC analysis (Chiralcel®ADH 5-50% CH3CN).  tR(minor) = 3.3 min.  tS(major) = 3.5 min. 
 
O
F
 
 (R)-2-Fluoro-4-(propan-2-ylidene)cyclohexanone (Table 5, entry 4): Prepared 
according to the general procedure from 4-(propan-2-ylidene)cyclohexanone (145 mg, 
1.04 mmol) to afford a colorless oil.  Purification on silica gel (10–20% Et2O/Petroleum 
Ether) afforded (S)-2-Fluoro-4-(propan-2-ylidene)cyclohexanone as a colorless oil (57 
mg, 73% yield, 79% GC yield, 98% ee).  IR (film) 2987, 2915, 2859, 1734, 1450, 1429, 
1376, 1105, 1070, 1026, 858.0 cm-1; 1H NMR (500 MHz, CDCl3). δ 4.84 (ddd, J = 49.2, 
11.8, 6.6 Hz, 1H, FCH), δ 3.14–3.37 (m, 1H, O=CCH2), δ 2.73–2.90 (m, 1H, O=CCH2), 
δ 2.45–2.64 (m, 1H, O=CCH2), δ 2.26–2.43 (m, 2H, FCHCH2, O=CCH2CH2), δ 2.13–
2.26 (m, 1H, O=CCH2CH2), 1.79 (s, 3H, CH3), δ 1.77 (s, 3H, CH3); 13C NMR (125 MHz, 
CDCl3)  δ;  205.8 (d, J = 14.0 Hz), 129.1, 123.1, 91.8 (d, J = 193.4 Hz), 39.4, 36.5 (d, J = 
19.7 Hz), 28.6, 20.7.  19F NMR (282 MHz, CDCl3) δ: –188.2 (dm, J = 49.3 Hz).  HRMS 
(ES) exact mass calculated for [M+H]+ (C9H14FO) requires m/z 156.0950, found m/z 
156.0949.  [α]D = +1.8 (c = 0.58, CHCl3).  Enantiopurity was determined by GLC using a 
Macherey-Nagel Hydrodex-B-TBDAc (50 m x 0.25 mm) column (120 °C, 15 min; 140 
ºC, 40 min);  (R) isomer tr = 45.8 min and (S) isomer tr = 48.1 min. 
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 (R)-2-Fluoro-1,4-dioxaspiro[4.5]decan-8-one (Table 5, entry 5): Prepared 
according to the general procedure from 1,4-dioxaspiro[4.5]decan-8-one (158 mg, 1.00 
mmol) to afford a colorless oil.  Purification on silica gel (10–30% EtOAc/Petroleum 
Ether) afforded (S)-2-Fluoro-1,4-dioxaspiro[4.5]decan-8-one as a colorless crystalline 
solid (74 mg, 85% yield, 90% GC yield, 94% ee).  IR (film) 2962, 2938, 2904, 1737, 
1443, 1424, 1372, 1353, 1310, 1244, 1146, 1123, 1089, 1047, 984.5, 950.9, 930.5, 844.8, 
706.8 cm-1; 1H NMR (500 MHz, CDCl3). δ 5.11 (dm, J = 48.3 Hz, 1H, FCH), δ 3.94–4.15 
(m, 4H, (OCH2)2), δ 2.58–2.70 (m, 1H, O=CCH2), δ 2.37–2.58 (m, 2H, O=CCH2, 
FCHCH2), δ 2.08–2.26 (m, 1H, FCHCH2), δ 1.87–2.08 (m, 2H, O=CCH2CH2); 13C NMR 
(125 MHz, CDCl3)  δ;  204.6 (d, J = 14.3 Hz), 107.4 (d, J = 13.8 Hz), 90.2 (d, J = 191.2 
Hz), 65.1 (d, J = 3.3 Hz), 41.7 (d, J = 17.6 Hz), 35.3, 34.5.  19F NMR (282 MHz, CDCl3) 
δ: –194.1 (dm, J = 48.1 Hz).  HRMS (ES) exact mass calculated for [M+H]+ (C8H12FO3) 
requires m/z 174.0692, found m/z 174.0692.  [α]D = +40.5 (c = 1.1, CHCl3).  
Enantiopurity was determined by GLC using a Macherey-Nagel Hydrodex-B-TBDAc (50 
m x 0.25 mm) column (120 °C, 15 min; 140 ºC, 40 min);  (R) isomer tr = 50.9 min and (S) 
isomer tr = 52.1 min. 
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Chapter 5  
SOMO Catalysis: A New Mode of Organocatalytic Activation∗† 
 
Introduction 
Over the last four decades, the capacity to induce asymmetric transformations 
using enantioselective catalysts has remained a focal point for extensive research efforts 
in both industrial and academic settings.  During this time, thousands of new asymmetric 
catalytic reactions have been invented, yet most are derived from a small number of long-
established activation modes.  Activation methods such as Lewis acid catalysis1, metal-
insertions2, and hydrogen-bonding catalysis3 have spawned countless reactions within 
each class, dramatically expanding the synthetic toolbox available to practitioners of 
chemical synthesis.  Therefore, the design and implementation of novel catalytic 
activation modes that enable the invention of previously unknown transformations is a 
necessary objective for the continued advancement of the field of organic chemistry. 
                                                
∗ A report of this work has been published.  Portions taken in part from: Beeson, T. D.; Mastracchio, A.; Hong, 
J.-B.; Ashton, K.; MacMillan, D. W. C. Science 2007, 316, 582. 
† The work reported in this chapter was conducted by T. D. Beeson, with the exception of the aldehyde 
α-allylation substrate scope, which was conducted in cooperation with A. Mastracchio. 
1 Yamamoto, H., Ed. Lewis Acids in Organic Synthesis; Wiley-VCH; New York, 2000. 
2 (a) Crabtree, R. H. The Organometallic Chemistry of the Transition Metals, 4th edition; Wiley-Interscience; Hoboken, 
NJ, 2005.  (b) Noyori, R. in Asymmetric Catalysis in Organic Synthesis; Wiley-VCH; New York, 1994, pp 123–173.  
(c) Ojima, I., Ed. Catalytic Asymmetric Synthesis, 2nd edition; Wiley-VCH; New York, 2000. 
3 Taylor, M. S.; Jacobsen, E. N. Angew. Chem. Int. Ed. 2006, 45, 1520. 
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Figure 1.  Singly occupied molecular orbital (SOMO) catalysis, a new 
activation mode that electronically bisects iminium and enamine catalysis. 
The previous chapters have discussed both iminium and enamine catalysis, two 
activation modes that have enabled the discovery of more than sixty new asymmetric 
chemical reactions to date.4  Although both have proved to be broadly useful strategies 
for the enantioselective functionalization of aldehydes and ketones, their expansion to 
include alkylations,5 alkenylations, and arylations has been scarce or not yet come to 
fruition.  Given that the π-systems of an iminium and an enamine differ by two electrons, 
we questioned whether it might be possible to access a new mode of catalytic activation 
by chemically intercepting the three-electron species that electronically bisects 
Scheme 1.  Formation of a reactive radical cation by enamine single-electron oxidation 
N
R
N
R
N
R
N
R
N
R
H HH H H
– 1 e–– H+
 
enamine and iminium formation (Figure 1).  Whereas enamines react specifically with 
electrophiles, we hypothesized that a one-electron oxidation of a transient enamine 
                                                
4 (a) Lelais, G.; MacMillan, D. W. C. Aldrichim. Acta 2006, 39, 79.  (b) Erkkilä, A.; Majander, I.; Pihko, P. Chem. 
Rev. 2007, 107, 5416.  (c) Mukerjee, S.; Yang, J. W.; Hoffmann, S.; List, B. Chem. Rev. 2007, 107, 5471. 
5 The intramolecular enamine-catalyzed α-alkylation of aldehydes has been accomplished:  Vignola, N.; List, B. J. 
Am. Chem. Soc. 2004, 126, 450. 
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species should generate a three-π-electron radical cation that is activated toward a range 
of nucleophiles, thereby enabling a diverse range of previously unknown asymmetric 
transformations (Scheme 1). 
Proof of Concept Validation 
From the outset we recognized that the viability of this concept relied upon the 
meeting of two key requirements.  First, the oxidation potential of the enamine would 
need to be sufficiently lower than its aldehyde and amine precursors such that a single-
electron oxidant could chemoselectively oxidize the enamine in preference to the other 
species present.  The first ionization potential of 1-(but-1-enyl)pyrrolidine6 has been 
measured to be 1.56 eV lower than pyrrolidine7 and 2.6 eV lower than butanal7 (Figure 
2).  This data reveals the transient enamine component to be sufficiently more susceptible 
to oxidation than the accompanying reaction partners.  
H
O
Me
N
H
H
N
Butanal
IP = 9.84 eV
Pyrrolidine
IP = 8.8 eV
1-(But-1-enyl)pyrrolidine
IP = 7.24 eV
Me
>> >>
 
Figure 2.  First ionization potentials of an enamine and its precursor aldehyde 
and amine. 
Second, an amine catalyst class was needed that would enforce high levels of 
facial selectivity to the radical cation.  We recognized that like enamines, the radical 
cation’s 3-π-electron system is delocalized with the p-orbital of the nitrogen lone pair 
                                                
6 The second ionization potential of 1-(but-1-enyl)pyrrolidine is 10.04 eV.  Müller, K.; Previdoli, F.; Desilvesro, 
H. Helv. Chim. Acta 1981, 64, 2497.  
7 Lide, D. R., Ed., Handbook of Chemistry and Physics; 76th edition; CRC Press; New York, 1995; p 220. 
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(Scheme 1) and therefore, the orbitals should maintain a geometry nearly identical to that 
of its parent enamine.  We were able to confirm this on the basis of density functional 
theory (DFT) calculations performed on the enamine and its radical cation formed 
between proprionaldehyde and imidazolidinone catalyst 1.  As shown in Figure 3,  
Enamine:  ΔE = +0.6 Kcal/mol
Radical Cation:  ΔE = 0.0 Kcal/mol
A B
Enamine:  ΔE = 0.0 Kcal/mol
Radical Cation:  ΔE = +2.5 Kcal/mol
N
N
H
Ph
O Me
Me
Me
Me
• TFA
1
 
Figure 3. 3-D representations depicting the two lowest energy conformations for both the 
enantio-differentiated enamine and its radical cation formed between imidazolidinone catalyst 
1 and propionaldehyde. Relative energies calculated using density functional theory (DFT).8 
the two lowest energy conformations, A and B, display significant facial bias towards one 
face of the π-system.  In conformation B, the benzene ring rests directly over the π-
system and generates a highly effective facial bias, while in conformation A, it is rotated 
away from the π-system and the facial bias is slightly diminished.  Interestingly, while 
the enamine has a slight preference for conformation B (ΔE = 0.6 Kcal/mol), the radical 
cation highly favors conformation A (ΔE = 2.5 Kcal/mol), presumably due to a type of 
“cation-π” interaction between the benzene ring and the delocalized radical cation of the 
π-system. 
 
                                                
8 Gaussian DFT calculations performed by Prof. Robert Pascal, Department of Chemistry, Princeton University.  
Calculations performed using B3LYP/6-311+G(2d,p)//B3LYP/6-31G(d). 
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Scheme 2.  The interaction of the SOMO of a radical with (a) HOMO and (b) LUMO orbitals9  
SOMO
HOMO
LUMO
SOMO
HOMO
LUMO
(a) SOMO-HOMO (b) SOMO-LUMO  
 
Since radical cations generated from the oxidation of enamines are stabilized due 
to delocalization of the radical with the π-system (Scheme 1), the singly occupied 
molecular orbital (SOMO) is relatively low in energy and prefers to interact with the 
highest occupied molecular orbital (HOMO) of nucleophiles rather than the lowest 
unoccupied molecular orbital (LUMO) of electrophiles (Scheme 2).  Radical cations 
generated from pre-formed enamines have been shown to react with both unactivated 
olefins10 and electron-rich olefins such as silylenolethers.11  Therefore, as a first attempt 
at our proposed SOMO-catalyzed reaction, the intramolecular cyclization of cis-6-
nonenal was studied using our second-generation imidazolidinone catalyst12 1 in the 
presence of a variety of oxidants.  Both organic and metal-based oxidants were analyzed 
                                                
9 Figure adapted from: Fleming, I. Frontier Orbitals and Organic Chemical Reactions; John Wiley & Sons, Ltd.; 
Chichester, 2000; p 183. 
10 Cossy, J.; Bouzide, A. J. Chem. Soc., Chem. Commun. 1993, 1218. 
11 Narasaka, K.; Okauchi, T.; Tanaka, K.; Murakami, M. Chem. Lett. 1992, 2099. 
12 Austin, J. F.; MacMillan, D. W. C. J. Am. Chem. Soc. 2002, 124, 1172. 
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and, to our delight, reactions performed with ceric ammonium nitrate (CAN) generated 
the 5-exo cyclized product 2 with subsequent trapping by a nitrate ligand (equation 1). 
2 equiv. CAN
CH3CN, –10 ºC
O
H
O
H
ONO2
37% yield (1)
N
N
H
t-BuBn
O Me
20 mol% 1 2
•TFA
 
α -Allylation of Aldehydes 
With this proof of concept in hand, we recognized the potential of this new 
activation mode to enable the invention of many new and useful enantioselective 
reactions.  Radical cations have been shown to participate in many non-catalytic C–C, C–
O, C–N, C–S and C–X (where X is a halogen) bond formations,13 leading us to believe 
that SOMO catalysis might provide access to a diverse and powerful collection of 
previously unknown asymmetric reactions.  One such reaction of intense interest within 
our group and others was the direct and enantioselective α-allylation of aldehydes, due to 
the established importance of allylation products as chiral synthons in chemical synthesis.  
While advancements in the α-allylation of other carbonyl species had been 
accomplished,14 at the time of this work, there were no aldehyde α-allylation methods in 
existence.15,16  In fact, direct allylic alkylations of dicarbonyl species had been established 
                                                
13 Also see references 8 and 9.  (a) Kirchgessner, M.; Sreenath, K.; Gopidas, K. R. J. Org. Chem. 2006, 71, 9849.  (b) 
Sutterer, A.; Moeller, K. D. J. Am. Chem. Soc. 2000, 122, 5636.  (c) Lee, H. B.; Sung, M. J.; Blackstock, S. C.; Cha, 
J. K. J. Am. Chem. Soc. 2001, 123, 11322.  (d) Renaud, P.; Sibi, M. P., Eds.; Radicals in Organic Synthesis; Wiley-
VHC; Weinheim, 2001; Vol. 2, pp 144–205. 
14 Trost, B. M.; Crawley, M. L. Chem. Rev. 2003, 103 2921. 
15 Before publication of this work, a non-enantioselective α-allylation of aldehydes appeared in the literature: 
Ibrahem, I.; Córdova, J. A. Angew. Chem. Int. Ed. 2006, 45, 1952. 
16 After completion of this work, the following enantioselective α-allylation of aldehydes appeared in the 
literature: Mukerjee, S.; List, B. J. Am. Chem. Soc. 2007, 129, 11336. 
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but methods for the allylic alkylation of ketones have required covalent attachment of the 
allylating species for intramolecular alkylation17 or preforming of the silylenol ether18a or 
metal enolate18 to act as the reactive species.19 
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Figure 4.  Proposed catalytic cycle of the SOMO-catalyzed aldehyde α-allylation 
reaction. 
 Mechanistically, we speculated that a transiently formed radical cation 4 could 
combine with an allyl π-nucleophile 8 with a facile leaving group to generate a secondary 
radical 5 (Figure 4).  Upon further oxidation to the secondary carbocation 6, the leaving 
                                                
17 (a) Behenna, D. C.; Stoltz, B. M. J. Am. Chem. Soc. 2004, 126, 15044.  (b) Trost, B. M.; Xu, J. J. Am. Chem. Soc. 
2005, 127, 2846. (c) Trost, B. M.; Xu, J. J. Am. Chem. Soc. 2005, 127, 17180. 
18 Doyle, A. G.; Jacobsen, E. N. J. Am. Chem. Soc. 2005, 127, 62. 
19 Direct ketone allylic alkylation via in situ formation of lithium enolates has now been accomplished: (a) Braun, 
M.; Meier, T. Synlett, 2968.  (b) Zheng, W.-H.; Zheng, B.-H.; Zhang, Y.; Hou, X.-L. J. Am. Chem. Soc. 2007, 129, 
7718. 
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group could eliminate to generate the α-allylated iminium species 7, which upon 
hydrolysis would provide the desired α-allylated aldehyde 9 and regenerate the catalyst.  
With this in mind, we first examined a variety of allylating reagents with the 
capacity to generate stabilized intermediates and/or leaving groups.  Of the reagents 
studied, only allyltributylstannane and allyltrimethylsilane afforded the desired α-
allylated aldehyde, however, allyltributylstannane predominantly reacted with the 
carbonyl of the starting material (equation 2).  On the other hand, allyltrimethylsilane 
reacted solely with the transient enamine radical cation, and to our delight, generated the 
desired product in 66% ee and 48% yield (equation 3). 
20 mol% 1
2 equiv. CAN
CH3CN, –10 ºC
O
H
OH
n-Hexn-Hex
1 equiv. 2 equiv.
SnBu4 (2)72% yield
 
20 mol% 1
2 equiv. CAN
CH3CN, –10 ºC
O
H
O
H
n-Hexn-Hex
1 equiv. 2 equiv.
TMS 48% yield
66% ee
(3)
 
A broad survey of potential single–electron oxidants was conducted to ascertain 
whether CAN was the optimal oxidant for the SOMO-catalyzed α-allylation reaction, 
including hypervalent idodides, quinones and an assortment of transition metals. Since 
oxidation potentials can vary widely with the choice of solvent, oxidants were studied in 
both CH3CN and methylene chloride (CH2Cl2).  While certain iron and copper oxidants 
were shown to generate product in CH3CN,20 the reactions progressed with much lower 
efficiency than CAN and therefore, we chose to pursue further optimization of the CAN-
mediated reaction. 
                                                
20 Approximately 5% conversion was obtained with Fe(NO3)3, Cu(NO3)2, and Cu(OTFA)2.  11% conversion was 
obtained with Fe(Phen)3(PF6)3. 
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The first major achievement came after literature analysis suggested that the 
radical cation might be able to react with oxygen in the atmosphere,21 competing with the 
allylsilane for product formation.  Degassing the reaction mixture prior to addition of the 
starting aldehyde dramatically improved the conversion and at +4 ºC in CH3CN, the 
conversion more than doubled from 23% to 53%.  Reactions subsequently performed in 
acetone achieved higher enantioselectivities and also saw a dramatic increase in 
conversion upon oxygen exclusion (equations 4 and 5).   
Reaction without degassing: 
20 mol% 1
2 equiv. CAN
acetone, +4 ºC
O
H
O
H
n-Hexn-Hex
1 equiv. 2 equiv.
TMS 27% conv.
71% ee
(4)
 
Degassed reaction conditions: 
20 mol% 1
2 equiv. CAN
acetone, +4 ºC
O
H
O
H
n-Hexn-Hex
1 equiv. 2 equiv.
TMS 57% conv.
74% ee
(5)
 
Additionally, as our understanding of the reaction mechanism dictated that a 
minimum of 2 moles of CAN were required per mole of aldehyde, we increased the 
relative stoichiometry of the reaction and determined that 2.5 equivalents of oxidant and 
allylsilane were optimal (equation 6).  Additional amounts of oxidant prohibited efficient 
stirring of the reaction and provided lower overall yields. 
20 mol% 1
2.5 equiv. CAN
acetone, +4 ºC
O
H
O
H
n-Hexn-Hex
1 equiv. 2.5 equiv.
TMS 66% conv.
74% ee
(6)
 
Next we studied the effect of temperature and concentration, hoping to obtain the 
needed improvement in enantiocontrol.  As shown in Table 1, a slight increase in 
                                                
21 Nair, V.; Rajan, R.; Mohana, K.; Sheeba, V. Tetrahedron Lett. 2003, 44, 4585. 
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selectivity was achieved at –20 ºC, with maximum conversions obtained at more dilute 
concentrations.  At the same time, a variety of imidazolidinone catalyst architectures 
were studied, including geminally disubstituted and trans-oriented catalysts, however, 
catalyst 1 consistently yielded the best results.  Acid co-catalysts of varying pKa values 
were also studied, and while a few of the acids achieved comparable conversions and 
enantioselectivities, they did not improve on the results already obtained with the 
trifluoroacetic acid (TFA) salt of catalyst 1.  Likewise, the electronic requirement of the 
trialkylsilane component was investigated with a variety of alkyl- and aryl-substituted 
allylsilanes, and allyltrimethylsilane was shown to be the preferable allylating reagent.  
Full details of these experiments can be found in Appendix A on page 115. 
Table 1.  Effect of Temperature and Concentration 
0.0625
0.0625
0.0625
0.0833
0.125
0.167
0.250
entry
1
2
3
4
5
6
7
75
77
80
80
80
80
80
% eeb
64
72
75
75
67
44
48
% conversionaConc. (M)
20 mol% 1
2.5 equiv. CAN
Acetone
O
H
O
H
n-Hex
+4
–10
–20
–20
–20
–20
–20
Temp (ºC)
n-Hex
1 equiv. 2.5 equiv.
3
6
18
18
18
18
18
time (h)
TMS
 
(a) Conversion determined by GLC analysis relative to an internal 
standard (methyl cyclohexanecarboxylate).  (b) Enantiomeric excess 
determined by GLC analysis (Varian Chirasil-Dex-CB).  
Since we had achieved such a dramatic improvement in enantioselectivity when 
the reaction medium was changed from CH3CN to acetone (66% ee versus 74% ee), 
additional solvents were studied to ascertain whether further improvements in selectivity 
could be attained.  As shown in Table 2, reactions performed in ethyl acetate (EtOAc) 
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were similar to those in acetone while chloroform provided no desired product.  
Surprisingly, reactions performed in the etherial solvents tetrahydrofuran (THF) and 
dimethoxyethane (DME) attained significantly higher levels of enantioselectivity; 
however, the reaction efficiencies were much lower than those in other solvents.   
Table 2.  Effect of Solvent on the α-Allylation Reaction 
CH3CN
Acetone
EtOAc
CHCl3
THF
DME
entry
1
2
3
4
5
6
66
74
73
–
82
85
% eeb
53
66
44
0
19
31
% conversionasolvent
20 mol% 1
2.5 equiv. CAN
solvent, +4 ºC
O
H
O
H
n-Hexn-Hex
1 equiv. 2.5 equiv.
2
3
13
13
6
6
time (h)
TMS
 
(a) Conversion determined by GLC analysis relative to an internal 
standard (methyl cyclohexanecarboxylate).  (b) Enantiomeric excess 
determined by GLC analysis (Varian Chirasil-Dex-CB). 
 
Nevertheless, further optimization of the reaction performed in DME 
demonstrated that excellent enantioselectivity and improved reaction efficiency could be 
achieved with lower reaction temperatures and higher concentrations (equations 7 and 8), 
a surprising result considering that lower concentrations were optimal for reactions 
performed in acetone.  Although excellent enantioselectivities for the α-allylation 
reaction had been realized, reaction efficiencies remained inadequate and needed further 
optimization. 
20 mol% 1
2.5 equiv. CAN
DME, 0.0625M, –20 ºC
O
H
O
H
n-Hexn-Hex
1 equiv. 2.5 equiv.
TMS 47% conv.
91% ee
(7)
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20 mol% 1
2.5 equiv. CAN
DME, 0.25M, –20 ºC
O
H
O
H
n-Hexn-Hex
1 equiv. 2.5 equiv.
TMS 58% conv.
93% ee
(8)
 
At this point in time, we began to question whether the large excess of allylsilane 
required in the reaction was possibly the result of acidic degradation induced by the 
silane cation or nitric acid formed during the reaction.  For this reason, we studied a 
variety of base additives that could act as scavengers of these acidic byproducts.  Of the 
bases studied, sodium bicarbonate (NaHCO3), potassium bicarbonate (KHCO3), and di-
tert-buylpyridine (DTBP) provided the most improvement, with 1.5 equivalents of 
NaHCO3 consistently achieving the best results.  Gratifyingly, the α-allylation of octanal 
could now be accomplished in 81% yield and 91% ee (equation 9). 
20 mol% 1
1.5 equiv. NaHCO3
CAN, DME, –20 ºC
O
H
O
H
n-Hexn-Hex
1 equiv. 2.5 equiv.
TMS 81% yield
91% ee
(9)
 
Furthermore, we explored the generality of the α-allylation reaction by investigating 
a variety of substituted allylsilanes and aldehydes containing common functionalities.  As 
demonstrated in Table 3, an assortment of π-rich substituted allylsilanes readily 
participate as allylic alkylating reagents in this new catalytic protocol. Both methyl and 
phenyl 2-substituted allylsilanes reacted without loss in reaction efficiency or 
enantiocontrol (entries 1–2).  Perhaps most striking is the electron-deficient acrylate 
substrate (entry 4), which reacted as effectively as the more π-rich substrates, likely due 
to its capacity to stabilize the subsequently formed radical through the captodative effect.  
The ester appendage acts effectively as an electron-withdrawing “captor,” while the β-
silicon serves in a “dative” capacity to donate electrons from the silicon-carbon σ-bond to 
the radical p-orbital. 
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Table 3.  SOMO-Catalyzed Reactions with Substituted Allylsilanes 
2.5 equiv. CAN
NaHCO3, DME
H
n-Hex
O
H
n-Hex
O
TMS
1 equiv. 2.5 equiv. 20 mol%
N
N
H
Ph
O Me
Me
Me
Me
• TFA
–20 °C, 24 h
entry allylsilane product allylsilane product
1
O
H
Me
4
(  )
O
H
Me
4
(  )
87% yield, 90% ee
88% yield, 91% ee
2
3
4
TMS
Me
TMS
Ph
TMS
Ph
TMS
CO2Et
Me
Ph
O
H
Me
4
(  )
O
H
Me
4
(  )
81% yield, 90% ee
77% yield, 88% ee
CO2Et
Ph
X
entry
X
1
 
 
Table 4.  SOMO-Catalyzed α-Allylation of Various Aldehydes 
2.5 equiv. CAN
NaHCO3, DME
entry
1
aldehyde product
H
R
O
H
R
O
TMS
1 equiv. 2.5 equiv. 20 mol% product
N
N
H
Ph
O Me
Me
Me
Me
• TFA
–20 °C, 24 h
75% yield, 92% ee
2
3
aldehyde product
4
O
H
O
H
75% yielda, 94% ee
5
6
81% yield, 91% ee
O
H
7
(  )
O
H
7
(  )
O
H
Me
4
(  )
O
H
Me
4
(  )
72% yield, 95% ee
O
H
OBz
7
(  )
O
H
OBz
7
(  )
72% yield, 87% ee
O
H
2
(  )
Me
OO
H
2
(  )
Me
O
O
H
O
H
70% yield, 93% ee
NBocNBoc
entry
1
 
(a) Yield determined by GLC analysis relative to an internal standard (methyl cyclohexanecarboxylate).  
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Additionally, aldehyde substrates with various functionalities including olefins, 
ketones, and esters, as well as protected alcohols and amines were well tolerated in the α-
allylation reaction (Table 4, entries 1–4).  We were very pleased to find that the more 
sterically demanding cyclohexyl and piperidine substrates reacted just as effectively, 
achieving good yields and excellent enantioselectivities (Table 4, entries 5–6). 
SOMO-Catalysis Applications 
Over the last few years, the advent of SOMO-catalysis as a new activation mode 
has allowed our lab to rapidly invent many previously unknown catalytic and 
enantioselective transformations.  For example, Drs. Jang and Hong showed that silylenol 
ethers were able to act efficiently as SOMO nucleophiles to produce enantiopure 1,4-
dicarbonyls (equation 10), presumably through a similar mechanism as the α-allylation 
reaction in which a β-silyl radical intermediate at the carbonyl carbon undergoes 
oxidation to the carbocation, and subsequent silyl cation elimination.22  Similarly, 
postdoctoral fellow Dr. Hahn Kim realized the potential of vinyl boronates to act as π-
nucleophiles that could undergo radical combination alpha to the boronate (equation 11),  
20 mol% 1
CAN, DTBP
DME, –20 ºC
O
H
O
Hn-Hex
n-Hex
aldehyde enolsilane
Ph
85% yield
90% ee
(10)
OTMS
Ph
O
!-ketoaldehyde  
 
20 mol% 1
CAN, NaHCO3
DME, –50 ºC
O
H
O
Hn-Hex
n-Hex
aldehyde styryl-BF3K
KF3B
81% yield
94% ee
(11)
Ph
!-vinylaldehyde
Ph
 
 
 
                                                
22 Jang, H.-Y.; Hong, J.-B.; MacMillan, D. W. C. J. Am. Chem. Soc. 2007, 129, 7004. 
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generating a beta-stabilized radical intermediate similar to that produced in the α-
allylation reaction.23  Interestingly, postdoctoral fellow Dr. Kate Ashton discovered that 
the intramolecular 5-exo-cyclization reaction of cis-6-nonenal could be terminated with a 
halogen nucleophile, out-competing the nitrate ligand, and generating three contiguous 
stereocenters (equation 12).24  In addition, SOMO-catalyzed α-arylations24 and α-carbo-
oxidations25 have also been accomplished, and to date, a total of fourteen new 
transformations have been invented in our lab using the SOMO-catalysis protocol.  
O
H
Me
85% yield
95% ee
8:1 dr
(12)
20 mol% 1
CAN, LiCl
THF, –10 ºC
OHC
Me
Cl
H
 
Finally, a demonstration of the radical-based mechanism of SOMO-catalysis has 
been carried out using the radical clock 11 developed by Newcomb and coworkers to 
distinguish between radical and cationic pathways.26  Exposing 11 to our SOMO-
catalysis reaction conditions resulted in scission of the benzylic cyclopropyl bond 
followed by nitrate trapping to form 12, which is in complete accord with a radical-based 
pathway (equation 13). 
20 mol% 1
NaHCO3, –20 ºC
acetone-d6
O
H
O
H
(13)
n-Hex
2 equiv. CAN
12
Ph
OMe
n-Hex
OMe
Ph
ONO2
11  
                                                
23 Kim, H.; MacMillan, D. W. C. J. Am. Chem. Soc. 2008, 130, 398. 
24 Beeson, T. D.; Mastracchio, A.; Hong, J.-B.; Ashton, K.; MacMillan, D. W. C. Science 2007, 316, 582. 
25 Jones, C. M.; Graham, T. H.; MacMillan, D. W. C. in press. 
26 (a) Newcomb M.; Chestney, D. L. J. Am. Chem. Soc. 1994, 116, 9753.  (b) Le Tadic-Biadatti, M.-H.; Newcomb, 
M. J. Chem. Soc. Perkin Trans. 1996, 2, 1467. 
                                                    95 
In addition, graduate student Robert Knowles has shown that the cyclopropyl 
aldehyde 13 undergoes facile ring opening to generate the α,β-unsaturated aldehyde 14 
with subsequent nitrate trapping (equation 14).  The nitrated product rapidly eliminates 
nitric acid while standing at ambient temperature to form the fully conjugated diene 15.  
Notably, there was no detection of any α-allylated cyclopropyl aldehyde in these 
experiments. 
20 mol% 1
NaHCO3, DME
–20 ºC, 20 h
O
H
O
H
(14)
Ph
Ph
O
H
PhO2NO
60% yield
2 equiv. CAN
14 1513
TMS
 
Conclusion 
In summary, we have described a new mode of chemical activation based on the 
catalytic formation of chiral radical cations.  While enamines react only with electrophiles, 
single-electron oxidation to the radical cation allows reactions with SOMO nucleophiles at 
the same reacting center and enabling a diverse range of previously unknown asymmetric 
transformations.  This technology, termed SOMO-catalysis, has enabled the first 
enantioselective α-allylation of aldehydes through a radical mechanism with simple 
allylsilanes.  Using this new platform of reactivity, several previously unknown asymmetric 
methodologies have been developed, demonstrating the value of SOMO-catalysis as a new 
activation mode for the field of organic chemistry. 
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S u p p o r t i n g  I n f o r m a t i o n  
General Information.  Commercial reagents were distilled prior to use following the 
guidelines of Perrin and Armarego.27  Organic solutions were concentrated under reduced 
pressure on a Büchi rotary evaporator. Chromatographic purification of products was 
accomplished using forced-flow chromatography on Iatrobeads 6RS–8060 according to 
the method of Still.28  Filtration of reactions was performed using EMD Silica Gel 60 
230-400 mesh. Thin-layer chromatography (TLC) was performed on EM Reagents 0.25 
mm silica gel 60-F plates.  Visualization of the developed chromatogram was performed 
by fluorescence quenching using anisaldehyde, ceric ammonium molybdenate, potassium 
permanganate or iodine stain.  Supercritical fluid chromatography (SFC) and gas liquid 
chromatography (GLC) assays to determine enantiomeric excess were developed using 
racemic samples. 
1H and 13C NMR spectra were recorded on Varian Mercury 300 (300 MHz and 75 
MHz respectively) unless otherwise noted, and are internally referenced to residual protio 
solvent signals.  Data for 1H and 13C NMR are reported as follows: chemical shift (δ 
ppm), multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet), 
integration, coupling constant (Hz), and assignment.  IR spectra were recorded on a 
Perkin Elmer Spectrum BX FT-IR spectrometer and are reported in terms of frequency of 
absorption (cm-1).  Mass spectra were obtained from the California Institute of 
                                                
27 Perrin, D. D.; Armarego, W. L. F.  Purification of Laboratory Chemicals, 3rd edition; Pergamon Press; Oxford, 1988. 
28 Still, W. C.; Kahn, M.; Mitra, A. J. J. Org. Chem. 1978, 43, 2923. 
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Technology Mass Spectral Facility unless otherwise noted.  Gas liquid chromatography 
(GLC) was performed on a Hewlett-Packard 6850 Series gas chromatograph equipped 
with a split-mode capillary injection system and flame ionization detectors using a Varian 
Chirasil-Dex-CB (25 m x 0.25 mm) column or Hewlett Packard HP-1 (30m x 0.32mm) 
column.  Supercritical fluid chromatography (SFC) was performed on a Berger Minigram 
equipped with a variable-wavelength UV detector using a Chiralcel® OJH, ODH and 
Chiralpak®ADH column (25 cm) as noted (4.0 mL/min.).  Optical rotations were 
recorded on a Jasco P-1010 Polarimeter. 
 
O
H
ONO2
2  
1-(2-formylcyclopentyl)propyl nitrate 2 (equation 1):  To an oven-dried 50 mL 
round-bottom flask equipped with a magnetic stir bar and charged with (2R,5R)-5-benzyl-
2-tert-butyl-3-methyl-imidazolidin-4-one trifluoroacetic acid salt 1 (72 mg, 0.20 mmol) 
and ceric ammonium nitrate (CAN) (1.10g, 2.0 mmol) was added acetonitrile (CH3CN) 
(16 mL) and the mixture cooled to –10 ºC.  Cis-6-nonenal (167 µL, 1.00 mmol) was 
added and the reaction stirred vigorously 24 h at –10 ºC, and then filtered through a pad 
of silica gel, eluting with ether (Et2O).  Purification on silica gel (5–50% Et2O/Pentanes) 
afforded 1-(2-formylcyclopentyl)propyl nitrate as a mixture of two diastereomers.  (75 
mg, 37% yield).  IR (film) 2962, 2876, 2815, 2719, 1719, 1616, 1459, 1386, 1269, 912.9, 
852.2, 784.0, 753.7, 695.5 cm-1; 1H NMR (300 MHz, CDCl3) for the major diastereomer 
δ 9.64 (d, J = 2.4 Hz, 1H, CHO), 4.99–5.05 (m, 1H, CHNO3), 2.57–2.72 (m, 2H, 
CHCHCHO), 1.20–1.97 (m, 8H, CH(CH2)3, CH2CH3), 0.99 (t, J = 7.5 Hz, 3H, CH3); 13C 
NMR (75 MHz, acetone-d6) major diastereomer: δ 202.4, 88.1, 55.3, 41.9, 30.1, 27.4, 
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25.5, 25.3, 9.3.  Minor diastereomer: δ 202.4, 87.1, 54.0, 41.6, 27.9, 27.6, 25.2, 25.0, 9.9.  
HRMS (ES) exact mass calculated for [M+H]+ (C9H16NO4) requires m/z 201.1001, found 
m/z 201.1002.  
General Procedure for the α -Allylation of Aldehydes:   
To an oven-dried 25 mL round-bottom flask equipped with a magnetic stir bar 
and charged with (2S,5S)-5-benzyl-2-tert-butyl-3-methyl-imidazolidin-4-one 
trifluoroacetic acid salt 1 (72 mg, 0.20 mmol), ceric ammonium nitrate (CAN) (1.37g, 2.5 
mmol), and oven-dried sodium bicarbonate (126 mg, 1.5 mmol) was added 
dimethoxyethane29 (DME) (4.0 mL).  The suspension was cooled to –50 ºC and 
deoxygenated by stirring vigorously under vacuum for 3–5 min.30  The mixture was back-
filled with argon and degassed twice more.  The allyltrimethylsilane substrate (2.5 mmol) 
was added followed by the aldehyde substrate (1.0 mmol).  The reaction was warmed to 
-20 ºC and stirred for 24 h under an argon atmosphere.  The reaction was then cooled to 
-50 ºC and quickly filtered through a pad of silica gel, eluting with Et2O.  The flask was 
washed with a minimal amount of DME to transfer any remaining yellow solid to the 
silica pad.  The filtrate was concentrated in vacuo and purified by forced flow 
chromatography to afford the title compounds. The enantioselectivity was determined 
either by chiral GLC analysis or chiral SFC analysis after reduction to the primary 
alcohol and acylation with 2-naphthoylchloride.   
                                                
29 Wet, non-distilled DME.  Alternatively, 0.3 equiv. H2O can be added to dry DME. 
30 The method of freeze-pump thaw, when used to deoxygenate the reaction mixture, showed less consistent 
results and lower yields, possibly due to the heterogeneity of the reactions. 
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α -Allyl Aldehydes 
H Me
O
 
 (R)-2-Allyloctanal (Table 4, entry 1): Prepared according to the general 
procedure from octanal (156 µL, 1.00 mmol) to afford a yellow oil.  Purification on 
Iatrobeads (2–10% Et2O/Pentanes) afforded (R)-2-allyloctanal as a colorless oil (137 mg, 
81% yield, 91% ee).  IR (film) 3075, 2928, 2858, 2703, 1728, 1708, 1641, 1458, 992.6, 
915.5, 724.0 cm-1; 1H NMR (300 MHz, acetone-d6) δ 9.59 (d, J = 2.4 Hz, 1H, CHO), 
5.69–5.84 (m, 1H, CH=CH2), 4.97–5.10 (m, 2H, CH=CH2), 2.30–2.46 (m, 2H, 
CHCH2CH, CHCHO), 2.17–2.28 (m, 1H, CHCH2CH), δ 1.38–1.72 (dm, 2H, 
CH2(CH2)4), 1.20–1.38 (m, 8H, CH2(CH2)4), 0.87 (t, J = 6.9 Hz, 3H, CH3); 13C NMR (75 
MHz, acetone-d6) δ 204.7, 136.4, 116.9, 51.7, 33.5, 32.2, 29.9, 28.8, 27.4, 23.1, 14.2.  
HRMS (EI+) exact mass calculated for [M-H]+ (C11H20O) requires m/z 168.1514, found 
m/z 168.1508.  [α]D = +12.7 (c = 1.0, CHCl3).  Enantiopurity was determined by GLC 
using a Varian Chirasil-Dex-CB (25 m x 0.25 mm) column (100 °C isotherm);  (S) 
isomer tr = 23.2 min and (R) isomer tr = 23.8 min. 
 
H
O
 
(R)-2-Allyl-undec-10-enal (Table 4, entry 2):  Prepared according to the general 
procedure from undecylenic aldehyde (200 µL, 1.00 mmol) to afford a yellow oil.  
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Purification on Iatrobeads (2–10% Et2O/Pentanes) afforded (R)-2-allyl-undec-10-enal as 
a colorless oil (156 mg, 75% yield, 92% ee).  IR (film) 3077, 2927, 2855, 2704, 1728, 
1641, 1441, 993.1, 912.1, 721.4 cm-1; 1H NMR (300 MHz, acetone-d6) δ 9.59 (d, J = 2.2 
Hz, 1H, CHO), 5.69–5.86 (m, 2H, CHCH2CH=CH2, CH2CH2CH=CH2), 4.86–5.10 (m, 
4H, CHCH2CH=CH2, CH2CH2CH=CH2), 2.30–2.46 (m, 2H, CHCH2CH, 
CHCHO), 2.17–2.28 (m, 1H, CHCH2CH), 1.98–2.06 (m, 2H, CH2CH2CH=CH2), 1.20–
1.72 (m, 12H, CH(CH2)6); 13C NMR (75 MHz, acetone-d6) δ 204.7, 139.7, 136.5, 116.9, 
114.6, 51.7, 34.4, 33.5, 29.9, 29.6, 29.5, 28.8, 27.5.  HRMS (FAB+) exact mass 
calculated for [M+•]+ (C14H24O) requires m/z 208.1827, found m/z 208.1822.  [α]D = 
+12.1 (c = 1.0, CHCl3). Enantiopurity was determined by SFC analysis after reduction to 
the primary alcohol and acylation with 2-naphthoylchloride. (Chiralcel®OJH 5% Isocratic 
MeCN).  tS(minor) = 3.9 min.  tR(major) = 4.4 min. 
 
H
O
OBz
 
(R)-9-Formyldodec-11-enyl benzoate (Table 4, entry 3):  Prepared according to 
the general procedure from 9-formylnonyl benzoate (138 mg, 0.5 mmol) to afford a 
yellow oil.  Purification on Iatrobeads (10–50% Et2O/Pentanes) afforded (R)-9-
formyldodec-11-enyl benzoate as a colorless oil (114 mg, 72% yield, 95% ee).  IR (film) 
3077, 2927, 2855, 2704, 1728, 1641, 1441, 993.1, 912.1, 721.4 cm-1; 1H NMR (300 MHz, 
acetone-d6) δ 9.59 (d, J = 2.1 Hz, 1H, CHO), 7.99–8.04 (m, 2H, Ph), 7.59–7.66 (m, 1H, 
Ph), 7.47–7.54 (m, 2H, Ph), 5.69–5.84 (m, 1H, CH=CH2), 4.97–5.10 (m, 2H, CH=CH2), 
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4.30 (t, J = 6.5 Hz, 2H, CH2OBz), 2.30–2.46 (m, 2H, CHCH2CH, CHCHO), 2.17–2.28 
(m, 1H, CHCH2CH), 1.20–1.82 (m, 14H, (CH2)7CH2OBz); 13C NMR (75 MHz, acetone-
d6) δ 204.7, 166.6, 136.5, 133.7, 131.4, 130.0, 129.3, 116.9, 65.4, 51.7, 33.5, 30.2, 29.9, 
29.8, 29.3, 28.8, 27.4, 26.6.  HRMS (EI+) exact mass calculated for [M+•]+ (C20H28O3) 
requires m/z 316.2039, found m/z 316.2041.  [α]D = +5.8 (c = 1.0, CHCl3). Enantiopurity 
was determined by SFC analysis after acetal formation with (R,R)-pentadiol of both (R)-
9-formyldodec-11-enyl benzoate and (S)-9-formyldodec-11-enyl benzoate, separately. 
(Chiralcel®ODH 5–10% MeCN).  (R,R,S) isomer tr = 6.2 min and (R,R,R) isomer tr = 6.9 
min.  
 
9-Formylnonyl Benzoate:  A solution of 10-hydroxydecyl benzoate (2.9 g, 10.4 
mmol) in dichloromethane (DCM) (40 mL) was cooled to 0 ºC and pyridinium 
chlorochromate (PCC) was added (3.4 g, 15.6 mmol).  The reaction was warmed to 
ambient temperature and stirred for 4 h.  The reaction was filtered through Florisil®, 
washed with Et2O, and concentrated in vacuo.  Purification by forced flow 
chromatography (30% Et2O/Pentanes) afforded the title compound (1.58 g, 55% yield). 
IR (film) 2922, 2851, 1714, 1451, 1386, 1309, 1269, 1173, 1105, 1070, 1024, 708 cm-1; 
1H NMR (600 MHz, CDCl3) δ 9.77 (t, J = 1.83 Hz, 1H, CHO), 8.04–8.06 (m, 2H, ortho-
phenyl), 7.54–7.58 (m, 1H, para-phenyl), 7.43–7.46 (m, 2H, meta-phenyl), 4.32 (t, J = 
6.78 Hz, 2H, CH2OC(O)Ph), 2.34–2.44 (m, 2H, CH2CHO), 1.75–1.79 (m, 2H, 
CH2CH2OC(O)Ph), 1.62–1.65 (m, 2H, CH2CH2CHO), 1.33–1.47 (m, 10H, 
CH2(CH2)5CH2); 13C NMR (125 MHz, acetone-d6) δ 202.9, 166.7, 133.8, 131.5, 130.1, 
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129.4, 64.6, 44.3, 34.2, 30.1, 30.0, 29.9, 26.8, 25.7, 22.7.  HRMS (EI+) exact mass 
calculated for [M+H]+ (C17H25O3) requires m/z 277.1804, found m/z 277.1795. 
 
10-Hydroxydecyl benzoate:  To a solution of 1,10-decanediol (5.0 g, 28.7 mmol) 
in 100 mL of tetrahydrofuran (THF) was added triethylamine (TEA) (4.8 mL, 34.4 
mmol) and the reaction mixture was cooled to 0 ºC.  Benzoyl chloride (1.7 mL, 14.3 
mmol) was slowly added and the reaction mixture was stirred at 0 ºC for 45 min, then at 
ambient temperature overnight.  The reaction was concentrated in vacuo until 15 mL of 
solvent remained, then filtered and washed with Et2O.  The filtrate was concentrated in 
vacuo and filtered a second time, and the filtrate purified by forced flow chromatography 
(30–100% Et2O/Pentanes) (2.91 g, 73% yield).  IR (film) 3362, 2922, 2851, 1717, 1451, 
1383, 1312, 1269, 1173, 1110, 1067, 1024, 706 cm-1; 1H NMR (400 MHz, acetone-d6) δ 
8.04 (dd, J = 8.4 Hz, 1.2 Hz, 2H, ortho-phenyl), 7.62–7.66 (m, 1H, para-phenyl), 7.50–
7.55 (m, 2H, meta-phenyl), 4.32 (t, J = 6.8 Hz, 2H, CH2OC(O)Ph), 3.51–3.55 (m, 2H, 
CH2OH), 3.38–3.44 (m, 1H, OH), 1.75–1.82 (m, 2H, CH2CH2OC(O)Ph), 1.31–1.54 (m, 
14H, (CH2)7CH2OH; 13C NMR (125 MHz, CDCl3) δ 166.9, 133.0, 130.7, 129.7, 128.5, 
65.3, 63.3, 33.0, 29.7, 29.6, 29.6, 29.4, 28.9 26.2, 25.9.  HRMS (EI+) exact mass 
calculated for [M+•]+ (C17H26O3) requires m/z 278.1882, found m/z 278.1879.31 
 
 
                                                
31 Mass spectra obtained from the Princeton University Mass Spectral Facility. 
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(R)-2-Allyl-6-oxoheptanal (Table 4, entry 4): Prepared according to the general 
procedure from 6-oxoheptanal32 (128 mg, 1.0 mmol) to afford a yellow oil.  Purification 
on Iatrobeads (20–60% Et2O/Pentanes) afforded (R)-2-allyl-6-oxoheptanal as a colorless 
oil (121 mg, 72% yield, 87% ee).  IR (film) 3418, 3079, 2931, 2862, 2720, 1718, 1642, 
1416, 1361, 1164, 996.4, 919.5, 725.7 cm-1; 1H NMR (300 MHz, acetone-d6) δ 9.60 (d, J 
= 2.1 Hz, 1H, CHO), 5.69–5.84 (m, 1H, CH=CH2), 4.97–5.11 (m, 2H, CH=CH2), 2.46 (t, 
J = 6.9 Hz, 2H, CH2OCH3), 2.32–2.44 (m, 2H, CHCH2CH, CHCHO), 2.18–2.28 (m, 1H, 
CHCH2CH), 2.06 (s, 3H, CH3), 1.39–1.68 (m, 4H, CH(CH2)2); 13C NMR (75 MHz, 
acetone-d6) δ 207.6, 204.6, 136.3, 117.0, 51.6, 43.4, 33.4, 29.6, 28.1, 21.6.  HRMS (EI+) 
exact mass calculated for [M+•]+ (C10H16O2) requires m/z 168.1150, found m/z 168.1149.  
[α]D = –8.0 (c = 1.0, CHCl3). Enantiopurity was determined by GLC analysis after acetal 
formation with (R,R)-pentadiol of both (R)-2-allyl-6-oxoheptanal and (S)-2-allyl-6-
oxoheptanal, separately. Varian Chirasil-Dex-CB (25M x 0.25mm) column (115 0C 
isotherm); (R,R,R) isomer tr = 93.5 min and (R,R,S) isomer tr = 96.6 min.   
 
 
 
                                                
32 Hong, B.-C.; Chen, F.-L.; Chen, S.-H.; Liao, J.-H.; Lee, G.-H. Org. Lett. 2005, 7, 557. 
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 (S)-2-Cyclohexylpent-4-enal (Table 4, entry 5): Prepared according to the 
general procedure from 2-cyclohexylacetaldehyde (15.6 mg, 0.125 mmol) and methyl 
cyclohexanecarboxylate (19.9 mg, 0.140 mmol) as an internal standard (75% GC yield, 
94% ee).  Purification on Iatrobeads for characterization (10–50% Et2O/Pentanes) 
afforded (S)-2-cyclohexylpent-4-enal as a volatile colorless oil containing Et2O.  IR 
(film) 3078, 2927, 2854, 2706, 1726, 1642, 1449, 994.1, 914.8, 851.6 cm-1; 1H NMR (300 
MHz, acetone-d6) δ 9.62 (d, J = 2.7 Hz, 1H, CHO), 5.68–5.81 (m, 1H, CH=CH2), 4.94–
5.08 (m, 2H, CH=CH2), 2.36–2.47 (m, 1H, CHCH2CH), 2.16–2.30 (m, 2H, CHCH2CH, 
CHCHO), 1.60–1.78 and 1.02–1.33 (m, 11H, cyclohexyl);  13C NMR (75 MHz, acetone-
d6) δ 205.0, 137.1, 116.5, 57.4, 38.4, 31.1, 30.8, 30.6, 27.0, 27.0, 26.8.  HRMS (EI+) 
exact mass calculated for [M+•]+ (C11H18O) requires m/z 166.1358, found m/z 166.1361.  
[α]D = +33.9 (c = 1.0, CHCl3). Enantiopurity was determined by GLC using a Varian 
Chirasil-Dex-CB (25 m x 0.25 mm) column (100 °C isotherm);  (S) isomer tr = 36.3 min 
and (R) isomer tr = 37.7 min. 
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 tert-Butyl 4-((S)-1-formylbut-3-enyl)piperidine-1-carboxylate (Table 4, entry 
6): Prepared according to the general procedure from tert-butyl 4-
(formylmethyl)piperidine-1-carboxylate33 (114 mg, 0.5 mmol) to afford a yellow oil.  
Purification on Iatrobeads (25–50% Et2O/Pentanes) afforded tert-butyl 4-((S)-1-
formylbut-3-enyl)piperidine-1-carboxylate as a colorless oil (94 mg, 70% yield, 93% ee).  
IR (film) 2977, 2932, 2854, 2713, 1726, 1692, 1423, 1366, 1281, 1249, 1172, 918.0, 
866.6, 769.3 cm-1; 1H NMR (300 MHz, acetone-d6) δ 9.65 (d, J = 2.7 Hz, 1H, CHO), 
5.69–5.84 (m, 1H, CH=CH2), 4.98–5.10 (m, 2H, CH=CH2), 4.08 (bs, 2H, 
(CHaHb)2NBoc), 2.67 (bs, 2H, (CHaHb)2NBoc), 2.24–2.46 (m, 3H, CHCH2CH, 
CHCHO), 1.84–1.98 (m, 1H, CHCHCHO), 1.58–1.72 (m, 2H, (CHaHbCH2)2NBoc), 1.41 
(s, 9H, (CH3)3), 1.13–1.31 (m, 2H, (CHaHbCH2)2NBoc); 13C NMR (75 MHz, acetone-d6) 
δ 204.7, 154.8, 136.7, 116.9, 79.1, 56.5, 36.5, 30.8, 28.4.  HRMS (EI+) exact mass 
calculated for [M-H]+ (C15H24NO3) requires m/z 266.1756, found m/z 266.1762.  [α]D = 
+7.8 (c = 1.0, CHCl3). Enantiopurity was determined by SFC analysis after reduction to 
the primary alcohol and acylation with 2-naphthoylchloride. (Chiralcel®ODH 5–50% 
MeCN).  tR(major) = 5.9 min.  tS(minor) = 6.2 min. 
 
                                                
33 Sato, T.; Okamoto, K.; Nakano, Y.; Uenishi, J.; Ikeda, M. Heterocycles, 2001, 54, 747. 
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 (R)-2-(2-Methylallyl)octanal (Table 3, entry 1): Prepared according to the 
general procedure from octanal (156 µL, 1.00 mmol)  and methallyltrimethylsilane 
(440µL, 2.50 mmol) to afford a yellow oil.  Purification on Iatrobeads (2–10% 
Et2O/Pentanes) afforded (R)-2-(2-methylallyl)octanal as a colorless oil (160 mg, 88% 
yield, 91% ee).  IR (film) 3075, 2929, 2857, 2703, 1729, 1651, 1456, 1377, 892.5, 724.0 
cm-1; 1H NMR (300 MHz, acetone-d6) δ 9.56 (d, J = 2.7 Hz, 1H, CHO), 4.74–4.77 (m, 
1H, C=CHaHb), 4.70–4.72 (m, 1H, C=CHaHb), 2.35–2.52 (m, 2H, CHCH2C=, 
CHCHO), 2.10–2.16 (m, 1H, CHCH2C=), 1.70 (s, 3H, CCH3), 1.40–1.66 (dm, 2H, 
CH2(CH2)4), 1.22–1.34 (m, 8H, CH2(CH2)4), 0.86 (t, J = 6.6 Hz, 3H, CH3); 13C NMR (75 
MHz, acetone-d6) δ 204.9, 143.7, 112.6, 50.1, 37.7, 32.3, 29.3, 27.5, 23.1, 22.3, 14.2.  
HRMS (EI+) exact mass calculated for [M+•]+ (C12H22O) requires m/z 182.1671, found 
m/z 182.1663.  [α]D = +14.5 (c = 1.0, CHCl3).  Enantiopurity was determined by GLC 
using a Varian Chirasil-Dex-CB (25 m x 0.25 mm) column (100 °C isotherm);  (S) 
isomer tr = 35.4 min and (R) isomer tr = 36.1 min.   
 
H Me
O
Ph
 
(R)-2-(2-Phenylallyl)octanal (Table 3, entry 2): Prepared according to the 
general procedure from octanal (156 µL, 1.00 mmol) and trimethyl(2-
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phenylallyl)silane:34 (476 mg, 2.50 mmol) to afford a yellow oil.  Purification on 
Iatrobeads (3–30% Et2O/Pentanes) afforded (R)-2-(2-phenylallyl)octanal as a colorless 
oil (213 mg, 87% yield, 90% ee).  IR (film) 3082, 3057, 3025, 2955, 2929, 2857, 2710, 
1727, 1628, 1600, 1574, 1495, 1456, 1378, 1303, 1076, 1028, 900.6, 778.7, 705.8 cm-1; 
1H NMR (300 MHz, acetone-d6) δ 9.58 (d, J = 2.7 Hz, 1H, CHO), 7.12–7.30 (m, 5H, 
Ph), 5.32 (d, J = 1.3 Hz, 1H, C=CHaHb), 5.13 (q, J = 1.3 Hz, 1H, C=CHaHb), 2.96 (ddd, J 
= 14.6 Hz, 7.4 Hz, 1.3 Hz, 1H, CHOCHCHaHb), 2.63 (ddd, J = 14.6 Hz, 6.9 Hz, 1.1 Hz, 
1H, CHOCHCHaHb), 2.31–2.42 (m, 1H, CHCHO), 1.42–1.68 (m, 2H, CH2(CH2)4), 1.18–
1.34 (m, 8H, CH2(CH2)4), 0.84 (t, J = 7.2 Hz, 3H, CH3); 13C NMR (75 MHz, acetone-d6) 
δ 204.5, 147.0, 141.3, 129.2, 128.4, 127.0, 114.7, 50.4, 35.2, 32.2, 29.9, 29.0, 27.2, 23.1, 
14.2.  HRMS (EI+) exact mass calculated for [M+•]+ (C17H24O) requires m/z 244.1827, 
found m/z 244.1837.  [α]D = +13.4 (c = 1.0, CHCl3).  Enantiopurity was determined by 
SFC analysis after reduction to the primary alcohol. (Chiralcel®OJH 2–5% IPA).  
tR(major) = 5.2 min.  tS(minor) = 6.1 min. 
 
H Me
O
Ph
 
(R)-2-Hexyl-4-phenethyl-pent-4-enal (Table 3, entry 3):  Prepared according to 
the general procedure from octanal (156 µL, 1.00 mmol) and trimethyl(2-methylene-4-
phenylbutyl)silane35 (546 mg, 2.50 mmol) to afford a yellow oil.  Purification on 
                                                
34 Narayanan, B. A.; Bunnelle, W. H. Tetrahedron Lett. 1987, 28, 6261. 
35 Clark, J. S.; Dossetter, A. G.; Wong, Y. S.; Townsend, R. J.; Whittingham, W. G.; Russell, C. A. J. Org. Chem, 
2004, 69, 3886. 
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Iatrobeads (3–30% Et2O/Pentanes) afforded (R)-2-hexyl-4-phenethyl-pent-4-enal as a 
colorless oil (209 mg, 77% yield, 88% ee).  IR (film) 3085, 3027, 2955, 2929, 2857, 
2708, 1727, 1645, 1604, 1496, 1454, 1077, 1031, 895.9, 747.2, 698.7 cm-1; 1H NMR (300 
MHz, acetone-d6) δ 9.57 (d, J = 2.9 Hz, 1H, CHO), 7.13–7.30 (m, 5H, Ph), 4.84 (app. d, 
J = 1.3 Hz, 1H, C=CHaHb), 4.79 (app. d, J = 1.1 Hz, 1H, C=CHaHb), 2.76 (dd, J = 8.2 Hz, 
8.0 Hz, 2H, CH2Ph), 2.14–2.57 (m, 5H, CHCHO, CHCH2C=C, CH2CH2Ph), 1.38–1.68 
(dm, 2H, CH2(CH2)4), 1.20–1.38 (m, 8H, CH2(CH2)4), 0.86 (t, J = 6.9 Hz, 3H, CH3); 13C 
NMR (75 MHz, acetone-d6) δ 204.9, 147.2, 142.7, 129.1, 129.0, 126.5, 112.0, 50.2, 38.3, 
36.1, 34.8, 32.3, 29.4, 27.5, 23.1, 14.2.  HRMS (EI+) exact mass calculated for [M+•]+ 
(C19H28O) requires m/z 272.2140, found m/z 272.2129.  [α]D = +11.6 (c = 1.0, CHCl3).  
Enantiopurity was determined by SFC analysis after reduction to the primary alcohol and 
acylation with 2-naphthoylchloride.  (Chiralpak®ADH 2–25% IPA).  tS(minor) = 7.4 min.  
tR(major) = 7.8 min. 
 
H Me
O
CO2Et
 
(R)-Ethyl 4-formyl-2-methylenedecanoate (Table 3, entry 4):  Prepared 
according to the general procedure from octanal (156 µL, 1.00 mmol) to afford a yellow 
oil.  Purification on Iatrobeads (10–50% Et2O/Pentanes) afforded (R)-ethyl 4-formyl-2-
methylenedecanoate as a colorless oil (194 mg, 81% yield, 90% ee).  IR (film) 2930, 
2858, 2712, 1720, 1630, 1466, 1370, 1302, 1185, 1153, 1027, 948.7, 854.3, 818.8, 724.7 
cm-1; 1H NMR (300 MHz, acetone-d6) δ 9.58 (d, J = 2.7 Hz, 1H, CHO), 6.16 (d, J = 1.3 
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Hz, 1H, C=CHaHb), 5.66 (d, J = 1.3 Hz, 1H, C=CHaHb), 4.16 (q, J = 7.2 Hz, 2H, 
OCH2CH3), 2.64–2.73 (m, 1H, CHaHbC=CH2), 2.47–2.58 (m, 1H, CHCHO), 2.37–2.45 
(m, 1H, CHaHbC=CH2), 1.38–1.72 (dm, 2H, CH2(CH2)4), 1.26 (t, J = 7.2 Hz, 3H, 
OCH2CH3), 1.22–1.36 (m, 8H, CH2(CH2)4), 0.86 (t, J = 6.6 Hz, 3H, CH3); 13C NMR (75 
MHz, acetone-d6) δ 204.3, 166.9, 139.2, 126.9, 61.1, 51.2, 32.2, 31.8, 29.9, 29.2, 27.4, 
23.1, 14.3, 14.2.  HRMS (EI+) exact mass calculated for [M-H]+ (C14H23O3) requires m/z 
239.1647, found m/z 239.1659.  [α]D = +13.0 (c = 1.0, CHCl3).  Enantiopurity was 
determined by achiral GLC after acetal formation with (R,R)-pentanediol and (S,S)-
pentanediol, separately.  Hewlett Packard HP-1 (30 m x 0.32 mm) column (140 °C 
isotherm);  (R,R,R) and (S,S,S) isomer tr = 91.5 min and (R,R,S) and (S,S,R) isomer tr = 
93.7 min. 
Determination of Absolute Stereochemistry 
HO Me
O
 
 (R)-2-Allyloctanoic acid:  To a flask containing (R)-2-allyloctanal (45 mg, 0.267 
mmol, 91% ee) and dissolved in tert-butanol (800 µL) and water (300 µL) at 0 ºC was 
added sodium dihydrogenphosphate hydrate (9.2 mg, 0.067 mmol) followed by 2-methyl-
2-butene (124 µL, 1.17 mmol).  Separately, sodium chlorite (42 mg, 0.374 mmol) was 
dissolved in water (500 µL) and cooled to 0 ºC, and the solution added to the aldehyde 
solution.  The reaction was allowed to warm to ambient temperature over 4 h.  Saturated 
sodium sulfite (1.00 mL) was added and stirred vigorously 5 min.  The reaction was 
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acidified to pH~2, extracted with Et2O (3 x 25 mL), and dried over Na2SO4.  Purification 
by forced flow chromatography on Iatrobeads (5–50% Et2O/Pentanes) afforded a 
colorless oil (31 mg, 63% yield), which corresponded to the reported literature 
compound.36  [α]D = +12.7 (c = 1.0, EtOH), Lit. (S)-2-allyloctanoic acid [α]D = –11.1 (c = 
1.0, EtOH).   
 
HO
O
Me
 
 (R)-2-Allylnonanoic acid:  Prepared according to the oxidation procedure for 
(R)-2-allyloctanoic acid from (R)-2-allylnonanal37 (45 mg, 0.250 mmol, 91% ee). 
Purification by forced flow chromatography on Iatrobeads (5–50% Et2O/Pentanes) 
afforded a colorless oil (37 mg, 76% yield).  Spectral data for the title compound matched 
the reported literature compound.38  [α]D = +5.99 (c = 1.0, CHCl3), Lit. (S)-2-
allylnonanoic acid [α]D = –8.1 (c = 2.78, CHCl3).   
 
 
 
                                                
36 Hasegawa, T.; Yamamoto, H. Bull. Chem. Soc. Jpn. 2000, 73, 423. 
37 (R)-2-Allylnonanal was prepared according to the general procedure from nonanal (132 mg, 73% yield, 91% ee). 
38 Expósito, A.; Fernández-Suárez, M.; Iglesias, T.; Muñoz, L.; Riguera, R. J. Org. Chem. 2001, 66, 4206. 
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HO
O NBoc
 
 (S)-2-(1-tert-Butoxycarbonyl)piperidin-4-yl)pent-4-enoic acid: Prepared 
according to the oxidation procedure for (R)-2-allyloctanoic acid from tert-butyl 4-((S)-1-
formylbut-3-enyl)piperidine-1-carboxylate (52 mg, 0.194 mmol, 93% ee).  The reaction 
was extracted with EtOAc (3 x 25 mL) in place of Et2O (40 mg, 73% yield).  IR (film) 
3073, 2977, 2934, 2861, 1733, 1659, 1428, 1367, 1282, 1249, 1167, 1138, 993.8, 916.7, 
866.4, 766.3 cm-1; 1H NMR (400 MHz, acetone-d6) δ 5.74–5.85 (m, 1H, CH=CH2), 4.96–
5.10 (m, 2H, CH=CH2), 4.08 (bs, 2H, (CHaHb)2NBoc), 2.67 (bs, 2H, (CHaHb)2NBoc), 
2.24–2.38 (m, 3H, CHCH2CH, CHCHO), 1.58–1.80 (m, 3H, (CHaHbCH2)2NBoc, 
CHCHCHO), 1.41 (s, 9H, (CH3)3), 1.10–1.32 (m, 2H, (CHaHbCH2)2NBoc); 13C NMR 
(Bruker Avance II 500, APT experiment, 125 MHz, acetone-d6) δ 176.2, 155.8, 137.8, 
117.6, 80.1, 52.1, 39.6, 35.1, 31.4, 29.4.  HRMS (FAB+) exact mass calculated for 
[M+H]+ (C15H26NO4) requires m/z 284.1862, found m/z 284.1872. [α]D = +12.23 (c = 1.0, 
EtOH). 
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HO
O NBoc
N
O NBoc
O
O
Bn
N
O NBoc
O
O
Bn
HO
O NBoc
i) pivaloyl chloride, TEA, THF
ii) (R)-4-benzyloxazolidin-2-one,
LiCl
i) NaHMDS, THF, –78 ºC
ii) allylbromide, –20 ºC
LiOH, H2O2, 0 ºC
14
15
16 17  
 (R)-2-(1-tert-Butoxycarbonyl)piperidin-4-yl)pent-4-enoic acid: tert-Butyl 4-
(formylmethyl)piperidine-1-carboxylate31 (500 mg, 2.2 mmol) was converted to the 
corresponding carboxylic acid 14 using the procedure described for (R)-2-allyloctanoic 
acid (473 mg, 88% yield).   
The carboxylic acid 14 was converted to the 4-[2-((R)-4-benzyl-2-oxo-oxazolidin-
3-yl)-2-oxo-ethyl]-piperidine-1-carboxylic acid tert-butyl ester 15 in like manner as 
described by Fuwa et al.39  The carboxylic acid 14 (217 mg, 0.89 mmol) was dissolved in 
dry THF (7.0 mL) and TEA (248 µL, 1.78 mmol) and cooled to –78 ºC.  Pivaloyl 
chloride (132 µL, 1.07 mmol) was added and the reaction was gradually warmed to 0 ºC 
over 90 min.  (R)-4-benzyloxazolidin-2-one (158 mg, 0.89 mmol) was added followed by 
lithium chloride (113 mg, 2.67 mmol) and the reaction was warmed to ambient 
temperature and stirred overnight.  The reaction was diluted with ethyl acetate (EtOAc) 
(25 mL) and washed with water (10 mL), brine (10 mL), dried over Na2SO4, filtered and 
concentrated in vacuo.  Purification by forced flow chromatography (silica gel, 10–50% 
EtOAc/Hexanes) afforded 15 (215 mg, 60% yield). 
                                                
39 Fuwa, H.; Okamura, Y.; Natsugari, H. Tetrahedron 2004, 60, 5341. 
                                                    113 
Allylation of 15 was performed in like manner to Evans et al.40  15 (172 mg, 
0.427 mmol) was dissolved in THF (4 mL) and cooled to –78 ºC. NaN(SiMe3)2 (641 µL, 
0.64 mmol) was added and the reaction was stirred for 1 h.  Allylbromide (145 µL, 1.71 
mmol) was then added and the reaction was warmed to –20 ºC over 6 h.  A saturated 
NH4Cl solution (5 mL) was added and the reaction stirred overnight.  The reaction was 
diluted with EtOAc (25 mL) and washed with saturated aqueous NH4Cl (10 mL), and 
brine (10 mL), dried over Na2SO4, filtered and concentrated in vacuo.  Purification by 
forced flow chromatography (silica gel, 5–50% EtOAc/hexanes) afforded 4-[(R)-1-((R)-
4-benzyl-2-oxo-oxazolidine-3-carbonyl)-but-3-enyl]-piperidine-1-carboxylic acid tert-
butyl ester 16 (60 mg, 32% yield). 
The allylated oxazolidinone 16 was converted to the title compound 17 in like 
manner to the method of Stončius, et al.41  16 (40 mg, 0.09 mmol) was dissolved in THF 
(1 mL) and cooled to 0 ºC.  H2O2 (30% aqueous, 44 µL, 0.39 mmol) was added dropwise 
followed by a solution of LiOH hydrate (8.4 mg, 0.20 mmol) in water (500 µL).  Stirring 
was continued at 0 ºC for 3 h.  Saturated Na2SO3 (500 µL) and saturated NaHCO3 (500 
µL) aqueous solutions were added and the mixture stirred vigorously allowing to warm to 
ambient temperature overnight.   The reaction was acidified with 1N HCl to pH~2, and 
extracted with EtOAc (3 x 10 mL), dried over Na2SO4, filtered and concentrated in vacuo 
to afford the title compound 17 (20 mg, 80% yield).  Spectral data was identical to the 
(S)-enantiomer synthesized above.  [α]D = –11.07 (c = 1.0, EtOH). 
 
                                                
40 Evans, D. A.; Ennis, M. D.; Mathre, D. J. J. Am. Chem. Soc. 1982, 104, 1737. 
41 Stončius,  A.; Nahrwold, M.; Sewald N. Synthesis 2005, 11, 1829. 
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H Me
O
OMe
O2NO
 
2-((E)-4-methoxy-5-nitrooxy-5-phenylpent-2-enyl)octanal:  Prepared according 
to the general procedure, in acetone-d6 with water (18mg, 1.0 mmol), from octanal (78 µl, 
0.5 mmol) and (trans, trans-2-methoxy-3-phenylcyclopropyl)ethylene26 to afford a 
yellow oil.  Purification on Iatrobeads (5-50% Et2O/Pentanes) afforded 2-((E)-4-
methoxy-5-nitrooxy-5-phenylpent-2-enyl)octanal as a colorless oil.  The product obtained 
is a 2:1:1:0.5 mixture of diastereomers.  Data reported for the major diastereomer only.  
1H NMR (400 MHz, acetone-d6) δ 9.59 (d, 1H, J = 2.4 Hz, CHO), 7.26–7.44 (m, 5H, Ph), 
5.94 (d, 1H, J = 5.2, Hz, CHONO2), 5.66–5.73 (m, 1H, CH=CH), 5.35–5.42 (m, 1H, 
CH=CH), 4.04–4.09 (m, 1H, CH-OMe), 3.21 (s, 3H, OCH3), 2.36–2.46 (m, 3H, 
CHCHO, CH2CH=CH), 1.29–1.66 (m, 10H, (CH2)5CH3) 0.87–0.89 (m, 3H, CH3); 13C 
NMR (150 MHz, acetone-d6) δ 205.3, 135.9, 130.29, 130.0, 129.7, 129.4, 129.1, 87.5, 
83.9, 57.2, 52.3, 34.7, 32.8, 32.5, 30.0, 28.0, 23.8, 14.9. 
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Table 5.  Effect of Co-catalyst on the α-Allylation Reaction 
TfOH
HClO4
HCl
MsOH
pTSA
TFA
DCA
AcOH
4-NO2-Phenol
entry
1
2
3
4
5
6
7
8
9
56
75
74
74
74
74
74
74
75
% eeb
50
49
36
44
47
46
42
40
40
% conversionaCo-catalyst
20 mol% 1
2 equiv. CAN
acetone, +4 ºC, 3 h
O
H
O
H
n-Hex
–14
–10
–6.1
–2.6
–1.3
0.52
1.4
4.8
7.1
pKa
n-Hex
1 equiv. 2.0 equiv.
TMS
 
(a) Conversion determined by GLC analysis relative to an internal 
standard (methyl cyclohexanecarboxylate).  (b) Enantiomeric excess 
determined by GLC analysis (Varian Chirasil-Dex-CB). 
 
Table 6. Effect of Catalyst Architecture on the α-Allylation Reaction 
entry
1
1
3
4
2
6
7
3
catalyst
2.5 equiv. CAN
acetone, –20 ºC
O
H
O
H
n-Hex
resultsa
n-Hex
1 equiv. 2.5 equiv.
TMS
N
N
H
t-BuBn
O Me
entry
1
6
3
4
7
6
7
8
56% conv.
21% ee
34% conv.
13% ee
69% conv.
80% ee
resultsa
23% conv.
46% ee
26% conv.
38% ee
N
N
H
R2R1
O Me
20 mol%
•TFA
catalyst
N
N
H
t-Bu
O Me
HN
N
N
H
t-Bu
O Me
N
Bn
N
N
H
Bn
O Me
Me
Me
N
N
H
Bn
O Me
O
Me
N
N
H
t-Bu
O Me
54% conv.
78% ee
 
(a) After 18 h.  Conversion determined by GLC analysis relative to an internal standard (methyl 
cyclohexanecarboxylate).  Enantiomeric excess determined by GLC analysis (Varian Chirasil-Dex-CB). 
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Table 7.  Effect of Catalyst Architecture on the α-Allylation Reaction 
entrya
1
1
3
4
2
6
7
3
9
9
4
9
9
5
catalyst
2.5 equiv. CAN
acetone, 4 h
O
H
O
H
n-Hex
+4 ºC
n-Hex
1 equiv. 2.5 equiv.
TMS
N
N
H
t-BuBn
O Me
N
N
H
MeBn
O Me
Me
N
N
H
t-BuMe
O Me
N
N
H
PhBn
O Me
N
N
H
Ph
O Me
N
N
H
t-BuBn
O Me
N
N
H
Bn
O Me
N
N
H
PhPh
O Me
N
N
H
MeMe
O Me
Me
N
N
H
MePh
O Me
Me
entrya
1
6
3
4
7
6
7
8
9
9
9
9
9
10
catalyst +23 ºC
6% conv.
84% ee
13% conv.
82% ee
31% conv.
61% ee
15% conv.
61% ee
7% conv.
64% ee
4% conv.
56% ee
23% conv.
65% ee
58% conv.
74% ee
+23 ºC
5% conv.
69% ee
12% conv.
76% ee
32% conv.
68% ee
+4 ºC
3% conv.
81% ee
17% conv.
71% ee
10% conv.
44% ee
10% conv.
43% ee
6% conv.
81% ee
N
N
H
R2R1
O Me
20 mol%
•TFA
R3
 
(a) Conversion determined by GLC analysis relative to an internal standard (methyl cyclohexanecarboxylate).  
Enantiomeric excess determined by GLC analysis (Varian Chirasil-Dex-CB).  (b) After 4 h. 
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Table 8.  Steric and Electronic Effects of the Allylsilane Component 
SiMe3
SiMe2Cl
SiMe2CH2Cl
SiMe2p-OMePh
Si(i-Pr)3
SiPh3
SiCl3
Si(OMe)3
Si(OEt)3
entry
1
2
3
4
5
6
7
8
9
74
11
71
71
–
37
–
54
86
% eeb
64
3
26
58
trace
12
0
5
23
% conversionaR
20 mol% 1
2.5 equiv. CAN
acetone, +4 ºC
O
H
O
H
n-Hexn-Hex
1 equiv. 2.5 equiv.
R
 
(a) After 2 h.  Conversion determined by GLC analysis relative to an 
internal standard (methyl cyclohexanecarboxylate).  (b) Enantiomeric 
excess determined by GLC analysis (Varian Chirasil-Dex-CB). 
 
Table 9.  Effect of Solvent with Water on the α-Allylation Reaction 
DME
THF
Et2O
EtOAc
DCM
CHCl3
DMF
entry
1
2
3
4
5
6
7
93
83
86
82
66
70
69
% eeb
64
80
23
53
32
18
6
% conversionasolvent (0.25M)
20 mol% 1
4 equiv. H2O
 –20 ºC, 24 h
O
H
O
H
n-Hexn-Hex
1 equiv. 2.5 equiv.
TMS
CAN, NaHCO3
 
(a) Conversion determined by GLC analysis relative to an internal 
standard (methyl cyclohexanecarboxylate).  (b) Enantiomeric excess 
determined by GLC analysis (Varian Chirasil-Dex-CB). 
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Table 10.  Effect of Base Additive on the α-Allylation Reaction 
None
NaHCO3
NaHCO3
DTBP
DTBP
entry
1
2
3
4
5
90
94
93
92
92
% eeb
27
75
50
36
37
% conversionabase
20 mol% 1
2.5 equiv. CAN
DME, –20 ºC
O
H
O
H
1 equiv. 2.5 equiv.
R
–
1.5
3.0
1.5
3.0
equiv.
 
(a) After 24 h.  Conversion determined by GLC analysis relative to an 
internal standard (methyl cyclohexanecarboxylate).  (b) Enantiomeric 
excess determined by GLC analysis (Varian Chirasil-Dex-CB). 
 
